conceptID,concept,rank,PMID
,validity,1,8619104
,ischaemic,1,8619104
,ischaemic heart disease,1,8619104
,heart,1,8619104
,heart disease,1,8619104
,disease,2,8619104
,chronic,1,8619104
,chronic obstructive pulmonary disease,1,8619104
,obstructive pulmonary disease,1,8619104
,pulmonary,1,8619104
,pulmonary disease,1,8619104
,saskatchewan,1,8619104
,health,1,8619104
,health care,1,8619104
,care,1,8619104
,internal,1,8619104
,validity,1,8619104
,information,2,8619104
,ischaemic,1,8619104
,ischaemic heart disease,1,8619104
,heart,1,8619104
,heart disease,1,8619104
,disease,2,8619104
,chronic,2,8619104
,chronic obstructive pulmonary disease,1,8619104
,obstructive pulmonary disease,1,8619104
,pulmonary,1,8619104
,pulmonary disease,1,8619104
,copd,3,8619104
,administrative,1,8619104
,administrative health care,1,8619104
,health,1,8619104
,health care,1,8619104
,care,1,8619104
,canadian,1,8619104
,province,1,8619104
,saskatchewan,1,8619104
,comparisons,1,8619104
,hospital,1,8619104
,data,1,8619104
,medical,1,8619104
,charts,1,8619104
,acute,1,8619104
,acute myocardial infarction,1,8619104
,myocardial,1,8619104
,myocardial infarction,1,8619104
,infarction,1,8619104
,chronic airways obstruction,1,8619104
,airways,1,8619104
,airways obstruction,1,8619104
,obstruction,1,8619104
,patients,1,8619104
,excellent,1,8619104
,diagnostic,1,8619104
,agreement,1,8619104
,cent,7,8619104
,physician,2,8619104
,physician service,1,8619104
,service,1,8619104
,hospitalizations,2,8619104
,ihd,4,8619104
,exact,1,8619104
,concordance,2,8619104
,diagnoses,1,8619104
,asthma,1,8619104
,diagnosis,1,8619104
,same,1,8619104
,broad,1,8619104
,category,1,8619104
,cop,1,8619104
,epidemiologically,1,8619104
,trial,1,8551821
,intravenous,1,8551821
,diltiazem,1,8551821
,glyceryl trinitrate,1,8551821
,unstable,1,8551821
,unstable angina,1,8551821
,unstable angina pectoris,1,8551821
,angina,1,8551821
,angina pectoris,1,8551821
,effect,2,8551821
,dihydropyridines,1,8551821
,patients,6,8551821
,unstable,3,8551821
,unstable angina,1,8551821
,angina,7,8551821
,out,1,8551821
,diltiazem,9,8551821
,trial,2,8551821
,glyceryl trinitrate,4,8551821
,intravenously,1,8551821
,ang,2,8551821
,endpoints,1,8551821
,refractory,6,8551821
,refractory angina,6,8551821
,myocardial,4,8551821
,myocardial infarction,4,8551821
,infarction,4,8551821
,individually,1,8551821
,composite,1,8551821
,endpoint,1,8551821
,alone,1,8551821
,together,1,8551821
,significantly,5,8551821
,less,2,8551821
,group,7,8551821
,trial drugs,1,8551821
,drugs,2,8551821
,numbers,2,8551821
,relative,5,8551821
,relative risk,5,8551821
,risk,5,8551821
,number,1,8551821
,better,1,8551821
,survival,1,8551821
,pressure,1,8551821
,product,1,8551821
,only,1,8551821
,incidence,1,8551821
,bradyarrhythmias,1,8551821
,not,2,8551821
,atrioventricular conduction,1,8551821
,conduction,1,8551821
,conduction disturbances,1,8551821
,disturbances,2,8551821
,dose,2,8551821
,drug,1,8551821
,temporary,1,8551821
,temporary pacemakers,1,8551821
,pacemakers,1,8551821
,headache,1,8551821
,analgesic,1,8551821
,dose adjustment,1,8551821
,adjustment,1,8551821
,results,1,8551821
,intravenous,2,8551821
,ischaemic,1,8551821
,events,1,8551821
,clinical,1,7477219
,clinical trial,1,7477219
,trial,1,7477219
,inhibitor,1,7477219
,trandolapril,2,7477219
,patients,1,7477219
,left,1,7477219
,left ventricular dysfunction,1,7477219
,ventricular,1,7477219
,ventricular dysfunction,1,7477219
,dysfunction,1,7477219
,myocardial,1,7477219
,myocardial infarction,1,7477219
,infarction,1,7477219
,cardiac,1,7477219
,cardiac evaluation,1,7477219
,evaluation,1,7477219
,trace,1,7477219
,study,1,7477219
,group,1,7477219
,background,1,7477219
,treatment,2,7477219
,ace,3,7477219
,inhibitors,2,7477219
,mortality,4,7477219
,survivors,1,7477219
,acute,1,7477219
,acute myocardial infarction,1,7477219
,myocardial,5,7477219
,myocardial infarction,4,7477219
,infarction,5,7477219
,ace inhibitors,1,7477219
,patients,9,7477219
,only,1,7477219
,uncertain,1,7477219
,methods,1,7477219
,consecutive,2,7477219
,myocardial infarctions,1,7477219
,infarctions,1,7477219
,enzyme,1,7477219
,studies,1,7477219
,total,1,7477219
,echocardiographic,1,7477219
,evidence,1,7477219
,ventricular,2,7477219
,ventricular systolic,1,7477219
,systolic,1,7477219
,systolic dysfunction,1,7477219
,dysfunction,1,7477219
,fraction,1,7477219
,percent,9,7477219
,days,1,7477219
,oral,1,7477219
,trandolapril,6,7477219
,placebo,3,7477219
,duration,1,7477219
,followup,1,7477219
,months,1,7477219
,results,1,7477219
,study,2,7477219
,period,1,7477219
,group,5,7477219
,relative,5,7477219
,relative risk,5,7477219
,risk,8,7477219
,death,4,7477219
,confidence,5,7477219
,confidence interval,5,7477219
,interval,5,7477219
,cardiovascular,2,7477219
,causes,2,7477219
,sudden,2,7477219
,sudden death,2,7477219
,progression,1,7477219
,severe,2,7477219
,heart,2,7477219
,heart failure,2,7477219
,failure,2,7477219
,less,1,7477219
,frequent,1,7477219
,contrast,1,7477219
,recurrent,1,7477219
,recurrent myocardial infarction,1,7477219
,fatal,1,7477219
,not,1,7477219
,not significantly,1,7477219
,significantly,2,7477219
,conclusions,1,7477219
,reduced,1,7477219
,left,1,7477219
,left ventricular function,1,7477219
,ventricular function,1,7477219
,function,1,7477219
,overall,1,7477219
,development,1,7477219
,randomized,1,7477219
,use,1,7477219
,inhibition,1,7477219
,ethnic,1,7500535
,ethnic differences,1,7500535
,differences,1,7500535
,use,1,7500535
,peritoneal,1,7500535
,peritoneal dialysis,1,7500535
,dialysis,1,7500535
,initial,1,7500535
,treatment,1,7500535
,renal,1,7500535
,renal disease,1,7500535
,disease,1,7500535
,objective,1,7500535
,ethnicity,2,7500535
,use,3,7500535
,peritoneal,1,7500535
,peritoneal dialysis,1,7500535
,dialysis,2,7500535
,initial,4,7500535
,treatment,4,7500535
,renal,1,7500535
,renal disease,1,7500535
,disease,1,7500535
,esrd,4,7500535
,other,1,7500535
,patient,1,7500535
,patient characteristics,1,7500535
,characteristics,1,7500535
,design,1,7500535
,cohort,1,7500535
,cohort analysis,1,7500535
,analysis,1,7500535
,incident,1,7500535
,patients,4,7500535
,white,1,7500535
,dialysis centers,1,7500535
,centers,1,7500535
,north,1,7500535
,north carolina,1,7500535
,south,1,7500535
,south carolina,1,7500535
,georgia,1,7500535
,network,1,7500535
,january,1,7500535
,december,1,7500535
,main,1,7500535
,outcome,1,7500535
,outcome measure,1,7500535
,measure,1,7500535
,odds ratios,1,7500535
,ratios,1,7500535
,ors,1,7500535
,association,1,7500535
,modality,1,7500535
,results,1,7500535
,less,1,7500535
,likely,1,7500535
,whites,1,7500535
,confidence,1,7500535
,confidence interval,1,7500535
,interval,1,7500535
,difference,1,7500535
,adjustment,1,7500535
,age,1,7500535
,education,1,7500535
,social,1,7500535
,social support,1,7500535
,support,1,7500535
,home,1,7500535
,ownership,1,7500535
,functional,1,7500535
,functional status,1,7500535
,status,1,7500535
,level,1,7500535
,hypertension,1,7500535
,history,1,7500535
,myocardial,1,7500535
,myocardial infarction,1,7500535
,infarction,1,7500535
,peripheral,1,7500535
,peripheral neuropathy,1,7500535
,neuropathy,1,7500535
,diabetes,1,7500535
,conclusions,1,7500535
,ethnic,1,7500535
,ethnic differences,1,7500535
,differences,1,7500535
,many,1,7500535
,demographic,1,7500535
,socioeconomic,1,7500535
,factors,1,7500535
,coronary,1,7500756
,coronary artery,1,7500756
,coronary artery bypass,1,7500756
,coronary artery bypass surgery,1,7500756
,artery,1,7500756
,bypass,1,7500756
,bypass surgery,1,7500756
,surgery,1,7500756
,study,1,7500756
,consecutive,1,7500756
,patients,1,7500756
,ontario,2,7500756
,steering,1,7500756
,steering committee,1,7500756
,committee,1,7500756
,adult,1,7500756
,cardiac,1,7500756
,network,1,7500756
,deaths,1,7500756
,coronary,2,7500756
,surgery,8,7500756
,canada,1,7500756
,american,1,7500756
,interest,1,7500756
,interest groups,1,7500756
,groups,1,7500756
,socialized,1,7500756
,socialized medicine,1,7500756
,medicine,1,7500756
,cardiac,1,7500756
,cardiac surgery,1,7500756
,centres,1,7500756
,ontario,2,7500756
,register,1,7500756
,patients,6,7500756
,experience,1,7500756
,consecutive,1,7500756
,registry,1,7500756
,october,1,7500756
,july,1,7500756
,individual,2,7500756
,acuity,5,7500756
,scores,2,7500756
,symptoms,2,7500756
,angiographic,1,7500756
,findings,1,7500756
,ventricular,1,7500756
,ventricular function,1,7500756
,function,1,7500756
,available,1,7500756
,noninvasive,1,7500756
,tests,1,7500756
,ischaemic,1,7500756
,queue,2,7500756
,indefinitely,1,7500756
,myocardial,1,7500756
,myocardial infarction,1,7500756
,infarction,1,7500756
,median,1,7500756
,wait,1,7500756
,days,2,7500756
,interquartile range,1,7500756
,range,1,7500756
,day,1,7500756
,very,2,7500756
,urgent,1,7500756
,score,2,7500756
,low,1,7500756
,priority,1,7500756
,multivariate analysis,1,7500756
,analysis,1,7500756
,most,1,7500756
,determinant,1,7500756
,time,2,7500756
,symptom,1,7500756
,symptom status,1,7500756
,status,1,7500756
,anatomy,1,7500756
,age,1,7500756
,not,2,7500756
,statistical,1,7500756
,statistical methods,1,7500756
,methods,1,7500756
,female,1,7500756
,female sex,1,7500756
,sex,1,7500756
,either,1,7500756
,not significant,1,7500756
,significant,2,7500756
,independently,1,7500756
,approximately,1,7500756
,relative,1,7500756
,delay,1,7500756
,clinical,2,7500756
,factors,1,7500756
,times,3,7500756
,hospitals,2,7500756
,rarely,1,7500756
,critical,1,7500756
,events,1,7500756
,extreme,1,7500756
,variation,1,7500756
,exertion,1,7500756
,effect,1,7500749
,different,1,7500749
,progestagens,1,7500749
,low,1,7500749
,low oestrogen,1,7500749
,oestrogen,1,7500749
,oral,1,7500749
,oral contraceptives,1,7500749
,contraceptives,1,7500749
,venous,1,7500749
,venous thromboembolic,1,7500749
,venous thromboembolic disease,1,7500749
,thromboembolic,1,7500749
,thromboembolic disease,1,7500749
,disease,2,7500749
,world,1,7500749
,world health,1,7500749
,world health organization,1,7500749
,health,1,7500749
,health organization,1,7500749
,organization,1,7500749
,collaborative,1,7500749
,collaborative study,1,7500749
,study,1,7500749
,cardiovascular,1,7500749
,cardiovascular disease,1,7500749
,steroid,1,7500749
,steroid hormone,1,7500749
,hormone,1,7500749
,contraception,1,7500749
,study,2,7500749
,risk,6,7500749
,venous,2,7500749
,venous thromboembolic,1,7500749
,venous thromboembolic disease,1,7500749
,thromboembolic,1,7500749
,thromboembolic disease,1,7500749
,disease,2,7500749
,oral,1,7500749
,oral contraceptives,1,7500749
,contraceptives,1,7500749
,separate,1,7500749
,inquiry,1,7500749
,venous thromboembolism,1,7500749
,thromboembolism,1,7500749
,low,3,7500749
,low oestrogen,3,7500749
,oestrogen,3,7500749
,micrograms,1,7500749
,ethinyloestradiol,1,7500749
,levonorgestrel,7,7500749
,risks,2,7500749
,preparations,1,7500749
,progestagens,3,7500749
,desogestrel,6,7500749
,gestodene,7,7500749
,analysis,1,7500749
,data,1,7500749
,countries,1,7500749
,cases,5,7500749
,age,2,7500749
,hospital,1,7500749
,controls,4,7500749
,centre,2,7500749
,community,1,7500749
,general,1,7500749
,general practice,1,7500749
,practice,1,7500749
,current,4,7500749
,users,5,7500749
,odds ratio,1,7500749
,ratio,1,7500749
,confidence,1,7500749
,confidence interval,1,7500749
,interval,1,7500749
,reference,1,7500749
,ratios,1,7500749
,products,1,7500749
,body,1,7500749
,body mass,1,7500749
,body mass index,1,7500749
,mass,1,7500749
,index,1,7500749
,bmi,1,7500749
,dose,1,7500749
,vte,1,7500749
,results,2,7500749
,secondary,1,7500749
,study objective,1,7500749
,objective,1,7500749
,due,1,7500749
,chance,1,7500749
,bias,1,7500749
,residual,1,7500749
,independent,1,7500749
,studies,1,7500749
,variance,1,7500749
,apparently,1,7500749
,more,1,7500749
,metabolic,1,7500749
,metabolic effects,1,7500749
,effects,1,7500749
,new,1,7500749
,lower,1,7500749
,arterial,1,7500749
,arterial disease,1,7500749
,stroke,1,7500749
,myocardial,1,7500749
,myocardial infarction,1,7500749
,infarction,1,7500749
,further,1,7500749
,risk,1,8747258
,myocardial,1,8747258
,myocardial infarction,1,8747258
,infarction,1,8747258
,subjects,1,8747258
,doctor,1,8747258
,back,1,8747258
,back disorder,1,8747258
,disorder,1,8747258
,study,1,8747258
,finnish,1,8747258
,farmers,1,8747258
,study,3,8747258
,study design,1,8747258
,design,1,8747258
,correlation,1,8747258
,back,9,8747258
,back trouble,2,8747258
,myocardial,6,8747258
,myocardial infarction,6,8747258
,infarction,6,8747258
,objectives,1,8747258
,purpose,1,8747258
,present,1,8747258
,individuals,2,8747258
,doctor,4,8747258
,risk,2,8747258
,summary,1,8747258
,background,1,8747258
,data,1,8747258
,previous,2,8747258
,results,3,8747258
,back pain,4,8747258
,pain,4,8747258
,young,1,8747258
,male,1,8747258
,farmers,2,8747258
,patients,1,8747258
,methods,1,8747258
,basic,1,8747258
,cohort,1,8747258
,finnish,1,8747258
,february,2,8747258
,december,1,8747258
,case,6,8747258
,case studies,1,8747258
,studies,1,8747258
,control,4,8747258
,subjects,7,8747258
,case subject,2,8747258
,subject,2,8747258
,final,1,8747258
,group,1,8747258
,case subjects,3,8747258
,doctor visits,1,8747258
,visits,1,8747258
,complaint,2,8747258
,followup,2,8747258
,period,2,8747258
,date,1,8747258
,back disorders,1,8747258
,disorders,1,8747258
,true,1,8747258
,nonspecific,1,8747258
,odds ratio,1,8747258
,ratio,1,8747258
,confidence,1,8747258
,confidence interval,1,8747258
,interval,1,8747258
,conclusion,1,8747258
,atherosclerosis,1,8747258
,not,1,8747258
,probable,1,8747258
,cause,1,8747258
,kind,1,8747258
,general,1,8747258
,general practitioner,1,8747258
,practitioner,1,8747258
,31p,1,8521576
,nuclear,1,8521576
,nuclear magnetic resonance,1,8521576
,nuclear magnetic resonance spectroscopic,1,8521576
,magnetic,1,8521576
,magnetic resonance,1,8521576
,magnetic resonance spectroscopic,1,8521576
,magnetic resonance spectroscopic imaging,1,8521576
,resonance,1,8521576
,imaging,1,8521576
,regions,1,8521576
,myocardium,1,8521576
,infarcted,1,8521576
,rat,1,8521576
,rat heart,1,8521576
,heart,1,8521576
,background,1,8521576
,clinical,1,8521576
,clinical course,1,8521576
,course,1,8521576
,patient,1,8521576
,myocardial,1,8521576
,myocardial infarction,1,8521576
,infarction,2,8521576
,ability,1,8521576
,region,2,8521576
,loss,1,8521576
,infarcted,1,8521576
,previous,1,8521576
,studies,1,8521576
,viable,6,8521576
,myocardium,8,8521576
,morphologically,1,8521576
,functionally,1,8521576
,biochemically,1,8521576
,purpose,1,8521576
,study,1,8521576
,regional,2,8521576
,distribution,2,8521576
,biochemical,2,8521576
,remodeling,2,8521576
,rat,2,8521576
,rat hearts,2,8521576
,hearts,3,8521576
,use,1,8521576
,technique,1,8521576
,noninvasively,1,8521576
,human,1,8521576
,human subjects,1,8521576
,subjects,1,8521576
,methods,1,8521576
,results,1,8521576
,infarcts,1,8521576
,left,1,8521576
,left ventricular apex,1,8521576
,ventricular,1,8521576
,apex,1,8521576
,anterolateral,1,8521576
,wall,1,8521576
,coronary,1,8521576
,coronary artery,1,8521576
,artery,1,8521576
,weeks,1,8521576
,chemical,1,8521576
,shift,1,8521576
,31p,4,8521576
,nuclear,1,8521576
,nuclear magnetic resonance,1,8521576
,magnetic,1,8521576
,magnetic resonance,1,8521576
,resonance,1,8521576
,spectra,1,8521576
,long,1,8521576
,long axis,1,8521576
,axis,1,8521576
,base,1,8521576
,atp,5,8521576
,phosphocreatine,1,8521576
,contents,1,8521576
,normal,1,8521576
,sham,1,8521576
,mass,4,8521576
,slice,3,8521576
,calculations,1,8521576
,metabolite,1,8521576
,amount,4,8521576
,unit,3,8521576
,hypertrophy,3,8521576
,not,1,8521576
,scar,3,8521576
,tissue,6,8521576
,contrast,2,8521576
,less,1,8521576
,signal,4,8521576
,distal,1,8521576
,occlusion,2,8521576
,scar tissue,1,8521576
,signal intensity,2,8521576
,intensity,2,8521576
,proximal,1,8521576
,myocyte,1,8521576
,direct,1,8521576
,proportion,1,8521576
,same,1,8521576
,pcr,3,8521576
,decrease,2,8521576
,uniform,1,8521576
,infarct,2,8521576
,size,2,8521576
,parallels,1,8521576
,similar,1,8521576
,creatine,1,8521576
,content,1,8521576
,conclusions,1,8521576
,postmi,1,8521576
,independent,1,8521576
,distance,1,8521576
,profile,1,8521576
,biochemical marker,1,8521576
,marker,3,8521576
,morphological,1,8521576
,regions,1,8521576
,tissue injury,1,8521576
,injury,2,8521576
,decreased,1,8521576
,extent,1,8521576
,response,1,8521576
,single,1,8521576
,set,1,8521576
,noninvasive,1,8521576
,measurements,1,8521576
,catheter,1,8521570
,catheter ablation,1,8521570
,ablation,1,8521570
,mitral,1,8521570
,isthmus,1,8521570
,ventricular,1,8521570
,ventricular tachycardia,1,8521570
,tachycardia,1,8521570
,inferior,1,8521570
,inferior infarction,1,8521570
,infarction,1,8521570
,background,1,8521570
,intraoperative,1,8521570
,mapping,1,8521570
,studies,1,8521570
,isthmus,4,8521570
,myocardium,1,8521570
,mitral,4,8521570
,mitral valve,1,8521570
,mitral valve annulus,1,8521570
,valve,1,8521570
,annulus,1,8521570
,border,1,8521570
,inferior,3,8521570
,inferior myocardial infarction,2,8521570
,myocardial,2,8521570
,myocardial infarction,2,8521570
,infarction,3,8521570
,role,1,8521570
,genesis,1,8521570
,ventricular,3,8521570
,ventricular tachycardia,3,8521570
,tachycardia,7,8521570
,frequency,1,8521570
,slow,5,8521570
,conduction,5,8521570
,zone,3,8521570
,critical,3,8521570
,maintenance,1,8521570
,remote,1,8521570
,inferior infarction,1,8521570
,patients,4,8521570
,catheter,2,8521570
,catheter ablation,2,8521570
,ablation,2,8521570
,methods,1,8521570
,results,1,8521570
,characteristic,2,8521570
,morphologically,1,8521570
,distinct,1,8521570
,tachycardias,1,8521570
,left,1,8521570
,superior,2,8521570
,superior axis,1,8521570
,axis,1,8521570
,morphology,2,8521570
,right,2,8521570
,right superior,1,8521570
,cycle,3,8521570
,length,3,8521570
,patient,3,8521570
,diastolic,1,8521570
,potentials,1,8521570
,intervals,2,8521570
,fusion,1,8521570
,pacing,1,8521570
,single,1,8521570
,radiofrequency,1,8521570
,energy,1,8521570
,application,1,8521570
,site,1,8521570
,followup,1,8521570
,months,1,8521570
,recurrent,1,8521570
,conclusions,1,8521570
,region,1,8521570
,anatomically,1,8521570
,localized,1,8521570
,target,1,8521570
,clinical,1,8521570
,clinical markers,1,8521570
,markers,1,8521570
,mechanism,1,8521570
,evaluation,1,8521562
,central,1,8521562
,effects,1,8521562
,atenolol,1,8521562
,metoprolol,1,8521562
,heart,1,8521562
,heart rate,1,8521562
,rate,1,8521562
,variability,1,8521562
,mental,1,8521562
,performance,1,8521562
,physical,1,8521562
,physical exercise,1,8521562
,exercise,1,8521562
,daily,1,8521562
,life,1,8521562
,stable,1,8521562
,patients,1,8521562
,background,1,8521562
,physical,2,8521562
,physical exercise,1,8521562
,exercise,3,8521562
,mental,5,8521562
,work,1,8521562
,cause,1,8521562
,alterations,1,8521562
,cardiac,1,8521562
,autonomic,2,8521562
,control,1,8521562
,heart,2,8521562
,stress,2,8521562
,effect,1,8521562
,part,1,8521562
,context,1,8521562
,lipophilicity,2,8521562
,drug,1,8521562
,relevant,1,8521562
,methods,1,8521562
,results,1,8521562
,thirty,1,8521562
,patients,3,8521562
,metoprolol,6,8521562
,crossover,1,8521562
,period,1,8521562
,heart rate,1,8521562
,rate,1,8521562
,variability,5,8521562
,study,2,8521562
,autonomic effects,1,8521562
,effects,3,8521562
,physical stress,1,8521562
,variations,1,8521562
,minute,2,8521562
,atenolol,4,8521562
,baseline,1,8521562
,performance,3,8521562
,not,5,8521562
,index,2,8521562
,milliseconds,1,8521562
,power,5,8521562
,treatment,3,8521562
,bicycle,1,8521562
,bicycle exercise,1,8521562
,difference,1,8521562
,decrease,1,8521562
,differences,3,8521562
,absolute,1,8521562
,high,1,8521562
,adjustment,1,8521562
,blockade,1,8521562
,methylatropine,1,8521562
,chronic,2,8521562
,nearly,1,8521562
,components,1,8521562
,spectral,1,8521562
,parameter,1,8521562
,most,1,8521562
,conclusions,1,8521562
,stable,2,8521562
,attenuates,1,8521562
,reduction,3,8521562
,patient,1,8521562
,group,1,8521562
,point,1,8521562
,action,1,8521562
,probably,1,8521562
,due,1,8521562
,activation,1,8521562
,significant,1,8521562
,degree,1,8521562
,specific,1,8521562
,challenges,1,8521562
,value,1,8521560
,myoglobin,1,8521560
,troponin,1,8521560
,out,1,8521560
,acute,1,8521560
,acute myocardial infarction,1,8521560
,myocardial,1,8521560
,myocardial infarction,1,8521560
,infarction,1,8521560
,emergency,1,8521560
,emergency room,1,8521560
,room,1,8521560
,background,1,8521560
,out,3,8521560
,acute,1,8521560
,acute myocardial infarction,1,8521560
,myocardial,1,8521560
,myocardial infarction,1,8521560
,infarction,1,8521560
,ami,9,8521560
,basis,1,8521560
,rapid,1,8521560
,cardiac,3,8521560
,cardiac markers,3,8521560
,markers,4,8521560
,early,3,8521560
,triage,1,8521560
,patients,7,8521560
,use,1,8521560
,available,1,8521560
,coronary,1,8521560
,care,1,8521560
,methods,1,8521560
,results,1,8521560
,value,2,8521560
,myoglobin,4,8521560
,creatine,1,8521560
,creatine kinase,1,8521560
,kinase,1,8521560
,troponin,3,8521560
,emergency,2,8521560
,emergency room,2,8521560
,room,2,8521560
,consecutive,1,8521560
,chest,1,8521560
,chest pain,1,8521560
,pain,1,8521560
,gold,1,8521560
,gold standard,1,8521560
,standard,1,8521560
,combination,1,8521560
,history,1,8521560
,ecg,1,8521560
,typical,1,8521560
,curve,1,8521560
,ckmb,1,8521560
,activity,1,8521560
,marker,4,8521560
,negative,1,8521560
,negative predictive value,1,8521560
,predictive,1,8521560
,predictive value,1,8521560
,significantly,1,8521560
,hours,5,8521560
,onset,4,8521560
,symptoms,4,8521560
,npv,6,8521560
,not,1,8521560
,time,2,8521560
,together,1,8521560
,subgroup,1,8521560
,low,1,8521560
,probability,2,8521560
,presence,2,8521560
,earlier,1,8521560
,large,1,8521560
,infarcts,2,8521560
,small,1,8521560
,cumulative,1,8521560
,proportion,1,8521560
,upper,1,8521560
,reference,1,8521560
,limit,1,8521560
,time point,1,8521560
,point,1,8521560
,conclusions,1,8521560
,better,1,8521560
,maximal,1,8521560
,only,1,8521560
,test,1,8521560
,characteristics,1,8521560
,size,2,8521560
,infarct,1,8521560
,studies,1,8521560
,evaluation,1,7503005
,end,1,7503005
,end points,1,7503005
,serial,1,7503005
,drug,1,7503005
,patients,1,7503005
,sustained,1,7503005
,sustained ventricular tachycardia,1,7503005
,ventricular,1,7503005
,ventricular tachycardia,1,7503005
,tachycardia,1,7503005
,healing,1,7503005
,acute,1,7503005
,acute myocardial infarction,1,7503005
,myocardial,1,7503005
,myocardial infarction,1,7503005
,infarction,1,7503005
,serial,1,7503005
,electrophysiologic,1,7503005
,drug,8,7503005
,drug testing,2,7503005
,testing,2,7503005
,antiarrhythmic,2,7503005
,therapy,2,7503005
,consecutive,1,7503005
,series,1,7503005
,patients,6,7503005
,clinical,2,7503005
,ventricular,1,7503005
,ventricular tachycardia,1,7503005
,tachycardia,1,7503005
,cardiac,2,7503005
,cardiac arrest,2,7503005
,arrest,2,7503005
,inducible,1,7503005
,coronary,1,7503005
,coronary artery,1,7503005
,coronary artery disease,1,7503005
,artery,1,7503005
,artery disease,1,7503005
,disease,1,7503005
,history,1,7503005
,myocardial,1,7503005
,myocardial infarction,1,7503005
,infarction,1,7503005
,partial,2,7503005
,rate,1,7503005
,systolic,1,7503005
,systolic blood pressure,1,7503005
,blood,1,7503005
,blood pressure,1,7503005
,pressure,1,7503005
,similar,2,7503005
,total,1,7503005
,mortality,1,7503005
,mortality rates,1,7503005
,survival,2,7503005
,statistically,1,7503005
,different,1,7503005
,high,1,7503005
,arrhythmia,1,7503005
,recurrence,1,7503005
,survivors,1,7503005
,results,1,7503005
,not,1,7503005
,prognosis,2,7503005
,change,1,7503005
,mode,1,7503005
,induction,1,7503005
,favorable,1,7503005
,deaths,1,7503005
,followup,1,7503005
,immediate,1,7503000
,reversible,1,7503000
,platelet,1,7503000
,inhibition,1,7503000
,intravenous,1,7503000
,intravenous administration,1,7503000
,administration,1,7503000
,peptide,1,7503000
,glycoprotein,1,7503000
,inhibitor,1,7503000
,percutaneous,1,7503000
,percutaneous coronary intervention,1,7503000
,coronary,1,7503000
,intervention,1,7503000
,pharmacokinetic,1,7503000
,pharmacodynamic,1,7503000
,properties,1,7503000
,integrelin,5,7503000
,novel,1,7503000
,platelet,5,7503000
,platelet glycoprotein,1,7503000
,platelet glycoprotein iib/iiia,1,7503000
,glycoprotein,1,7503000
,receptor,1,7503000
,inhibitor,1,7503000
,patients,7,7503000
,elective,2,7503000
,percutaneous,2,7503000
,percutaneous coronary intervention,2,7503000
,coronary,5,7503000
,intervention,5,7503000
,regimens,1,7503000
,total,1,7503000
,sequentially,1,7503000
,aspirin,2,7503000
,heparin,2,7503000
,discharge,1,7503000
,occurrence,1,7503000
,clinical,3,7503000
,clinical events,2,7503000
,events,3,7503000
,death,1,7503000
,myocardial,1,7503000
,myocardial infarction,1,7503000
,infarction,1,7503000
,coronary artery,1,7503000
,coronary artery bypass,1,7503000
,coronary artery bypass surgery,1,7503000
,artery,1,7503000
,bypass,1,7503000
,bypass surgery,1,7503000
,surgery,1,7503000
,repeat,1,7503000
,recurrent,1,7503000
,ischemia,1,7503000
,bleeding,3,7503000
,primary,1,7503000
,safety,1,7503000
,end,1,7503000
,end point,1,7503000
,point,1,7503000
,frequent,1,7503000
,blood,1,7503000
,blood sampling,1,7503000
,sampling,1,7503000
,adenosine,2,7503000
,platelet aggre,1,7503000
,platelet aggre gations,1,7503000
,bleeding times,1,7503000
,times,1,7503000
,less,1,7503000
,less often,1,7503000
,often,1,7503000
,overall,1,7503000
,numbers,1,7503000
,small,1,7503000
,definitive,1,7503000
,statement,1,7503000
,clinical efficacy,1,7503000
,efficacy,1,7503000
,significant,2,7503000
,increase,2,7503000
,serious,2,7503000
,highest,1,7503000
,micrograms/k,1,7503000
,immediately,1,7503000
,minutes,1,7503000
,bolus,1,7503000
,inhibition,2,7503000
,platelet aggregation,1,7503000
,aggregation,1,7503000
,treated,1,7503000
,constant,1,7503000
,infusion,2,7503000
,marked,1,7503000
,effect,1,7503000
,gradual,1,7503000
,recovery,1,7503000
,platelet function,1,7503000
,function,1,7503000
,regi men,1,7503000
,men,1,7503000
,rapid,1,7503000
,intense,1,7503000
,persistent,1,7503000
,ex vivo,1,7503000
,vivo,1,7503000
,new,1,7503000
,antiplatelet agent,1,7503000
,agent,1,7503000
,ischemic,1,7503000
,complications,1,7503000
,plasma,1,7502999
,levels,1,7502999
,antioxidant,1,7502999
,selenium,1,7502999
,risk,1,7502999
,myocardial,1,7502999
,myocardial infarction,1,7502999
,infarction,1,7502999
,antioxidant,1,7502999
,properties,1,7502999
,selenium,6,7502999
,lower,1,7502999
,incidence,1,7502999
,cardiovascular,2,7502999
,cardiovascular disease,1,7502999
,disease,1,7502999
,humans,1,7502999
,findings,1,7502999
,plasma,5,7502999
,plasma selenium,4,7502999
,level,1,7502999
,risk,4,7502999
,myocardial,1,7502999
,myocardial infarction,1,7502999
,infarction,1,7502999
,prospectively,1,7502999
,plasma samples,1,7502999
,samples,1,7502999
,study,3,7502999
,participants,1,7502999
,physicians,1,7502999
,health,1,7502999
,randomized,1,7502999
,trial,1,7502999
,aspirin,1,7502999
,betacarotene,1,7502999
,blood,1,7502999
,blood specimens,1,7502999
,specimens,1,7502999
,degrees,1,7502999
,infarcts,1,7502999
,medical,1,7502999
,medical records,1,7502999
,records,1,7502999
,subjects,2,7502999
,infarctions,1,7502999
,equal,1,7502999
,number,1,7502999
,healthy,1,7502999
,healthy controls,1,7502999
,controls,2,7502999
,age,1,7502999
,smoking,1,7502999
,smoking status,1,7502999
,status,1,7502999
,time,1,7502999
,randomization,1,7502999
,mean,1,7502999
,levels,3,7502999
,cases,1,7502999
,conditional,1,7502999
,logistic,1,7502999
,logistic regression,1,7502999
,logistic regression analysis,1,7502999
,regression,1,7502999
,regression analysis,1,7502999
,analysis,1,7502999
,quintile,3,7502999
,suggestion,1,7502999
,effect,1,7502999
,sele,1,7502999
,highest,1,7502999
,relative,1,7502999
,relative risk,1,7502999
,confidence,2,7502999
,confidence interval,2,7502999
,interval,2,7502999
,bottom,1,7502999
,adjustment,1,7502999
,other,1,7502999
,cardiovascular risk factors,1,7502999
,risk factors,1,7502999
,factors,1,7502999
,data,1,7502999
,evidence,1,7502999
,association,1,7502999
,current,1,7502999
,selenium intake,1,7502999
,intake,1,7502999
,pet,1,7502998
,pet ownership,1,7502998
,ownership,1,7502998
,social,1,7502998
,social support,1,7502998
,support,1,7502998
,survival,1,7502998
,acute,1,7502998
,acute myocardial infarction,1,7502998
,myocardial,1,7502998
,myocardial infarction,1,7502998
,infarction,1,7502998
,cardiac,1,7502998
,cardiac arrhythmia,1,7502998
,arrhythmia,1,7502998
,suppression,1,7502998
,trial,1,7502998
,cast,1,7502998
,social,8,7502998
,social support,8,7502998
,support,8,7502998
,pet,6,7502998
,pet ownership,5,7502998
,ownership,5,7502998
,form,1,7502998
,coronary,3,7502998
,coronary artery,2,7502998
,coronary artery disease,2,7502998
,artery,2,7502998
,artery disease,2,7502998
,disease,3,7502998
,survival,7,7502998
,independent,4,7502998
,effects,2,7502998
,disease severity,1,7502998
,severity,2,7502998
,other,3,7502998
,psychosocial,5,7502998
,psychosocial factors,3,7502998
,factors,3,7502998
,acute,1,7502998
,acute myocardial infarction,1,7502998
,myocardial,1,7502998
,myocardial infarction,1,7502998
,infarction,2,7502998
,prospectively,1,7502998
,cardiac,2,7502998
,cardiac arrhythmia,2,7502998
,arrhythmia,2,7502998
,suppression,2,7502998
,trial,2,7502998
,physiologic,3,7502998
,data,4,7502998
,group,1,7502998
,patients,4,7502998
,asymptomatic,1,7502998
,ventricular,1,7502998
,ventricular arrhythmias,1,7502998
,arrhythmias,1,7502998
,ancillary study,1,7502998
,study,1,7502998
,recent,1,7502998
,life,2,7502998
,life events,2,7502998
,events,2,7502998
,future,1,7502998
,anxiety,1,7502998
,depression,1,7502998
,coronary prone behavior,1,7502998
,prone,1,7502998
,behavior,1,7502998
,expression,1,7502998
,anger,1,7502998
,subjects,1,7502998
,trial sites,1,7502998
,sites,1,7502998
,baseline,1,7502998
,questionnaires,1,7502998
,year,2,7502998
,pets,1,7502998
,logistic,1,7502998
,logistic regression,1,7502998
,regression,1,7502998
,high,1,7502998
,demographic,1,7502998
,dog,1,7502998
,significantly,1,7502998
,less,1,7502998
,likely,1,7502998
,not,1,7502998
,dogs,1,7502998
,amount,1,7502998
,predictor,1,7502998
,significant,1,7502998
,predictors,1,7502998
,status,1,7502998
,previous,1,7502998
,findings,1,7502998
,management,1,8925146
,postinfarction,1,8925146
,postinfarction ventricular septal defect,1,8925146
,ventricular,1,8925146
,ventricular septal defect,1,8925146
,septal,1,8925146
,septal defect,1,8925146
,defect,1,8925146
,postinfarction,1,8925146
,postinfarction ventricular septal defect,1,8925146
,ventricular,1,8925146
,ventricular septal defect,1,8925146
,septal,1,8925146
,septal defect,1,8925146
,defect,1,8925146
,acute,1,8925146
,emergency,1,8925146
,very,1,8925146
,very high,1,8925146
,high,1,8925146
,mortality,1,8925146
,early,1,8925146
,early intervention,1,8925146
,intervention,1,8925146
,significantly,1,8925146
,survival,1,8925146
,survival rate,1,8925146
,rate,1,8925146
,article,1,8925146
,condition,1,8925146
,effects,1,7500507
,elevated,1,7500507
,elevated ldl,1,7500507
,ldl,1,7500507
,ldl cholesterol,1,7500507
,cholesterol,1,7500507
,cardiovascular,1,7500507
,risk,1,7500507
,lipoprotein(,1,7500507
,objective,1,7500507
,elevated,5,7500507
,lipoprotein,1,7500507
,lipoprotein cholesterol,1,7500507
,cholesterol,1,7500507
,levels,6,7500507
,offsets,1,7500507
,adverse effect,1,7500507
,effect,1,7500507
,lipoprotein(,2,7500507
,coronary,1,7500507
,coronary artery,1,7500507
,coronary artery disease,1,7500507
,artery,1,7500507
,artery disease,1,7500507
,disease,3,7500507
,cac,1,7500507
,men,3,7500507
,design,1,7500507
,randomized,1,7500507
,trial,1,7500507
,lipid,1,7500507
,cad,6,7500507
,setting,1,7500507
,post,1,7500507
,analysis,1,7500507
,familial,1,7500507
,atherosclerosis,1,7500507
,treatment,2,7500507
,treatment study,1,7500507
,study,1,7500507
,participants,1,7500507
,total,1,7500507
,years,3,7500507
,intervention,1,7500507
,patients,5,7500507
,step,1,7500507
,diet,1,7500507
,lovastatin,1,7500507
,daily,3,7500507
,colestipol,3,7500507
,niacin,1,7500507
,placebo,1,7500507
,percentile,2,7500507
,responses,1,7500507
,minimal,3,7500507
,less,1,7500507
,baseline,3,7500507
,change,4,7500507
,more,1,7500507
,main,1,7500507
,outcome,1,7500507
,outcome measure,1,7500507
,measure,1,7500507
,impact,1,7500507
,cardiac,1,7500507
,cardiac event,1,7500507
,event,2,7500507
,rate,2,7500507
,myocardial,1,7500507
,myocardial infarction,1,7500507
,infarction,1,7500507
,revascularization,1,7500507
,refractory,1,7500507
,ischemia,1,7500507
,results,1,7500507
,multivariate analyses,1,7500507
,best,1,7500507
,correlate,1,7500507
,severity,2,7500507
,reduction,4,7500507
,progression,2,7500507
,only,1,7500507
,not,2,7500507
,not significantly,1,7500507
,significantly,1,7500507
,group,1,7500507
,events,1,7500507
,frequent,1,7500507
,few,1,7500507
,relative,1,7500507
,relative risk,1,7500507
,risk,1,7500507
,confidence,1,7500507
,confidence interval,1,7500507
,interval,1,7500507
,conclusions,1,7500507
,dominant,1,7500507
,disease severity,1,7500507
,reductions,1,7500507
,persistent,1,7500507
,elevations,1,7500507
,possible,1,7500507
,direction,1,7500507
,physical,1,7500506
,psychosocial,1,7500506
,functioning,1,7500506
,women,1,7500506
,men,1,7500506
,coronary,1,7500506
,coronary artery,1,7500506
,coronary artery bypass,1,7500506
,coronary artery bypass surgery,1,7500506
,artery,1,7500506
,bypass,1,7500506
,bypass surgery,1,7500506
,surgery,1,7500506
,objective,1,7500506
,physical,2,7500506
,psychosocial,2,7500506
,functioning,2,7500506
,women,7,7500506
,men,7,7500506
,coronary,4,7500506
,coronary artery,4,7500506
,coronary artery bypass,3,7500506
,coronary artery bypass surgery,3,7500506
,artery,4,7500506
,bypass,3,7500506
,bypass surgery,3,7500506
,surgery,7,7500506
,design,1,7500506
,observational,1,7500506
,cohort,1,7500506
,cohort study,1,7500506
,study,1,7500506
,major,1,7500506
,teaching,1,7500506
,teaching hospital,1,7500506
,hospital,1,7500506
,patients,3,7500506
,total,1,7500506
,consecutive,1,7500506
,june,1,7500506
,march,1,7500506
,main,1,7500506
,outcome,1,7500506
,outcome measures,1,7500506
,measures,1,7500506
,nurse,1,7500506
,reviewers,1,7500506
,data,1,7500506
,severity,2,7500506
,coronary artery disease,1,7500506
,artery disease,1,7500506
,disease,1,7500506
,illnesses,2,7500506
,medical,1,7500506
,medical records,1,7500506
,records,1,7500506
,survey,1,7500506
,instrumental,1,7500506
,activities,4,7500506
,daily,1,7500506
,social,3,7500506
,social activities,3,7500506
,mental,3,7500506
,mental health,3,7500506
,health,3,7500506
,vitality,3,7500506
,alive,1,7500506
,months,2,7500506
,scale,1,7500506
,age,1,7500506
,marital,1,7500506
,marital status,1,7500506
,status,1,7500506
,education,1,7500506
,ang,1,7500506
,recent,2,7500506
,recent myocardial infarction,2,7500506
,myocardial,2,7500506
,myocardial infarction,2,7500506
,infarction,2,7500506
,congestive,2,7500506
,congestive heart failure,2,7500506
,heart,2,7500506
,heart failure,2,7500506
,failure,2,7500506
,time,2,7500506
,results,1,7500506
,much,1,7500506
,more,2,7500506
,likely,1,7500506
,class,1,7500506
,class iv,1,7500506
,class iv angina,1,7500506
,angina,1,7500506
,range,1,7500506
,impairment,2,7500506
,postoperative,1,7500506
,equivalent,1,7500506
,iadls,2,7500506
,similar,2,7500506
,greater,1,7500506
,improvements,1,7500506
,conclusions,1,7500506
,severely,1,7500506
,ill,1,7500506
,findings,1,7500506
,functional,1,7500506
,benefits,1,7500506
,procedure,1,7500506
,cocaine,1,8539739
,cocaine abuse,1,8539739
,abuse,1,8539739
,heart,1,8539739
,heart disease,1,8539739
,disease,1,8539739
,cocaine,3,8539739
,cocaine abuse,1,8539739
,abuse,1,8539739
,problem,1,8539739
,western,1,8539739
,societies,1,8539739
,health,1,8539739
,health personnel,1,8539739
,personnel,1,8539739
,aware,1,8539739
,cardiovascular,1,8539739
,effects,1,8539739
,myocardial,2,8539739
,myocardial infarction,2,8539739
,infarction,2,8539739
,most,1,8539739
,frequent,1,8539739
,complication,2,8539739
,cardiac,1,8539739
,cardiac arrhythmia,1,8539739
,arrhythmia,2,8539739
,serious,1,8539739
,young,1,8539739
,female,1,8539739
,intravenously,1,8539739
,circulatory,1,8539739
,circulatory collapse,1,8539739
,collapse,1,8539739
,authors,1,8539739
,pharmacological,1,8539739
,clinical,1,8539739
,clinical aspects,1,8539739
,aspects,1,8539739
,arrhythmias,1,8539739
,guidelines,1,8539739
,treatment,1,8539739
,development,1,8539737
,risk,1,8539737
,risk factors,1,8539737
,factors,1,8539737
,cardiovascular,1,8539737
,cardiovascular diseases,1,8539737
,diseases,1,8539737
,persons,1,8539737
,years,1,8539737
,county,1,8539737
,period,1,8539737
,national,1,8539737
,health,1,8539737
,health screening,1,8539737
,screening,1,8539737
,service,1,8539737
,screenings,1,8539737
,risk,2,8539737
,risk factors,1,8539737
,factors,1,8539737
,cardiovascular,1,8539737
,cardiovascular disease,1,8539737
,disease,1,8539737
,years,1,8539737
,age,1,8539737
,county,1,8539737
,myocardial,1,8539737
,myocardial infarction,1,8539737
,infarction,1,8539737
,due,1,8539737
,reductions,1,8539737
,total,1,8539737
,total cholesterol,1,8539737
,cholesterol,3,8539737
,more,1,8539737
,cholesterol levels,1,8539737
,levels,1,8539737
,now,1,8539737
,persons,1,8539737
,daily,2,8539737
,little,1,8539737
,change,1,8539737
,men,1,8539737
,percentage,1,8539737
,women,1,8539737
,systolic,1,8539737
,diastolic,1,8539737
,diastolic blood pressure,1,8539737
,blood,1,8539737
,blood pressure,1,8539737
,pressure,1,8539737
,slightly,1,8539737
,consumption,1,8539737
,butter,1,8539737
,traditionally,1,8539737
,coffee,2,8539737
,not,1,8539737
,other,1,8539737
,counties,1,8539737
,high,1,8539737
,values,1,8539737
,smoking,1,8539737
,habits,1,8539737
,preventive,1,8539737
,preventive measures,1,8539737
,measures,1,8539737
,still,1,8539737
,potential,1,8539737
,future,1,8539737
,trend,1,8539737
,favorable,1,8657319
,results,1,8657319
,primary,1,8657319
,percutaneous,1,8657319
,percutaneous transluminal coronary angioplasty,1,8657319
,transluminal,1,8657319
,coronary,1,8657319
,coronary angioplasty,1,8657319
,angioplasty,1,8657319
,acute,1,8657319
,acute myocardial infarction,1,8657319
,myocardial,1,8657319
,myocardial infarction,1,8657319
,infarction,1,8657319
,intravenous,1,8657319
,streptokinase,1,8657319
,treatment,1,8657319
,randomized,1,8657319
,study,1,8657319
,objective,1,8657319
,treatment,1,8657319
,patients,9,8657319
,acute,2,8657319
,acute myocardial infarction,2,8657319
,myocardial,3,8657319
,myocardial infarction,3,8657319
,infarction,3,8657319
,thrombolytic,1,8657319
,thrombolytic drugs,1,8657319
,drugs,1,8657319
,primary,3,8657319
,angioplasty,6,8657319
,randomized,2,8657319
,trial,3,8657319
,design,1,8657319
,setting,1,8657319
,hospital,2,8657319
,netherlands,1,8657319
,methods,1,8657319
,total,2,8657319
,intravenous,3,8657319
,streptokinase,5,8657319
,mean,1,8657319
,followup,3,8657319
,duration,1,8657319
,months,2,8657319
,ventricular,3,8657319
,ventricular function,2,8657319
,function,2,8657319
,radionuclide,1,8657319
,radionuclide technique,1,8657319
,technique,1,8657319
,hospital discharge,1,8657319
,discharge,1,8657319
,end,2,8657319
,period,2,8657319
,cost,1,8657319
,cost analysis,1,8657319
,analysis,1,8657319
,calculation,1,8657319
,medical,1,8657319
,costs,2,8657319
,results,1,8657319
,cardiac,2,8657319
,cause,1,8657319
,death,2,8657319
,sustained,1,8657319
,effect,1,8657319
,comparison,2,8657319
,most,1,8657319
,benefit,1,8657319
,anterior,1,8657319
,anterior wall,1,8657319
,anterior wall myocardial infarction,1,8657319
,wall,1,8657319
,conclusion,1,8657319
,average,1,8657319
,lower,1,8657319
,rate,1,8657319
,cardiac death,1,8657319
,better,1,8657319
,ventricular ejection,1,8657319
,ventricular ejection fraction,1,8657319
,ejection,1,8657319
,ejection fraction,1,8657319
,fraction,1,8657319
,increase,1,8657319
,enzyme,1,8545440
,inhibitors,1,8545440
,current,1,8545440
,knowledge,1,8545440
,angiotensin,1,8545440
,enzyme,1,8545440
,enzyme inhibitors,1,8545440
,inhibitors,1,8545440
,treatment,3,8545440
,hypertension,1,8545440
,heart,1,8545440
,heart failure,1,8545440
,failure,3,8545440
,effect,5,8545440
,arteriol,1,8545440
,resistance,1,8545440
,early,1,8545440
,myocardial,1,8545440
,myocardial infarction,1,8545440
,infarction,2,8545440
,mortality,1,8545440
,patients,2,8545440
,severely,1,8545440
,deteriorated,1,8545440
,myocardium,1,8545440
,lives,1,8545440
,additive,1,8545440
,aspirin,1,8545440
,first,2,8545440
,month,1,8545440
,hours,1,8545440
,tolerance,1,8545440
,good,1,8545440
,dosage,1,8545440
,case,1,8545440
,hypotension,1,8545440
,temporary,1,8545440
,renal,2,8545440
,renal failure,2,8545440
,nephropathy,1,8545440
,indication,1,8545440
,captopril,1,8545440
,enalapril,1,8545440
,progression,1,8545440
,risk,1,8545440
,death,1,8545440
,chronic,1,8545440
,chronic dialysis,1,8545440
,dialysis,1,8545440
,further,1,8545440
,studies,1,8545440
,diabetes,1,8545440
,experimental,1,8545440
,arguments,1,8545440
,atherosclerosis,1,8545440
,dependent,1,8545440
,system,1,8545440
,development,1,8545440
,most,1,8545440
,clinical,1,8545440
,clinical trials,1,8545440
,action,1,8545440
,atheromatosis,1,8545440
,carotid,1,8545440
,coronary,1,8545440
,coronary arteries,1,8545440
,arteries,1,8545440
,coronary,1,8545436
,best,1,8545436
,treatment,1,8545436
,acute,1,8545436
,acute myocardial infarction,1,8545436
,myocardial,1,8545436
,myocardial infarction,1,8545436
,infarction,1,8545436
,efficacy,1,8545436
,intravenous,1,8545436
,thrombolysis,5,8545436
,treatment,5,8545436
,acute,3,8545436
,acute myocardial infarction,3,8545436
,myocardial,3,8545436
,myocardial infarction,3,8545436
,infarction,4,8545436
,coronary,7,8545436
,coronary angioplasty,6,8545436
,angioplasty,8,8545436
,alternative,2,8545436
,disadvantage,1,8545436
,risk,2,8545436
,haemorrhage,1,8545436
,many,2,8545436
,cases,2,8545436
,addition,1,8545436
,little,1,8545436
,effect,1,8545436
,prognosis,1,8545436
,patients,5,8545436
,cardiogenic,1,8545436
,cardiogenic shock,1,8545436
,shock,1,8545436
,occlusion,1,8545436
,venous,1,8545436
,graft,1,8545436
,electrocardiographic,1,8545436
,electrocardiographic findings,1,8545436
,findings,1,8545436
,not,1,8545436
,patent,1,8545436
,benefit/,1,8545436
,risk ratio,1,8545436
,ratio,1,8545436
,uncertain,1,8545436
,selection,1,8545436
,main,1,8545436
,limitation,1,8545436
,only,2,8545436
,effective,3,8545436
,primary,2,8545436
,direct,1,8545436
,major,1,8545436
,series,1,8545436
,permeability,1,8545436
,preservation,1,8545436
,ventricular,1,8545436
,ventricular function,1,8545436
,function,1,8545436
,short,1,8545436
,survival,1,8545436
,several,1,8545436
,other,1,8545436
,randomized,1,8545436
,studies,1,8545436
,elderly,1,8545436
,subjects,1,8545436
,anterior,1,8545436
,anterior infarctions,1,8545436
,infarctions,1,8545436
,economic,1,8545436
,data,1,8545436
,available,1,8545436
,costs,2,8545436
,lower,1,8545436
,due,1,8545436
,reduction,1,8545436
,hospitalization,1,8545436
,time,2,8545436
,number,1,8545436
,best,1,8545436
,most,1,8545436
,severe,1,8545436
,often,1,8545436
,possible,1,8545436
,option,1,8545436
,contraindication,1,8545436
,requirements,1,8545436
,cardiology,1,8545436
,emergency,2,8545436
,hours,1,8545436
,day,1,8545436
,experienced,1,8545436
,interventional,1,8545436
,centres,2,8545436
,present,1,8545436
,indication,1,8545436
,transportation,1,8545436
,currently,1,8545436
,stress,1,8545430
,ultrasonography,1,8545430
,dobutamine,1,8545430
,diagnosis,1,8545430
,coronary,1,8545430
,coronary disease,1,8545430
,disease,1,8545430
,digital,1,8545430
,stress,3,8545430
,stress echocardiography,2,8545430
,echocardiography,2,8545430
,dobutamine,2,8545430
,infusion,1,8545430
,recently,1,8545430
,attractive,1,8545430
,alternative,1,8545430
,stress testing,1,8545430
,testing,1,8545430
,coronary,2,8545430
,coronary artery,2,8545430
,coronary artery disease,2,8545430
,artery,2,8545430
,artery disease,2,8545430
,disease,2,8545430
,useful,2,8545430
,diagnosis,2,8545430
,assessment,2,8545430
,ischemia,1,8545430
,patients,3,8545430
,unable,1,8545430
,test,1,8545430
,difficult,1,8545430
,preoperative,1,8545430
,evaluation,2,8545430
,cardiac,1,8545430
,risk,1,8545430
,residual,1,8545430
,myocardial,2,8545430
,viability,1,8545430
,previous,1,8545430
,previous myocardial infarction,1,8545430
,myocardial infarction,1,8545430
,infarction,1,8545430
,development,1,8545430
,description,1,8545430
,methodology,1,8545430
,dobutamine stress echocardiography,1,8545430
,article,1,8545430
,experience,1,8545430
,date,1,8545430
,technique,1,8545430
,postinfarction,1,8545429
,myocardial,1,8545429
,viability,1,8545429
,role,1,8545429
,evaluation,1,8545429
,myocardial,4,8545429
,myocardial scintigraphy,1,8545429
,scintigraphy,1,8545429
,relevant,1,8545429
,management,1,8545429
,patients,3,8545429
,previous,1,8545429
,previous myocardial infarction,1,8545429
,myocardial infarction,2,8545429
,infarction,2,8545429
,purpose,1,8545429
,investigation,1,8545429
,first,1,8545429
,infarcted,1,8545429
,area,1,8545429
,secondly,1,8545429
,residual,2,8545429
,myocardial ischaemia,1,8545429
,ischaemia,2,8545429
,thirdly,1,8545429
,evidence,1,8545429
,presence,1,8545429
,akinetic,1,8545429
,viable,1,8545429
,myocardium,2,8545429
,hibernating myocardium,1,8545429
,spect,3,8545429
,indication,1,8545429
,new,1,8545429
,tracers,1,8545429
,fatty acids,1,8545429
,acids,1,8545429
,pet,2,8545429
,cameras,1,8545429
,indications,1,8545429
,stress,2,8545429
,sometimes,1,8545429
,delayed,1,8545429
,rest,2,8545429
,acquisitions,1,8545429
,case,1,8545429
,negative,1,8545429
,pet scans,1,8545429
,scans,1,8545429
,useful,1,8545429
,large,1,8545429
,severe,1,8545429
,ventricular,1,8545429
,ventricular dysfunction,1,8545429
,dysfunction,1,8545429
,segmental,1,8545429
,segmental wall motion,1,8545429
,wall,1,8545429
,wall motion,1,8545429
,motion,1,8545429
,asynergy,1,8545429
,absence,1,8545429
,order,1,8545429
,eligible,1,8545429
,coronary,1,8545429
,coronary revascularization,1,8545429
,revascularization,1,8545429
,heart,1,8545429
,heart transplan,1,8545429
,transplan,1,8545429
,unstable,1,8545428
,ang,1,8545428
,physiopathology,1,8545428
,clinical,1,8545428
,clinical course,1,8545428
,course,1,8545428
,therapeutic,1,8545428
,pathogenic,1,8545428
,mechanism,1,8545428
,unstable,3,8545428
,ang,2,8545428
,clinical,2,8545428
,expression,1,8545428
,coronary,3,8545428
,coronary heart disease,2,8545428
,heart,2,8545428
,heart disease,2,8545428
,disease,2,8545428
,similar,1,8545428
,myocardial,4,8545428
,myocardial infarction,2,8545428
,infarction,2,8545428
,main,1,8545428
,event,2,8545428
,instability,1,8545428
,atheromatous,2,8545428
,atheromatous plaque,2,8545428
,plaque,2,8545428
,intima,1,8545428
,occlusion,1,8545428
,manifestations,1,8545428
,severe,1,8545428
,fatal,1,8545428
,case,1,8545428
,medical,1,8545428
,treatment,2,8545428
,most,1,8545428
,patients,4,8545428
,early,1,8545428
,preventive,1,8545428
,preventive treatment,1,8545428
,phase,1,8545428
,angina,2,8545428
,undiagnosed,1,8545428
,myocardial infarcts,1,8545428
,infarcts,1,8545428
,nearly,1,8545428
,major,3,8545428
,rapidly,1,8545428
,therapeutic,1,8545428
,strategy,2,8545428
,myocardial revascularization,1,8545428
,revascularization,1,8545428
,angioplasty,1,8545428
,often,1,8545428
,risk,4,8545428
,cardiac,2,8545428
,cardiac events,1,8545428
,events,1,8545428
,short,1,8545428
,moderate,1,8545428
,delay,1,8545428
,procedures,1,8545428
,thrombosis,1,8545428
,measures,1,8545428
,unstable angina,1,8545428
,new,1,8545428
,antiplatelet agents,1,8545428
,certain,1,8545428
,high,1,8545428
,high risk,1,8545428
,cardiac event,1,8545428
,search,1,8545428
,compounds,1,8545428
,rupture,1,8545428
,prime,1,8545428
,objective,1,8545428
,overall,1,8545428
,management,1,8545428
,trial,1,7491044
,streptokinase,1,7491044
,aspirin,1,7491044
,combination,1,7491044
,treatment,1,7491044
,acute,2,7491044
,ischaemic,1,7491044
,ischaemic stroke,1,7491044
,stroke,2,7491044
,acute stroke,1,7491044
,group,1,7491044
,ischaemic,3,7491044
,ischaemic stroke,3,7491044
,stroke,3,7491044
,thrombolytic,2,7491044
,thrombolytic drugs,1,7491044
,drugs,1,7491044
,recanalisation,1,7491044
,intracerebral,1,7491044
,arteries,1,7491044
,effects,1,7491044
,aspirin,8,7491044
,not,2,7491044
,trial,2,7491044
,together,1,7491044
,streptokinase,7,7491044
,clinical,1,7491044
,benefits,1,7491044
,acute,3,7491044
,similar,1,7491044
,acute myocardial infarction,1,7491044
,myocardial,1,7491044
,myocardial infarction,1,7491044
,infarction,1,7491044
,patients,2,7491044
,hours,1,7491044
,symptom,1,7491044
,onset,1,7491044
,factorial,1,7491044
,factorial design,1,7491044
,design,1,7491044
,intravenous,1,7491044
,intravenous infusion,1,7491044
,infusion,1,7491044
,days,1,7491044
,iii,1,7491044
,active,1,7491044
,treatments,2,7491044
,neither,1,7491044
,early,3,7491044
,results,1,7491044
,question,1,7491044
,alone,3,7491044
,excess,1,7491044
,case,2,7491044
,odds ratio,4,7491044
,ratio,4,7491044
,confidence,1,7491044
,confidence interval,1,7491044
,interval,1,7491044
,groups,1,7491044
,only,1,7491044
,significantly,2,7491044
,risk,2,7491044
,death,2,7491044
,not significantly,1,7491044
,incidence,1,7491044
,severe,2,7491044
,disability,2,7491044
,potential,1,7491044
,benefit,1,7491044
,marginal,1,7491044
,reduction,1,7491044
,first,1,7491044
,months,1,7491044
,treatment,1,10157380
,differences,1,10157380
,acute,1,10157380
,acute myocardial infarction,1,10157380
,myocardial,1,10157380
,myocardial infarction,1,10157380
,infarction,1,10157380
,previous,1,10157380
,research,2,10157380
,black,2,10157380
,patients,3,10157380
,acute,1,10157380
,acute myocardial infarction,1,10157380
,myocardial,1,10157380
,myocardial infarction,1,10157380
,infarction,1,10157380
,ami,3,10157380
,significantly,1,10157380
,less,3,10157380
,likely,3,10157380
,white,1,10157380
,cardiac,2,10157380
,cardiac procedures,1,10157380
,procedures,1,10157380
,article,1,10157380
,limited,1,10157380
,ability,1,10157380
,low,1,10157380
,low income,1,10157380
,income,1,10157380
,elderly,1,10157380
,care,1,10157380
,impact,1,10157380
,differential,1,10157380
,differential mortality,1,10157380
,mortality,1,10157380
,sample,1,10157380
,medicare,1,10157380
,days,1,10157380
,other,1,10157380
,factors,1,10157380
,cardiac catheterization,1,10157380
,catheterization,1,10157380
,revascularization,1,10157380
,procedure,1,10157380
,responses,1,12836714
,congestive,1,12836714
,congestive heart failure,1,12836714
,heart,1,12836714
,heart failure,1,12836714
,failure,1,12836714
,subsequent,1,12836714
,myocardial,1,12836714
,myocardial infarction,1,12836714
,infarction,1,12836714
,rats,1,12836714
,well,2,12836714
,positive,1,12836714
,positive inotropic,1,12836714
,effect,1,12836714
,catecholamines,3,12836714
,activation,1,12836714
,adrenergic,1,12836714
,adrenergic receptors,1,12836714
,receptors,2,12836714
,formation,1,12836714
,cyclic,4,12836714
,cyclic adenosine monophosphate,1,12836714
,adenosine,1,12836714
,adenosine monophosphate,1,12836714
,amp,4,12836714
,cardiac,1,12836714
,cardiac cell,1,12836714
,cell,1,12836714
,attenuated,1,12836714
,responses,1,12836714
,hearts,3,12836714
,patients,1,12836714
,experimental,3,12836714
,experimental animals,3,12836714
,animals,3,12836714
,coronary,2,12836714
,coronary artery,2,12836714
,coronary artery disease,1,12836714
,artery,2,12836714
,artery disease,1,12836714
,disease,1,12836714
,mechanisms,2,12836714
,poorly,1,12836714
,status,1,12836714
,receptor,2,12836714
,congestive,1,12836714
,congestive heart failure,1,12836714
,heart,2,12836714
,heart failure,1,12836714
,failure,1,12836714
,due,2,12836714
,myocardial,1,12836714
,myocardial infarction,1,12836714
,infarction,1,12836714
,rats,1,12836714
,weeks,1,12836714
,hemodynamic,2,12836714
,biochemical,1,12836714
,changes,3,12836714
,isoproterenol,2,12836714
,agonist,2,12836714
,forskolin,1,12836714
,rat,1,12836714
,rat heart,1,12836714
,preparations,1,12836714
,contractile,2,12836714
,function,1,12836714
,cyclic amp,3,12836714
,content,3,12836714
,actions,1,12836714
,left,2,12836714
,ventricular,1,12836714
,not,1,12836714
,only,1,12836714
,response,2,12836714
,density,1,12836714
,myocardium,1,12836714
,isolated,1,12836714
,increases,1,12836714
,force,1,12836714
,left ventricle,1,12836714
,ventricle,1,12836714
,data,1,12836714
,defects,1,12836714
,sites,1,12836714
,cardiac,1,9422204
,cardiac arrest,1,9422204
,arrest,1,9422204
,apparently,1,9422204
,healthy,1,9422204
,young,1,9422204
,women,1,9422204
,sudden,2,9422204
,death,2,9422204
,young,1,9422204
,people,1,9422204
,years,1,9422204
,old,1,9422204
,systematic,1,9422204
,studies,1,9422204
,anecdotal reports,1,9422204
,reports,1,9422204
,cases,1,9422204
,global,1,9422204
,survey,1,9422204
,incidence,1,9422204
,special,1,9422204
,reference,1,9422204
,belgian,1,9422204
,database,1,9422204
,prognosis,1,9422204
,specific,1,9422204
,age,1,9422204
,age group,1,9422204
,group,1,9422204
,atherosclerotic,1,9422204
,coronary,2,9422204
,coronary artery,1,9422204
,coronary artery disease,1,9422204
,artery,1,9422204
,artery disease,1,9422204
,disease,2,9422204
,cad,1,9422204
,causes,1,9422204
,well,1,9422204
,role,1,9422204
,intoxication,1,9422204
,drug,1,9422204
,substance,1,9422204
,substance abuse,1,9422204
,abuse,1,9422204
,conventional,1,9422204
,cardiopulmonary,1,9422204
,cardiopulmonary resuscitation,1,9422204
,resuscitation,1,9422204
,restoration,1,9422204
,spontaneous,1,9422204
,circulation,1,9422204
,neurological,1,9422204
,outcome,1,9422204
,search,1,9422204
,mandatory,1,9422204
,involvement,1,9422204
,drugs,1,9422204
,other,1,9422204
,toxins,1,9422204
,first,1,9422204
,place,1,9422204
,transoesophageal,1,9422204
,transoesophageal echocardiography,1,9422204
,echocardiography,1,9422204
,coronary angiography,1,9422204
,angiography,1,9422204
,testing,1,9422204
,serological,1,9422204
,myocardial,1,9422204
,myocardial biopsy,1,9422204
,biopsy,1,9422204
,magnetic,1,9422204
,magnetic resonance,1,9422204
,magnetic resonance imaging,1,9422204
,resonance,1,9422204
,imaging,1,9422204
,years,1,9002776
,experience,1,9002776
,mibg,1,9002776
,applications,1,9002776
,potential,1,9002776
,new,1,9002776
,radiolabeled,1,9002776
,peptides,1,9002776
,personal,1,9002776
,overview,1,9002776
,remarks,1,9002776
,international,1,9002776
,workshop,1,9002776
,metaiodobenzylguanidine,1,9002776
,mibg,12,9002776
,somatostatin,4,9002776
,somatostatin analogs,2,9002776
,analogs,3,9002776
,rome,1,9002776
,june,1,9002776
,wide,2,9002776
,range,5,9002776
,broad,1,9002776
,general,2,9002776
,role,3,9002776
,location,3,9002776
,neuroendocrine,5,9002776
,neuroendocrine tumors,3,9002776
,tumors,11,9002776
,scintigraphy,4,9002776
,effective,2,9002776
,pheochromocytomas,2,9002776
,neuroblastoma,2,9002776
,chemodectoma,1,9002776
,other,11,9002776
,apudomas,3,9002776
,popularity,1,9002776
,radiolabel,2,9002776
,potential,2,9002776
,advantages,1,9002776
,spect,1,9002776
,spect imaging,1,9002776
,imaging,1,9002776
,family,1,9002776
,radiopharmaceuticals,3,9002776
,biogenic amine,1,9002776
,amine,1,9002776
,uptake,2,9002776
,storage,1,9002776
,mechanisms,1,9002776
,pet,1,9002776
,vivo,2,9002776
,probe,1,9002776
,sympathetic nervous system,1,9002776
,nervous,2,9002776
,nervous system,2,9002776
,system,2,9002776
,cardiac,2,9002776
,innervation,1,9002776
,cardiomyopathy,1,9002776
,myocardial,1,9002776
,myocardial infarction,1,9002776
,infarction,1,9002776
,prognostic,1,9002776
,index,2,9002776
,cardiac transplantation,1,9002776
,transplantation,2,9002776
,pulmonary,2,9002776
,function,1,9002776
,intravenous,1,9002776
,routes,1,9002776
,administratio,1,9002776
,radiopharmaceutical,2,9002776
,radiopharmaceutical therapy,1,9002776
,therapy,3,9002776
,treatment,1,9002776
,early,1,9002776
,natural,1,9002776
,natural history,1,9002776
,history,1,9002776
,disease,1,9002776
,initial,1,9002776
,management,1,9002776
,modalitiese,1,9002776
,chemotherapy,1,9002776
,bone,1,9002776
,bone marrow,1,9002776
,bone marrow transplantation,1,9002776
,marrow,1,9002776
,marrow transplantation,1,9002776
,radiolabeled,2,9002776
,somatostatin receptor,2,9002776
,receptor,2,9002776
,pituitary,1,9002776
,pituitary tumors,1,9002776
,central,1,9002776
,central nervous system,1,9002776
,central nervous system tumors,1,9002776
,nervous system tumors,1,9002776
,carcinoids,2,9002776
,islet cell,2,9002776
,islet cell tumors,2,9002776
,cell,3,9002776
,medullary,1,9002776
,medullary thyroid carcinoma,1,9002776
,thyroid,1,9002776
,thyroid carcinoma,1,9002776
,carcinoma,1,9002776
,small,1,9002776
,small cell lung cancer,1,9002776
,lung,1,9002776
,lung cancer,1,9002776
,cancer,1,9002776
,superiority,1,9002776
,future,1,9002776
,labels,1,9002776
,somatostatin receptor scintigraphy,1,9002776
,autoimmune,1,9002776
,pentetreotide,2,9002776
,peptides,1,9002776
,receptors,1,9002776
,peptide,1,9002776
,peptide hormones,1,9002776
,hormones,1,9002776
,lymphokines,2,9002776
,paracrine,1,9002776
,information,1,9002776
,molecules,1,9002776
,concepts,1,9002776
,use,1,9002776
,slowly,1,9002776
,development,1,9002776
,applicable,1,9002776
,labeling,1,9002776
,techniques,1,9002776
,examples,1,9002776
,interleukins,1,9002776
,comparisons,1,9002776
,neuroblastomas,1,9002776
,use,1,9002748
,mibg,1,9002748
,cardiac,1,9002748
,adrenergic,1,9002748
,innervation,1,9002748
,experience,1,9002748
,hypertensive,1,9002748
,hypertensive cardiopathy,1,9002748
,cardiopathy,1,9002748
,ventricular,1,9002748
,ventricular aneurysms,1,9002748
,aneurysms,1,9002748
,mibg,7,9002748
,tracer,1,9002748
,adrenergic,3,9002748
,adrenergic system,1,9002748
,system,1,9002748
,heart,2,9002748
,aims,1,9002748
,study,1,9002748
,functional,2,9002748
,functional status,1,9002748
,status,1,9002748
,hypertensive,4,9002748
,patients,8,9002748
,left,2,9002748
,left ventricular hypertrophy,1,9002748
,ventricular,2,9002748
,ventricular hypertrophy,1,9002748
,hypertrophy,1,9002748
,lvh,2,9002748
,distribution,2,9002748
,terminals,1,9002748
,left ventricular aneurysms,1,9002748
,ventricular aneurysms,1,9002748
,aneurysms,1,9002748
,lva,2,9002748
,complex,3,9002748
,arrhythmias,3,9002748
,normals,2,9002748
,hypertension,1,9002748
,previous,1,9002748
,previous myocardial infarction,1,9002748
,myocardial,4,9002748
,myocardial infarction,2,9002748
,infarction,2,9002748
,series,1,9002748
,scans,2,9002748
,hours,1,9002748
,spect,2,9002748
,data,1,9002748
,quantification,1,9002748
,ratio,2,9002748
,scan,2,9002748
,percent,1,9002748
,percent uptake,1,9002748
,uptake,3,9002748
,regions,1,9002748
,significant,1,9002748
,differences,1,9002748
,either,1,9002748
,regional,1,9002748
,significantly,2,9002748
,septal,1,9002748
,wall,1,9002748
,lateral,1,9002748
,inferior,2,9002748
,walls,2,9002748
,lower,1,9002748
,anteroapical myocardial infarction,1,9002748
,size,1,9002748
,defect,3,9002748
,slightly,2,9002748
,smaller,1,9002748
,constant,1,9002748
,severe,1,9002748
,normal,1,9002748
,while,1,9002748
,innervation,1,9002748
,myocardial perfusion,1,9002748
,perfusion,2,9002748
,large,1,9002748
,area,1,9002748
,anatomical,1,9002748
,denervation,1,9002748
,preserved,1,9002748
,viability,1,9002748
,mismatch,1,9002748
,trigger,1,9002748
,regional,1,9002747
,sympathetic denervation,1,9002747
,denervation,1,9002747
,myocardial,1,9002747
,myocardial infarction,1,9002747
,infarction,1,9002747
,followup,1,9002747
,followup study,1,9002747
,study,1,9002747
,mibg,1,9002747
,previous,1,9002747
,studies,1,9002747
,dogs,2,9002747
,experimental,1,9002747
,infarction,5,9002747
,myocardial,4,9002747
,sympathetic denervation,2,9002747
,denervation,3,9002747
,not,1,9002747
,only,1,9002747
,infarcted,3,9002747
,area,3,9002747
,region,1,9002747
,apical,1,9002747
,myocardial scintigraphy,1,9002747
,scintigraphy,2,9002747
,normal,1,9002747
,few,1,9002747
,months,4,9002747
,time,2,9002747
,reinnervation,2,9002747
,mibg,3,9002747
,patients,2,9002747
,first,2,9002747
,acute,1,9002747
,acute transmural myocardial infarction,1,9002747
,transmural,1,9002747
,transmural myocardial infarction,1,9002747
,myocardial infarction,1,9002747
,scans,2,9002747
,year,1,9002747
,time course,1,9002747
,course,1,9002747
,possible,1,9002747
,hours,1,9002747
,therapy,1,9002747
,followup,1,9002747
,period,1,9002747
,cardiac,1,9002747
,cardiac events,1,9002747
,events,1,9002747
,week,1,9002747
,comparison,1,9002747
,perfusion,1,9002747
,denervated,1,9002747
,larger,1,9002747
,difference,1,9002747
,uptake,1,9002747
,myocardium,1,9002747
,clinical,1,9002746
,use,1,9002746
,metaiodobenzylguanidine,1,9002746
,imaging,1,9002746
,cardiology,1,9002746
,cardiac,4,9002746
,cardiac function,1,9002746
,function,3,9002746
,predominantly,1,9002746
,autonomic,1,9002746
,innervation,1,9002746
,many,1,9002746
,heart,2,9002746
,heart diseases,1,9002746
,diseases,1,9002746
,alterations,1,9002746
,adrenergic,4,9002746
,neurotransmission,1,9002746
,patients,8,9002746
,cardiomyopathies,1,9002746
,numerous,1,9002746
,therapeutic,1,9002746
,therapeutic agents,1,9002746
,act,1,9002746
,directly,1,9002746
,metaiodobenzylguanidine,1,9002746
,mibg,9,9002746
,imaging,4,9002746
,vivo,1,9002746
,information,1,9002746
,main,1,9002746
,components,1,9002746
,adrenergic nerve,2,9002746
,nerve,2,9002746
,norepinephrine,2,9002746
,norepinephrine reuptake,2,9002746
,reuptake,2,9002746
,storage,2,9002746
,system,2,9002746
,uptake,4,9002746
,congestive,1,9002746
,congestive heart failure,1,9002746
,heart failure,1,9002746
,failure,1,9002746
,impaired,1,9002746
,dilated,1,9002746
,dilated cardiomyopathy,1,9002746
,cardiomyopathy,3,9002746
,idiopathic,2,9002746
,ischemic,2,9002746
,alteration,1,9002746
,severity,2,9002746
,disease,1,9002746
,basis,1,9002746
,clinical,2,9002746
,hemodynamic,1,9002746
,parameters,1,9002746
,prognostic,1,9002746
,prognostic marker,1,9002746
,marker,1,9002746
,comparison,1,9002746
,other,1,9002746
,myocardial,1,9002746
,myocardial infarction,1,9002746
,infarction,1,9002746
,decrease,1,9002746
,transient,1,9002746
,viability,1,9002746
,indicator,1,9002746
,occurrence,1,9002746
,ventricular,3,9002746
,ventricular arrhythmias,2,9002746
,arrhythmias,3,9002746
,primary,1,9002746
,primary hypertrophic,1,9002746
,primary hypertrophic cardiomyopathy,1,9002746
,hypertrophic,1,9002746
,hypertrophic cardiomyopathy,1,9002746
,various,1,9002746
,arrhythmogenic right ventricular cardiomyopathy,1,9002746
,right,1,9002746
,right ventricular cardiomyopathy,1,9002746
,syndrome,1,9002746
,regional,1,9002746
,abnormalities,1,9002746
,new,1,9002746
,insights,1,9002746
,mechanisms,1,9002746
,scintigraphy,1,9002746
,evaluation,1,9002746
,anthracyclin,1,9002746
,cardiotoxicity,1,9002746
,tool,1,9002746
,cardiologist,1,9002746
,years,1,8964646
,treatment,1,8964646
,treatment efficacy,1,8964646
,efficacy,1,8964646
,patients,1,8964646
,severe,1,8964646
,hyperlipidemia,1,8964646
,lipid,1,8964646
,drugs,1,8964646
,total,2,8964646
,patients,5,8964646
,heterozygous,1,8964646
,hyperlipidemia,1,8964646
,years,2,8964646
,diet,2,8964646
,drugs,2,8964646
,only,1,8964646
,treatment,1,8964646
,periods,1,8964646
,apheresis,3,8964646
,group,7,8964646
,rug,1,8964646
,months,1,8964646
,results,2,8964646
,significant,1,8964646
,differences,1,8964646
,total cholesterol,1,8964646
,cholesterol,1,8964646
,ldl,1,8964646
,patient,1,8964646
,myocardial,2,8964646
,myocardial infarction,2,8964646
,infarction,2,8964646
,manifestation,1,8964646
,coronary,2,8964646
,coronary heart disease,2,8964646
,heart,2,8964646
,heart disease,2,8964646
,disease,2,8964646
,cases,1,8964646
,drug,2,8964646
,severe,1,8964646
,increased,1,8964646
,clinical,1,8964646
,performance,1,8964646
,other,1,8964646
,hand,1,8964646
,wellbeing,1,8964646
,lower,1,8964646
,scores,1,8964646
,present,1,8964646
,trial,1,8964646
,reduction,1,8964646
,serum,1,8964646
,serum lipid,1,8964646
,lipid,1,8964646
,concentrations,1,8964646
,dose,1,8964646
,dependent,1,8964646
,risk,1,8964646
,development,1,8964646
,progression,1,8964646
,respect,1,8964646
,laboratory,1,8964646
,laboratory results,1,8964646
,most,1,8964646
,effective,1,8964646
,therapy,1,8964646
,changes,1,8963353
,body,1,8963353
,body weight,1,8963353
,weight,1,8963353
,relation,1,8963353
,mortality,1,8963353
,european,1,8963353
,men,1,8963353
,countries,1,8963353
,study,1,8963353
,objectives,1,8963353
,study,5,8963353
,relation,1,8963353
,changes,1,8963353
,body,5,8963353
,body weight,5,8963353
,weight,13,8963353
,subsequent,1,8963353
,mortality,5,8963353
,design,1,8963353
,prospective,1,8963353
,followup,3,8963353
,followup study,1,8963353
,population,1,8963353
,population study,1,8963353
,subjects,1,8963353
,men,6,8963353
,baseline,1,8963353
,participating,1,8963353
,european,1,8963353
,cohorts,1,8963353
,countries,1,8963353
,groups,1,8963353
,pattern,1,8963353
,weight measurements,1,8963353
,measurements,1,8963353
,intervals,1,8963353
,years,3,8963353
,quartiles,1,8963353
,degree,1,8963353
,variability,2,8963353
,main,1,8963353
,outcome,1,8963353
,outcome measures,1,8963353
,measures,1,8963353
,last,1,8963353
,weight measurement,1,8963353
,measurement,1,8963353
,deaths,1,8963353
,first,1,8963353
,results,2,8963353
,significantly,1,8963353
,elevated,3,8963353
,hazard,2,8963353
,hazard ratios,2,8963353
,ratios,2,8963353
,death,1,8963353
,causes,3,8963353
,confidence,1,8963353
,confidence interval,1,8963353
,interval,1,8963353
,cardiovascular,2,8963353
,cardiovascular diseases,1,8963353
,diseases,1,8963353
,other,2,8963353
,constant,2,8963353
,fluctuating,2,8963353
,risk,2,8963353
,cause,1,8963353
,coronary,3,8963353
,coronary heart disease,3,8963353
,heart,3,8963353
,heart disease,3,8963353
,disease,4,8963353
,myocardial,3,8963353
,myocardial infarction,3,8963353
,infarction,3,8963353
,group,1,8963353
,only,1,8963353
,significant,1,8963353
,total,1,8963353
,risks,1,8963353
,cardiovascular disease,1,8963353
,cancer,1,8963353
,upper,1,8963353
,quartile,2,8963353
,lower,1,8963353
,conclusions,1,8963353
,present,1,8963353
,decreasing,1,8963353
,increased,1,8963353
,average,1,8963353
,increase,1,8963353
,kg body weight,1,8963353
,lowest,1,8963353
,effect,1,8919348
,myocardial,1,8919348
,myocardial infarction,1,8919348
,infarction,1,8919348
,ischemia,1,8919348
,induction,1,8919348
,cardiac,1,8919348
,ventricular,1,8919348
,present,1,8919348
,work,1,8919348
,effects,3,8919348
,myocardial,1,8919348
,myocardial infarction,1,8919348
,infarction,1,8919348
,ischemia,5,8919348
,induction,1,8919348
,ventricular,3,8919348
,electrophysiologic,1,8919348
,global,1,8919348
,local,2,8919348
,variation,1,8919348
,dispersion,3,8919348
,refractory,3,8919348
,refractory periods,3,8919348
,periods,3,8919348
,well,1,8919348
,conduction,1,8919348
,conduction velocity,1,8919348
,velocity,1,8919348
,initiation,1,8919348
,reentry,2,8919348
,mechanisms,1,8919348
,means,1,8919348
,computer,1,8919348
,computer simulations,1,8919348
,simulations,2,8919348
,cellular,1,8919348
,model,1,8919348
,activation,1,8919348
,wave,1,8919348
,surface,1,8919348
,element,1,8919348
,local area,1,8919348
,area,1,8919348
,then,1,8919348
,simulated,1,8919348
,gaussian,1,8919348
,gaussian distribution,1,8919348
,distribution,1,8919348
,mean,1,8919348
,standard,1,8919348
,standard deviation,1,8919348
,deviation,1,8919348
,phenomena,1,8919348
,whole,1,8919348
,ventricle,1,8919348
,responsible,1,8919348
,ventricular fibrillation,1,8919348
,fibrillation,1,8919348
,sudden,1,8919348
,sudden cardiac death,1,8919348
,cardiac,2,8919348
,cardiac death,1,8919348
,death,1,8919348
,only,1,8919348
,limited,1,8919348
,parts,1,8919348
,myocardium,1,8919348
,statistical,1,8919348
,statistical study,1,8919348
,study,1,8919348
,probability,1,8919348
,function,1,8919348
,size,1,8919348
,ischemic,1,8919348
,rate,1,8919348
,parameter,1,8919348
,primary,1,8919348
,ree,1,8919348
,evaluation,1,8907431
,performance,1,8907431
,equilibrium,1,8907431
,equilibrium radionuclide angiocardiography,1,8907431
,radionuclide,1,8907431
,radionuclide angiocardiography,1,8907431
,angiocardiography,1,8907431
,patients,2,8907431
,severe,1,8907431
,heart,2,8907431
,heart failure,1,8907431
,failure,1,8907431
,due,1,8907431
,myocardial,1,8907431
,myocardial infarction,1,8907431
,infarction,1,8907431
,ami,2,8907431
,breathing,1,8907431
,peep,2,8907431
,additional,1,8907431
,therapeutic,1,8907431
,value,1,8907431
,study,1,8907431
,effects,1,8907431
,cpap,1,8907431
,face,1,8907431
,face mask,1,8907431
,mask,1,8907431
,cm h2o,1,8907431
,performance,2,8907431
,equilibrium,1,8907431
,equilibrium radionuclide angiocardiography,1,8907431
,radionuclide,1,8907431
,radionuclide angiocardiography,1,8907431
,angiocardiography,1,8907431
,era,1,8907431
,response,1,8907431
,lung,1,8907431
,inflation,1,8907431
,high,1,8907431
,levels,1,8907431
,heart rate,1,8907431
,rate,1,8907431
,stroke,1,8907431
,stroke volume,1,8907431
,volume,1,8907431
,sum,1,8907431
,pathological,1,8907431
,reduction,1,8907431
,decrease,1,8907431
,left,1,8907431
,ventricular,1,8907431
,compliance,1,8907431
,restriction,1,8907431
,positive,1,8907431
,pressure,1,8907431
,global,1,8907431
,systolic,1,8907431
,cardiac,1,8903840
,cardiac troponin,1,8903840
,troponin,1,8903840
,immunoassay,1,8903840
,microplates,1,8903840
,preliminary,1,8903840
,performance,1,8903840
,acute,1,8903840
,acute myocardial infarction,1,8903840
,myocardial,1,8903840
,myocardial infarction,1,8903840
,infarction,1,8903840
,cardiac,1,8903840
,cardiac troponin,1,8903840
,troponin,2,8903840
,tnt,6,8903840
,immunoassay,2,8903840
,system,5,8903840
,elisa,1,8903840
,germany,1,8903840
,technology,1,8903840
,sensitive,1,8903840
,microplate,2,8903840
,coating,1,8903840
,microplates,1,8903840
,bovine,1,8903840
,serum,2,8903840
,stable,1,8903840
,months,1,8903840
,secondary,1,8903840
,streptavidin,1,8903840
,first,2,8903840
,first step,1,8903840
,step,1,8903840
,assay,2,8903840
,opd,1,8903840
,substrate,1,8903840
,conjugate,1,8903840
,rapid,1,8903840
,kinetic,2,8903840
,measurement,2,8903840
,levels,2,8903840
,upper,1,8903840
,limit,1,8903840
,reference,1,8903840
,population,1,8903840
,percentile,1,8903840
,imprecision,2,8903840
,studies,1,8903840
,ckmb,3,8903840
,mass,3,8903840
,mass concentration,3,8903840
,concentration,3,8903840
,acute,1,8903840
,acute myocardial infarction,1,8903840
,myocardial,1,8903840
,myocardial infarction,1,8903840
,infarction,1,8903840
,patients,4,8903840
,streptokinase,1,8903840
,clinical,1,8903840
,clinical sensitivity,1,8903840
,sensitivity,2,8903840
,similar,1,8903840
,test,1,8903840
,initiation,1,8903840
,thrombolytic,1,8903840
,thrombolytic therapy,1,8903840
,therapy,1,8903840
,early,2,8903840
,ratio,1,8903840
,lower,1,8903840
,signs,1,8903840
,successful,1,8903840
,reperfusion,1,8903840
,peak,1,8903840
,serum samples,1,8903840
,samples,1,8903840
,renal,1,8903840
,renal failure,1,8903840
,failure,1,8903840
,patient,1,8903840
,rhabdomyolysis,1,8903840
,strong,1,8903840
,behaviour,1,8903840
,dilution,1,8903840
,presence,1,8903840
,interfering,1,8903840
,factor,1,8903840
,endpoint,1,8903840
,analysis,2,8903840
,respect,1,8903840
,total,2,8903840
,time,2,8903840
,greatly,1,8903840
,costs,1,8903840
,measurements,1,8903840
,systems,1,8903840
,min,1,8903840
,angiotensin,1,8903616
,enzyme,1,8903616
,enzyme gene,1,8903616
,gene,1,8903616
,gene polymorphism,1,8903616
,polymorphism,1,8903616
,carotid,1,8903616
,carotid atherosclerosis,1,8903616
,atherosclerosis,1,8903616
,population,1,8903616
,objectives,1,8903616
,angiotensin,1,8903616
,enzyme,1,8903616
,ace,8,8903616
,polymorphism,4,8903616
,independent,1,8903616
,risk,3,8903616
,risk factor,1,8903616
,factor,1,8903616
,myocardial,1,8903616
,myocardial infarction,1,8903616
,infarction,1,8903616
,other,2,8903616
,other cardiovascular diseases,1,8903616
,cardiovascular,1,8903616
,cardiovascular diseases,1,8903616
,diseases,1,8903616
,aim,1,8903616
,study,1,8903616
,relationship,1,8903616
,genotype,5,8903616
,carotid,6,8903616
,carotid atherosclerosis,4,8903616
,atherosclerosis,5,8903616
,ultrasonography,1,8903616
,patients,5,8903616
,methods,1,8903616
,age,2,8903616
,years,1,8903616
,relation,1,8903616
,traditional,1,8903616
,risk factors,2,8903616
,factors,2,8903616
,degree,1,8903616
,thickness,5,8903616
,level,2,8903616
,common,1,8903616
,common carotid artery,1,8903616
,carotid artery,1,8903616
,artery,1,8903616
,bifurcation,1,8903616
,internal,1,8903616
,internal carotid,1,8903616
,normal,1,8903616
,wall,1,8903616
,atherosclerotic,1,8903616
,atherosclerotic plaque,1,8903616
,plaque,1,8903616
,examination,1,8903616
,sex,1,8903616
,body,1,8903616
,body mass,1,8903616
,body mass index,1,8903616
,mass,1,8903616
,index,1,8903616
,blood,1,8903616
,blood pressure,1,8903616
,pressure,1,8903616
,levels,3,8903616
,prevalence,1,8903616
,similar,2,8903616
,groups,2,8903616
,polymerase,1,8903616
,polymerase chain reaction,1,8903616
,chain,1,8903616
,reaction,1,8903616
,specific,1,8903616
,primers,1,8903616
,genomic,1,8903616
,genomic dna,1,8903616
,dna,1,8903616
,leukocytes,1,8903616
,template,1,8903616
,plasma,4,8903616
,plasma renin activity,1,8903616
,renin,1,8903616
,renin activity,1,8903616
,activity,1,8903616
,plasma aldosterone,1,8903616
,aldosterone,1,8903616
,standard,1,8903616
,procedures,1,8903616
,results,1,8903616
,significant,1,8903616
,differences,1,8903616
,parameters,1,8903616
,distribution,1,8903616
,allele,1,8903616
,allele frequency,1,8903616
,frequency,1,8903616
,only,1,8903616
,significantly,1,8903616
,genotypes,2,8903616
,mean,1,8903616
,conclusion,1,8903616
,coronary,1,8903616
,coronary atherosclerosis,1,8903616
,present,1,8903616
,data,1,8903616
,not,1,8903616
,further,1,8903616
,studies,1,8903616
,larger,1,8903616
,populations,1,8903616
,genetic,1,8903616
,lipoprotein(,1,8857237
,cerebrovascular,1,8857237
,coronary,1,8857237
,coronary atherosclerosis,1,8857237
,atherosclerosis,1,8857237
,serum,2,8857237
,serum lipoprotein(,1,8857237
,lipoprotein(,1,8857237
,healthy,1,8857237
,healthy controls,1,8857237
,controls,1,8857237
,control,3,8857237
,control group,2,8857237
,group,8,8857237
,patients,4,8857237
,cerebrovascular,1,8857237
,cerebrovascular disease,1,8857237
,disease,1,8857237
,cvd,4,8857237
,acute,1,8857237
,acute myocardial infarction,1,8857237
,myocardial,1,8857237
,myocardial infarction,1,8857237
,infarction,4,8857237
,ami,3,8857237
,concentration,3,8857237
,single,1,8857237
,radial,1,8857237
,immunodiffusion,1,8857237
,method,1,8857237
,skewed distribution,1,8857237
,distribution,1,8857237
,box,1,8857237
,box plot,1,8857237
,methods,1,8857237
,results,2,8857237
,levels,1,8857237
,significantly,1,8857237
,groups,3,8857237
,cerebral,4,8857237
,cerebral hemorrhage,1,8857237
,hemorrhage,1,8857237
,emb,1,8857237
,lacunar,1,8857237
,lacunar infarction,1,8857237
,lac,2,8857237
,thr,1,8857237
,elevated,1,8857237
,value,2,8857237
,severe,1,8857237
,lesions,1,8857237
,major,1,8857237
,cerebral arteries,1,8857237
,arteries,3,8857237
,cerebral arteriograms,1,8857237
,arteriograms,1,8857237
,coronary,4,8857237
,coronary angiography,1,8857237
,angiography,1,8857237
,level,1,8857237
,marked,1,8857237
,increase,2,8857237
,number,1,8857237
,affected,1,8857237
,vessels,1,8857237
,correlation,1,8857237
,index,1,8857237
,lesion,1,8857237
,severity,2,8857237
,coronary arteries,2,8857237
,high,1,8857237
,atherosclerosis,1,8857237
,effects,1,8850388
,exchange,1,8850388
,amiloride,1,8850388
,ventricular,1,8850388
,anterior,1,8850388
,anterior myocardial infarction,1,8850388
,myocardial,1,8850388
,myocardial infarction,1,8850388
,infarction,1,8850388
,rats,1,8850388
,effects,1,8850388
,amiloride,6,8850388
,exchange,1,8850388
,ventricular,4,8850388
,ventricular remodeling,1,8850388
,remodeling,1,8850388
,infarcted,1,8850388
,rat,1,8850388
,model,1,8850388
,group,7,8850388
,coronary,1,8850388
,coronary artery,1,8850388
,artery,1,8850388
,rats,3,8850388
,drinking,1,8850388
,drinking water,1,8850388
,water,2,8850388
,weeks,2,8850388
,control,3,8850388
,control group,3,8850388
,myocardial,3,8850388
,myocardial infarction,2,8850388
,infarction,2,8850388
,day,1,8850388
,ratio,1,8850388
,heart,1,8850388
,weight,4,8850388
,body,2,8850388
,body weight,2,8850388
,significantly,3,8850388
,less,1,8850388
,diameter,1,8850388
,fiber,1,8850388
,region,1,8850388
,adjacent,1,8850388
,operated,1,8850388
,area,1,8850388
,ventricular cavity,1,8850388
,cavity,1,8850388
,dimension,1,8850388
,smaller,1,8850388
,findings,1,8850388
,human,1,8850377
,myocardium,1,8850377
,recent,1,8850377
,advances,1,8850377
,aspirations,1,8850377
,development,1,8850377
,new,1,8850377
,means,1,8850377
,clinical,1,8850377
,practice,1,8850377
,ischemic,5,8850377
,ischemic preconditioning,2,8850377
,preconditioning,4,8850377
,most,2,8850377
,means,1,8850377
,myocardium,3,8850377
,injury,1,8850377
,experimental,1,8850377
,experimental animal,1,8850377
,experimental animal models,1,8850377
,animal,3,8850377
,animal models,3,8850377
,models,3,8850377
,mechanism,2,8850377
,incompletely,1,8850377
,review,1,8850377
,evidence,1,8850377
,syndromes,1,8850377
,humans,1,8850377
,human,3,8850377
,place,1,8850377
,therapeutic,1,8850377
,tool,1,8850377
,clinical,3,8850377
,practice,2,8850377
,studies,2,8850377
,patients,5,8850377
,acute,1,8850377
,acute myocardial infarction,1,8850377
,myocardial,1,8850377
,myocardial infarction,1,8850377
,infarction,2,8850377
,better,1,8850377
,outcome,1,8850377
,angina,2,8850377
,onset,1,8850377
,not,2,8850377
,universal,1,8850377
,finding,1,8850377
,difficult,1,8850377
,other,2,8850377
,confounding factors,1,8850377
,factors,1,8850377
,collateral,1,8850377
,flow,1,8850377
,results,1,8850377
,more,1,8850377
,prospective,1,8850377
,prospective studies,1,8850377
,percutaneous,1,8850377
,percutaneous transluminal coronary angioplasty,1,8850377
,transluminal,1,8850377
,coronary,2,8850377
,coronary angioplasty,1,8850377
,angioplasty,1,8850377
,less,2,8850377
,change,1,8850377
,second,1,8850377
,balloon,1,8850377
,inflation,1,8850377
,first,2,8850377
,completely,1,8850377
,causes,1,8850377
,effect,1,8850377
,dependence,1,8850377
,mechanisms,2,8850377
,phenomena,1,8850377
,same,1,8850377
,further,1,8850377
,experiments,1,8850377
,atrial,1,8850377
,muscle,1,8850377
,similar,1,8850377
,adenosine,1,8850377
,protein,1,8850377
,protein kinase,1,8850377
,kinase,1,8850377
,potassium,1,8850377
,potassium channels,1,8850377
,channels,1,8850377
,clinical medicine,1,8850377
,medicine,1,8850377
,most likely,1,8850377
,likely,2,8850377
,ischemia,1,8850377
,cardiac,1,8850377
,cardiac surgery,1,8850377
,surgery,1,8850377
,respect,1,8850377
,study,1,8850377
,coronary artery,1,8850377
,coronary artery bypass,1,8850377
,coronary artery bypass grafts,1,8850377
,artery,1,8850377
,artery bypass grafts,1,8850377
,bypass,1,8850377
,bypass grafts,1,8850377
,grafts,1,8850377
,reduction,1,8850377
,atp,1,8850377
,period,1,8850377
,protocol,1,8850377
,advances,1,8850377
,full,1,8850377
,potential,1,8850377
,whole,1,8850377
,protection,1,8850377
,pharmacological,1,8850377
,agent,1,8850377
,available,1,8850377
,oral,1,8848207
,transmural,1,8848207
,transmural myocardial infarction,1,8848207
,myocardial,1,8848207
,myocardial infarction,1,8848207
,infarction,1,8848207
,healthy,1,8848207
,man,1,8848207
,transmural,1,8848207
,transmural myocardial infarction,1,8848207
,myocardial,1,8848207
,myocardial infarction,1,8848207
,infarction,1,8848207
,sumatriptan,2,8848207
,sumatriptan succinate,1,8848207
,succinate,1,8848207
,migraine,1,8848207
,coronary,2,8848207
,coronary arteriography,1,8848207
,arteriography,1,8848207
,only,1,8848207
,minor,1,8848207
,left,1,8848207
,left anterior,1,8848207
,left anterior descending artery,1,8848207
,anterior,1,8848207
,descending,1,8848207
,artery,2,8848207
,oral,1,8848207
,oral sumatriptan,1,8848207
,patient,1,8848207
,vascular,1,8848207
,risk,1,8848207
,risk factors,1,8848207
,factors,1,8848207
,coronary artery,1,8848207
,coronary artery disease,1,8848207
,artery disease,1,8848207
,disease,1,8848207
,vasospasm,1,8848207
,relationship,1,8848181
,headaches,1,8848181
,experience,1,8848181
,chest,1,8848181
,chest pain,1,8848181
,pain,1,8848181
,subsequent,1,8848181
,risk,1,8848181
,myocardial,1,8848181
,myocardial infarction,1,8848181
,infarction,1,8848181
,study,1,8848181
,relationship,2,8848181
,migraine,5,8848181
,chest,4,8848181
,chest pain,3,8848181
,pain,4,8848181
,risk,3,8848181
,myocardial,1,8848181
,myocardial infarction,1,8848181
,infarction,1,8848181
,retrospective,1,8848181
,cohort,1,8848181
,northern,1,8848181
,california,1,8848181
,medical,2,8848181
,medical care,1,8848181
,care,1,8848181
,program,1,8848181
,comprehensive,1,8848181
,preventive,1,8848181
,preventive medicine,1,8848181
,medicine,1,8848181
,examinations,1,8848181
,questionnaire,1,8848181
,physician,2,8848181
,diagnosis,2,8848181
,questions,1,8848181
,feelings,1,8848181
,pressure,1,8848181
,tightness,1,8848181
,middle,1,8848181
,breastbone,1,8848181
,respondent,1,8848181
,followup,1,8848181
,time,1,8848181
,participants,1,8848181
,medical examination,1,8848181
,examination,1,8848181
,continued,1,8848181
,occurrence,1,8848181
,hospitalization,1,8848181
,death,1,8848181
,termination,1,8848181
,enrollment,1,8848181
,strong,1,8848181
,general,1,8848181
,significant,1,8848181
,association,1,8848181
,women,1,8848181
,family,1,8848181
,family history,1,8848181
,history,1,8848181
,greater,1,8848181
,increase,1,8848181
,serum,1,8847372
,levels,1,8847372
,vitamin,1,8847372
,relation,1,8847372
,cardiovascular,1,8847372
,cardiovascular diseases,1,8847372
,diseases,1,8847372
,serum,4,8847372
,levels,4,8847372
,healthy,1,8847372
,people,1,8847372
,patients,4,8847372
,cardiovascular,4,8847372
,cardiovascular diseases,1,8847372
,diseases,1,8847372
,cases,1,8847372
,cardiovascular disease,3,8847372
,disease,3,8847372
,acute,1,8847372
,acute myocardial infarction,1,8847372
,myocardial,2,8847372
,myocardial infarction,1,8847372
,infarction,1,8847372
,ami,2,8847372
,atherosclerosis,1,8847372
,myocardial ischaemia,1,8847372
,ischaemia,1,8847372
,mean,1,8847372
,control,3,8847372
,control group,3,8847372
,group,5,8847372
,overall,1,8847372
,lower,1,8847372
,respect,1,8847372
,number,1,8847372
,parameters,1,8847372
,age,1,8847372
,sex,1,8847372
,smoking,1,8847372
,smoking status,1,8847372
,status,1,8847372
,index,1,8847372
,alcohol,1,8847372
,alcohol consumption,1,8847372
,consumption,1,8847372
,dietary,1,8847372
,dietary intake,1,8847372
,intake,1,8847372
,lip,1,8847372
,ids,1,8847372
,hypertension,1,8845099
,other,1,8845099
,cardiovascular,1,8845099
,cardiovascular risk factors,1,8845099
,risk,1,8845099
,risk factors,1,8845099
,factors,1,8845099
,women,1,8845099
,coronary,4,8845099
,coronary heart disease,1,8845099
,heart,1,8845099
,heart disease,1,8845099
,disease,2,8845099
,chd,2,8845099
,cause,1,8845099
,death,1,8845099
,women,20,8845099
,deaths,1,8845099
,annually,1,8845099
,more,5,8845099
,increases,1,8845099
,years,4,8845099
,risk,6,8845099
,risk factors,2,8845099
,factors,2,8845099
,highly,1,8845099
,hypertension,5,8845099
,hypercholesterolemia,1,8845099
,overweight,1,8845099
,sedentary,1,8845099
,additio,1,8845099
,greater,2,8845099
,men,10,8845099
,risk factor,1,8845099
,factor,1,8845099
,prevalence,2,8845099
,lower,3,8845099
,socioeconomic,1,8845099
,socioeconomic status,1,8845099
,status,1,8845099
,educational,1,8845099
,educational level,1,8845099
,level,1,8845099
,decrease,2,8845099
,less,3,8845099
,past,1,8845099
,decades,1,8845099
,cardiovascular,1,8845099
,mortality,1,8845099
,example,1,8845099
,white,2,8845099
,black,2,8845099
,age,7,8845099
,systolic,1,8845099
,systolic blood pressure,1,8845099
,blood,1,8845099
,blood pressure,1,8845099
,pressure,1,8845099
,pressure peaks,1,8845099
,peaks,1,8845099
,middle,2,8845099
,middle age,1,8845099
,complications,1,8845099
,equal,1,8845099
,current,1,8845099
,cigarette,2,8845099
,cigarette smoking,2,8845099
,smoking,3,8845099
,genders,1,8845099
,due,1,8845099
,smoking cessation,1,8845099
,cessation,1,8845099
,triples,1,8845099
,myocardial,1,8845099
,myocardial infarction,1,8845099
,infarction,1,8845099
,premenopausal,1,8845099
,young,1,8845099
,hdl,1,8845099
,hdl cholesterol,1,8845099
,cholesterol,5,8845099
,cholesterol levels,3,8845099
,levels,3,8845099
,total,2,8845099
,total cholesterol,2,8845099
,progressively,1,8845099
,postmenopausal,1,8845099
,increase,1,8845099
,far,1,8845099
,association,1,8845099
,physical,1,8845099
,physical fitness,1,8845099
,fitness,1,8845099
,favorable,1,8845099
,profile,1,8845099
,education,1,8845099
,part,1,8845099
,illness,1,8845099
,experience,1,8845099
,unlikely,1,8845099
,preventive,1,8845099
,messages,1,8845099
,uses,1,8839396
,heparin,1,8839396
,fractions,1,8839396
,standard,1,8839396
,unfractionated heparin,5,8839396
,heparin,8,8839396
,similar,2,8839396
,many,1,8839396
,aspects,1,8839396
,main,1,8839396
,advantages,2,8839396
,new,2,8839396
,class,1,8839396
,antithrombotic agents,1,8839396
,bioavailability,1,8839396
,prolonged,1,8839396
,halflife,1,8839396
,laboratory,1,8839396
,monitoring,1,8839396
,single,1,8839396
,daily,1,8839396
,subcutaneous,1,8839396
,subcutaneous injection,1,8839396
,injection,1,8839396
,ratio,1,8839396
,less,1,8839396
,bleeding,1,8839396
,improved,1,8839396
,efficacy,2,8839396
,postoperative,1,8839396
,thromboembolism,1,8839396
,unresolved,1,8839396
,unresolved issues,1,8839396
,specific,1,8839396
,indications,1,8839396
,use,1,8839396
,patients,2,8839396
,arterial,1,8839396
,arterial thrombosis,1,8839396
,thrombosis,2,8839396
,unstable,1,8839396
,ang,1,8839396
,myocardial,1,8839396
,myocardial infarction,1,8839396
,infarction,1,8839396
,usually,1,8839396
,conjunction,1,8839396
,thrombolytic,1,8839396
,treatment,2,8839396
,symptomatic,1,8839396
,pulmonary,1,8839396
,pulmonary embolism,1,8839396
,embolism,1,8839396
,well,1,8839396
,new agents,1,8839396
,potential,1,8839396
,outpatient,1,8839396
,outpatient treatment,1,8839396
,economic,1,8839396
,logistic,1,8839396
,point,1,8839396
,view,1,8839396
,safety,1,8839396
,myocardial,1,8838048
,myocardial perfusion,1,8838048
,perfusion,1,8838048
,perfusion scintigraphy,1,8838048
,scintigraphy,1,8838048
,compounds,1,8838048
,correlations,1,8838048
,coronary,1,8838048
,coronary angiography,1,8838048
,angiography,1,8838048
,incidence,1,8838048
,ischaemic,1,8838048
,ischaemic heart disease,1,8838048
,heart,1,8838048
,heart disease,1,8838048
,disease,1,8838048
,high,1,8838048
,mortality,1,8838048
,mortality rate,1,8838048
,rate,1,8838048
,recent,1,8838048
,introduction,1,8838048
,myocardial,3,8838048
,myocardial perfusion,2,8838048
,perfusion,5,8838048
,coronary,4,8838048
,coronary angiography,2,8838048
,angiography,3,8838048
,programme,1,8838048
,trinidad,1,8838048
,ago,1,8838048
,comparison,1,8838048
,sensitivity,2,8838048
,specificity,2,8838048
,perfusion scintigraphy,1,8838048
,scintigraphy,2,8838048
,standard,1,8838048
,protocol,1,8838048
,single,1,8838048
,photon,1,8838048
,emission,1,8838048
,tomography,1,8838048
,spect,1,8838048
,ventricular,1,8838048
,ventricular myocardium,1,8838048
,myocardium,1,8838048
,patients,1,8838048
,rest,1,8838048
,exercise,1,8838048
,defects,1,8838048
,main,2,8838048
,coronary arteries,1,8838048
,arteries,3,8838048
,left,2,8838048
,left anterior,1,8838048
,anterior,1,8838048
,artery,4,8838048
,lad,4,8838048
,right,1,8838048
,right coronary artery,1,8838048
,coronary artery,1,8838048
,left circumflex artery,1,8838048
,circumflex,1,8838048
,circumflex artery,1,8838048
,lcx,3,8838048
,data,2,8838048
,then,1,8838048
,angiographic,1,8838048
,findings,1,8838048
,overall,1,8838048
,discordant,1,8838048
,analysis,1,8838048
,vascular,2,8838048
,false,4,8838048
,false positives,1,8838048
,positives,1,8838048
,false negative,2,8838048
,negative,2,8838048
,false positive,1,8838048
,positive,1,8838048
,cases,2,8838048
,males,2,8838048
,females,2,8838048
,tunnelling,1,8838048
,other,2,8838048
,differential,2,8838048
,syndrome,1,8838048
,patient,1,8838048
,good,1,8838048
,collateral,1,8838048
,collateral circulation,1,8838048
,circulation,1,8838048
,very,1,8838048
,very well,1,8838048
,well,1,8838048
,family,2,8826061
,heart,1,8826061
,heart attacks,1,8826061
,attacks,1,8826061
,hypercholesterolaemic,1,8826061
,men,1,8826061
,family history,1,8826061
,history,1,8826061
,patients,3,8826061
,often,1,8826061
,biomedically,1,8826061
,mild,1,8826061
,conditions,2,8826061
,previous,1,8826061
,study,3,8826061
,primary,1,8826061
,primary care,1,8826061
,care,1,8826061
,frequent,1,8826061
,associations,1,8826061
,cases,2,8826061
,serious,2,8826061
,serious illness,1,8826061
,illness,1,8826061
,family,6,8826061
,histories,2,8826061
,further,1,8826061
,phenomena,1,8826061
,middle,1,8826061
,men,4,8826061
,recent,1,8826061
,diagnosis,1,8826061
,hypercholesterolaemia,3,8826061
,male,1,8826061
,participants,1,8826061
,moderate,1,8826061
,health,1,8826061
,health survey,1,8826061
,survey,1,8826061
,minutes,1,8826061
,lifestyle,1,8826061
,sessions,1,8826061
,respect,1,8826061
,subjects,1,8826061
,family history,4,8826061
,history,4,8826061
,main,1,8826061
,content,1,8826061
,category,1,8826061
,talks,1,8826061
,threat,1,8826061
,risk,3,8826061
,seriousness,1,8826061
,event,2,8826061
,hand,1,8826061
,relevance,1,8826061
,other,1,8826061
,fatal,1,8826061
,premature,1,8826061
,disease,3,8826061
,knowledge,2,8826061
,beliefs,2,8826061
,risk factors,2,8826061
,factors,2,8826061
,disease causation,1,8826061
,causation,1,8826061
,relevant,1,8826061
,several,2,8826061
,heredity,1,8826061
,emotional,1,8826061
,few,1,8826061
,example,1,8826061
,support,1,8826061
,view,1,8826061
,role,1,8826061
,asymptomatic,1,8826061
,development,1,8826061
,consultation,1,8826061
,skills,1,8826061
,myosin,1,8825882
,myosin light chain,1,8825882
,light,1,8825882
,chain,1,8825882
,phosphorylation,1,8825882
,cardiac,1,8825882
,cardiac hypertrophy,1,8825882
,hypertrophy,1,8825882
,failure,1,8825882
,due,1,8825882
,myocardial,1,8825882
,myocardial infarction,1,8825882
,infarction,1,8825882
,regulatory,1,8825882
,myosin,2,8825882
,myosin light chain,2,8825882
,light,2,8825882
,chain,2,8825882
,cardiac,4,8825882
,cardiac muscle,2,8825882
,muscle,2,8825882
,dependent,1,8825882
,myosin light chain kinase,1,8825882
,kinase,1,8825882
,lck,1,8825882
,modulatory,1,8825882
,role,1,8825882
,process,1,8825882
,force,1,8825882
,generation,1,8825882
,order,1,8825882
,changes,4,8825882
,mlc,6,8825882
,phosphorylation,5,8825882
,cardiac hypertrophy,2,8825882
,hypertrophy,2,8825882
,heart,2,8825882
,heart failure,2,8825882
,failure,2,8825882
,relative,4,8825882
,content,2,8825882
,mlck,5,8825882
,sham,1,8825882
,control,4,8825882
,experimental,4,8825882
,rats,4,8825882
,weeks,2,8825882
,ligation,1,8825882
,left,3,8825882
,left coronary artery,1,8825882
,coronary,1,8825882
,coronary artery,1,8825882
,artery,1,8825882
,electrophoresis,1,8825882
,immunoblot,1,8825882
,immunoblot assay,1,8825882
,assay,1,8825882
,gel,1,8825882
,western,1,8825882
,western blotting,1,8825882
,amount,2,8825882
,viable,2,8825882
,left ventricle,2,8825882
,ventricle,4,8825882
,right,2,8825882
,right ventricle,2,8825882
,septum,2,8825882
,comparison,2,8825882
,values,2,8825882
,significantly,1,8825882
,markedly,1,8825882
,results,1,8825882
,region,1,8825882
,specific,1,8825882
,levels,1,8825882
,subsequent,1,8825882
,myocardial,1,8825882
,myocardial infarction,1,8825882
,infarction,1,8825882
,cardiac,1,8822332
,abnormalities,1,8822332
,hydrops,1,8822332
,hydrops fetalis,1,8822332
,cardiovascular,1,8822332
,cardiovascular abnormalities,1,8822332
,abnormalities,3,8822332
,hydrops,6,8822332
,hydrops fetalis,6,8822332
,cases,1,8822332
,era,1,8822332
,not,1,8822332
,only,2,8822332
,structural,3,8822332
,cardiac,4,8822332
,cardiac arrhythmias,1,8822332
,arrhythmias,1,8822332
,failure,1,8822332
,tumors,2,8822332
,myopathy,1,8822332
,infection,1,8822332
,inflammation,1,8822332
,infarction,2,8822332
,arterial,2,8822332
,arterial calcification,2,8822332
,calcification,2,8822332
,cardiac structural,1,8822332
,association,1,8822332
,lesions,1,8822332
,right,1,8822332
,right atrial pressure,1,8822332
,atrial,3,8822332
,atrial pressure,2,8822332
,pressure,2,8822332
,volume,1,8822332
,volume overload,1,8822332
,most,2,8822332
,fetal,4,8822332
,cardiac tumors,1,8822332
,cardiomyopathy,1,8822332
,myocarditis,1,8822332
,myocardial,1,8822332
,myocardial infarction,1,8822332
,probably,1,8822332
,similar,1,8822332
,mechanism,2,8822332
,fetal tachyarrhythmia,1,8822332
,tachyarrhythmia,1,8822332
,elevation,1,8822332
,atrial natriuretic peptide,1,8822332
,natriuretic,1,8822332
,natriuretic peptide,1,8822332
,peptide,1,8822332
,fetal tachyarrhythmias,1,8822332
,tachyarrhythmias,1,8822332
,causes,1,8822332
,fetal bradyarrhythmias,1,8822332
,bradyarrhythmias,1,8822332
,less,2,8822332
,easily,1,8822332
,coronary,1,8821473
,plaques,1,8821473
,clinical,1,8821473
,clinical presentation,1,8821473
,presentation,1,8821473
,prognosis,1,8821473
,coronary,3,8821473
,coronary atherosclerosis,1,8821473
,atherosclerosis,1,8821473
,more,1,8821473
,plaque,5,8821473
,type,1,8821473
,size,1,8821473
,stable,2,8821473
,plaques,6,8821473
,arterial,1,8821473
,arterial lumen,1,8821473
,lumen,1,8821473
,stable angina,1,8821473
,stable angina pectoris,1,8821473
,angina,1,8821473
,angina pectoris,1,8821473
,contrast,1,8821473
,thrombose,1,8821473
,event,1,8821473
,responsible,1,8821473
,development,1,8821473
,acute,1,8821473
,acute coronary syndromes,1,8821473
,syndromes,1,8821473
,unstable,2,8821473
,ang,1,8821473
,myocardial,1,8821473
,myocardial infarction,1,8821473
,infarction,1,8821473
,sudden,2,8821473
,sudden death,1,8821473
,death,1,8821473
,gradual,1,8821473
,lipid,1,8821473
,ongoing,2,8821473
,inflammation,1,8821473
,risk,1,8821473
,disruption,3,8821473
,thrombosis,3,8821473
,external,1,8821473
,factors,1,8821473
,mechanical,1,8821473
,hemodynamic,1,8821473
,response,2,8821473
,dynamic,1,8821473
,simultaneously,1,8821473
,thrombolysis,1,8821473
,frequently,1,8821473
,intermittent,1,8821473
,flow,1,8821473
,obstruction,1,8821473
,syndrome,1,8821473
,challenge,1,8821473
,today,1,8821473
,new,1,8821473
,formation,1,8821473
,intact,1,8821473
,coronary,1,8821469
,coronary atherosclerosis,1,8821469
,atherosclerosis,1,8821469
,stabilization,1,8821469
,goal,1,8821469
,coronary,4,8821469
,atherosclerotic,2,8821469
,atherosclerotic plaques,2,8821469
,plaques,4,8821469
,blood,1,8821469
,blood flow,1,8821469
,flow,1,8821469
,angina,1,8821469
,rupture,3,8821469
,unstable,1,8821469
,ang,1,8821469
,myocardial,2,8821469
,myocardial infarction,2,8821469
,infarction,2,8821469
,sudden,1,8821469
,sudden death,1,8821469
,death,1,8821469
,prone,1,8821469
,lipid,3,8821469
,rich,1,8821469
,thin,1,8821469
,fibrous,1,8821469
,caps,1,8821469
,often,1,8821469
,mild,1,8821469
,most,1,8821469
,treatment,1,8821469
,strategies,2,8821469
,relieving,1,8821469
,cardiac,2,8821469
,cardiac symptoms,1,8821469
,symptoms,1,8821469
,myocardium,1,8821469
,wake,1,8821469
,plaque,2,8821469
,animal,1,8821469
,animal studies,1,8821469
,studies,2,8821469
,consequently,1,8821469
,coronary artery,2,8821469
,coronary artery disease,2,8821469
,artery,2,8821469
,artery disease,2,8821469
,disease,3,8821469
,humans,1,8821469
,sixteen,1,8821469
,angiographic,2,8821469
,regression,1,8821469
,date,1,8821469
,consistently,1,8821469
,lipid levels,1,8821469
,levels,1,8821469
,results,1,8821469
,coronary artery disease progression,1,8821469
,disease progression,1,8821469
,progression,1,8821469
,markedly,1,8821469
,cardiac events,1,8821469
,events,1,8821469
,extent,1,8821469
,event,1,8821469
,reduction,1,8821469
,change,1,8821469
,concept,1,8821469
,favorable,1,8821469
,alterations,1,8821469
,stabilization,1,8821469
,need,1,8821469
,individuals,1,8821469
,risk,1,8821469
,more,1,8821469
,ever,1,8821469
,patients,1,8821469
,now,1,8821469
,factitious,1,8808097
,factitious hyperthyroidism,1,8808097
,hyperthyroidism,1,8808097
,acute,1,8808097
,acute myocardial infarction,1,8808097
,myocardial,1,8808097
,myocardial infarction,1,8808097
,infarction,1,8808097
,myocardial,4,8808097
,myocardial ischemia,1,8808097
,ischemia,2,8808097
,rare,1,8808097
,severe,1,8808097
,possibly,1,8808097
,life,1,8808097
,manifestation,1,8808097
,hyperthyroidism,1,8808097
,not,1,8808097
,usually,1,8808097
,persistent,2,8808097
,woman,1,8808097
,total,1,8808097
,total thyroidectomy,1,8808097
,thyroidectomy,1,8808097
,subsequent,2,8808097
,irradiation,1,8808097
,follicular,1,8808097
,follicular carcinoma,1,8808097
,carcinoma,1,8808097
,years,1,8808097
,ago,1,8808097
,then,1,8808097
,oral,1,8808097
,levothyroxine,3,8808097
,replacement,3,8808097
,replacement therapy,2,8808097
,therapy,2,8808097
,dose,3,8808097
,alternating,1,8808097
,daily,1,8808097
,latent,1,8808097
,latent hypothyroidism,1,8808097
,hypothyroidism,1,8808097
,day,1,8808097
,weeks,2,8808097
,later,1,8808097
,patient,1,8808097
,acute,1,8808097
,acute posterior myocardial infarction,1,8808097
,posterior,1,8808097
,posterior myocardial infarction,1,8808097
,myocardial infarction,2,8808097
,infarction,3,8808097
,previous,1,8808097
,history,1,8808097
,coronary,2,8808097
,coronary artery,1,8808097
,coronary artery disease,1,8808097
,artery,1,8808097
,artery disease,1,8808097
,disease,2,8808097
,coronary arteriograms,1,8808097
,arteriograms,1,8808097
,evidence,1,8808097
,major,1,8808097
,vessels,1,8808097
,myocardial scintigraphy,1,8808097
,scintigraphy,1,8808097
,still,1,8808097
,perfusion,1,8808097
,defect,1,8808097
,thyroid,1,8808097
,thyroid hormones,1,8808097
,thyroid hormones increase,1,8808097
,hormones,1,8808097
,increase,2,8808097
,oxygen,2,8808097
,demand,1,8808097
,rapid,1,8808097
,elevation,1,8808097
,utilization,1,8808097
,thyrotoxicosis,1,8808097
,thyrotoxicosis factitia,1,8808097
,likely,1,8808097
,responsible,1,8808097
,patients,1,8808097
,case,1,8808097
,sudden,1,8808097
,carotid,1,8789528
,carotid endarterectomy,1,8789528
,endarterectomy,1,8789528
,cervical,1,8789528
,cervical plexus,1,8789528
,cervical plexus block,1,8789528
,plexus,1,8789528
,plexus block,1,8789528
,block,1,8789528
,efficacy,1,8789528
,level,1,8789528
,patient,2,8789528
,patient satisfaction,1,8789528
,satisfaction,1,8789528
,well,1,8789528
,incidence,2,8789528
,neurological,3,8789528
,neurological manifestations,1,8789528
,manifestations,1,8789528
,hemodynamic,2,8789528
,changes,1,8789528
,other,1,8789528
,perioperative,1,8789528
,complications,4,8789528
,cervical,3,8789528
,cervical plexus,3,8789528
,cervical plexus block,3,8789528
,plexus,3,8789528
,plexus block,3,8789528
,block,3,8789528
,prospective,1,8789528
,prospective study,1,8789528
,study,1,8789528
,patients,6,8789528
,carotid,4,8789528
,carotid endarterectomy,2,8789528
,endarterectomy,2,8789528
,superficial,2,8789528
,deep,2,8789528
,deep cervical plexus,1,8789528
,deep cervical plexus block,1,8789528
,anesthetic,3,8789528
,technique,5,8789528
,effective,1,8789528
,cases,1,8789528
,supplementation,1,8789528
,local,2,8789528
,local anesthetic,1,8789528
,none,1,8789528
,general,1,8789528
,general anesthesia,1,8789528
,anesthesia,2,8789528
,good,1,8789528
,same,1,8789528
,case,1,8789528
,surgery,5,8789528
,contralateral,1,8789528
,carotid artery,1,8789528
,artery,1,8789528
,hypertension,1,8789528
,change,1,8789528
,most,2,8789528
,often,1,8789528
,serious,2,8789528
,transient,1,8789528
,dysphonia,1,8789528
,frequently,1,8789528
,effect,1,8789528
,signs,1,8789528
,symptoms,1,8789528
,placement,1,8789528
,shunt,2,8789528
,deaths,1,8789528
,due,1,8789528
,myocardial,1,8789528
,myocardial infarction,1,8789528
,infarction,1,8789528
,permanent,1,8789528
,cerebrovascular,1,8789528
,cerebrovascular accident,1,8789528
,accident,2,8789528
,regional,1,8789528
,regional anesthesia,1,8789528
,superficial cervical plexus,1,8789528
,superficial cervical plexus block,1,8789528
,continuous,1,8789528
,evaluation,1,8789528
,neurological status,1,8789528
,status,1,8789528
,use,1,8789528
,intraluminal,1,8789528
,prevention,1,8789528
,stroke,1,8789528
,not,2,8789528
,more,1,8789528
,difficult,1,8789528
,rise,1,8789528
,low,1,8789528
,postoperative,1,8789524
,postoperative complications,1,8789524
,complications,1,8789524
,mortality,1,8789524
,abdominal,1,8789524
,abdominal aortic aneurysm,1,8789524
,aortic,1,8789524
,aortic aneurysm,1,8789524
,aneurysm,1,8789524
,surger,1,8789524
,objective,1,8789524
,morbidity,1,8789524
,mortality,3,8789524
,patients,4,8789524
,surgery,4,8789524
,aneurysm,1,8789524
,abdominal,1,8789524
,abdominal aorta,1,8789524
,aorta,1,8789524
,order,1,8789524
,risk,2,8789524
,risk factors,1,8789524
,factors,3,8789524
,methods,1,8789524
,retrospective,1,8789524
,retrospective study,1,8789524
,study,1,8789524
,aortic,1,8789524
,january,1,8789524
,april,1,8789524
,aneurysms,2,8789524
,adjacent,1,8789524
,kidney,1,8789524
,results,1,8789524
,cases,1,8789524
,emergency,2,8789524
,groups,1,8789524
,place,1,8789524
,first,2,8789524
,hours,2,8789524
,admission,1,8789524
,secondary,1,8789524
,secondary diseases,1,8789524
,diseases,1,8789524
,usually,1,8789524
,ischemic,1,8789524
,cardiopathy,1,8789524
,present,1,8789524
,most,2,8789524
,frequently,1,8789524
,postoperative,1,8789524
,postoperative complications,1,8789524
,complications,1,8789524
,cardiovascular,2,8789524
,renal,1,8789524
,respiratory,1,8789524
,digestive,1,8789524
,digestive problems,1,8789524
,problems,1,8789524
,frequent,1,8789524
,cause,1,8789524
,death,1,8789524
,acute,1,8789524
,acute myocardial infarction,1,8789524
,myocardial,1,8789524
,myocardial infarction,1,8789524
,infarction,1,8789524
,hypovolemic,1,8789524
,hypovolemic shock,1,8789524
,shock,1,8789524
,significant,1,8789524
,age,1,8789524
,years,1,8789524
,rupture,1,8789524
,blood,1,8789524
,blood loss,1,8789524
,loss,1,8789524
,transfusion,1,8789524
,more,1,8789524
,units,1,8789524
,red,1,8789524
,red cells,1,8789524
,cells,1,8789524
,conclusions,1,8789524
,increase,1,8789524
,number,1,8789524
,elective,1,8789524
,elective procedures,1,8789524
,procedures,1,8789524
,resection,1,8789524
,small,1,8789524
,early,1,8789524
,early diagnosis,1,8789524
,diagnosis,1,8789524
,treatment,1,8789524
,ruptures,1,8789524
,aggressive,1,8789524
,hemodynamic,1,8789524
,management,1,8789524
,perioperative,1,8789524
,special,1,8789524
,attention,1,8789524
,status,1,8789524
,better,1,8789524
,outcome,1,8789524
,sudden,1,8789186
,sudden cardiac death,1,8789186
,cardiac,1,8789186
,cardiac death,1,8789186
,death,1,8789186
,indeterminate,1,8789186
,phase,1,8789186
,chagas,1,8789186
,chagas disease,1,8789186
,disease,1,8789186
,acute,1,8789186
,infarction,1,8789186
,right,1,8789186
,right carotid body,1,8789186
,carotid,1,8789186
,carotid body,1,8789186
,body,1,8789186
,recently,1,8789186
,case,2,8789186
,patient,1,8789186
,indeterminate,1,8789186
,phase,1,8789186
,chagas,1,8789186
,chagas disease,1,8789186
,disease,1,8789186
,cardiac,2,8789186
,cardiac arrhythmia,1,8789186
,arrhythmia,1,8789186
,acute,2,8789186
,infarction,4,8789186
,right,1,8789186
,right carotid body,1,8789186
,carotid,3,8789186
,carotid body,3,8789186
,body,3,8789186
,due,1,8789186
,occlusive,1,8789186
,thrombosis,1,8789186
,artery,1,8789186
,available,1,8789186
,data,1,8789186
,not,1,8789186
,definite,1,8789186
,evidence,1,8789186
,relationship,1,8789186
,patients,1,8789186
,sudden,1,8789186
,sudden cardiac arrest,1,8789186
,cardiac arrest,1,8789186
,arrest,1,8789186
,very,1,8789186
,very likely,1,8789186
,likely,1,8789186
,distinct,1,8789186
,morphological,1,8789186
,functional,1,8789186
,functional disturbance,1,8789186
,disturbance,1,8789186
,interactions,1,8789186
,action,1,8789186
,relationships,1,8789179
,left,1,8789179
,disturbances,1,8789179
,lipid,1,8789179
,lipid metabolism,1,8789179
,metabolism,1,8789179
,different,1,8789179
,ethnic,1,8789179
,ethnic groups,1,8789179
,groups,1,8789179
,purpose,1,8789179
,study,1,8789179
,relationships,1,8789179
,brain,2,8789179
,brain hemisphere,1,8789179
,disturbance,1,8789179
,lipid,3,8789179
,lipid metabolism,3,8789179
,metabolism,3,8789179
,atherosclerosis,1,8789179
,different,2,8789179
,ethnic,2,8789179
,ethnic groups,1,8789179
,groups,4,8789179
,subjects,4,8789179
,healthy,2,8789179
,ethnic population,1,8789179
,population,2,8789179
,far,1,8789179
,north,1,8789179
,russian,3,8789179
,men,2,8789179
,myocardial,1,8789179
,myocardial infarction,1,8789179
,infarction,1,8789179
,age,1,8789179
,blood,1,8789179
,blood cholesterol,1,8789179
,cholesterol,2,8789179
,low,2,8789179
,density,2,8789179
,ldl,1,8789179
,high,1,8789179
,levels,1,8789179
,brain functional,1,8789179
,functional,1,8789179
,asymmetry,1,8789179
,lack,1,8789179
,most,1,8789179
,common,1,8789179
,ups,1,8789179
,whole,1,8789179
,concentrations,1,8789179
,comparison,1,8789179
,pattern,1,8789179
,left,2,8789179
,changes,1,8789179
,dominant,1,8789179
,different,1,8787466
,effects,1,8787466
,adenosine,1,8787466
,analogue,1,8787466
,ischemic,1,8787466
,ischemic preconditioning,1,8787466
,preconditioning,1,8787466
,rabbit,1,8787466
,hearts,1,8787466
,background,1,8787466
,ischemic,6,8787466
,infarct,7,8787466
,size,7,8787466
,effects,5,8787466
,function,4,8787466
,variable,1,8787466
,adenosine,5,8787466
,role,1,8787466
,ischemic preconditioning,4,8787466
,preconditioning,4,8787466
,dysfunction,1,8787466
,purpose,1,8787466
,study,1,8787466
,adenosine a1 receptor,3,8787466
,adenosine a1 receptor agonist,1,8787466
,receptor,3,8787466
,agonist,2,8787466
,recovery,4,8787466
,isolated,1,8787466
,rabbit,1,8787466
,hearts,4,8787466
,methods,1,8787466
,group,1,8787466
,minutes,3,8787466
,global,1,8787466
,ischemia,3,8787466
,degrees,1,8787466
,reperfusion,1,8787466
,ventricular,4,8787466
,ventricular function,1,8787466
,pressure,3,8787466
,percentage,1,8787466
,left,2,8787466
,left ventricle,1,8787466
,ventricle,1,8787466
,tetrazolium,1,8787466
,staining,1,8787466
,results,2,8787466
,control,1,8787466
,effect,1,8787466
,immediately,1,8787466
,enhanced,1,8787466
,termination,1,8787466
,treatment,1,8787466
,adenosine a1 receptor antagonist,1,8787466
,antagonist,1,8787466
,dpcpx,1,8787466
,not,1,8787466
,conclusions,1,8787466
,differences,1,8787466
,receptor activation,1,8787466
,activation,1,8787466
,isotope,1,8787335
,methods,1,8787335
,determination,1,8787335
,myocardial,1,8787335
,viability,1,8787335
,decision,1,8787335
,myocardial,3,8787335
,myocardial revascularization,1,8787335
,revascularization,2,8787335
,patients,2,8787335
,chronic,1,8787335
,chronic ischaemic heart disease,1,8787335
,ischaemic,2,8787335
,ischaemic heart disease,1,8787335
,heart,1,8787335
,heart disease,1,8787335
,disease,1,8787335
,infarction,1,8787335
,many,1,8787335
,criteria,1,8787335
,coronary,1,8787335
,anatomy,1,8787335
,ventricular,1,8787335
,ventricular function,1,8787335
,function,1,8787335
,clinical,1,8787335
,context,1,8787335
,physiological,1,8787335
,age,1,8787335
,essential,1,8787335
,presence,1,8787335
,viable,2,8787335
,myocardium,4,8787335
,territory,1,8787335
,functional,2,8787335
,functional imaging,2,8787335
,imaging,3,8787335
,imaging techniques,1,8787335
,techniques,1,8787335
,hibernating myocardium,1,8787335
,clinician,1,8787335
,reliable,1,8787335
,answer,1,8787335
,great,1,8787335
,majority,1,8787335
,cases,1,8787335
,number,1,8787335
,examination,1,8787335
,protocols,1,8787335
,order,1,8787335
,investigation,2,8787335
,more,1,8787335
,efficient,1,8787335
,late,1,8787335
,films,1,8787335
,reinjection,1,8787335
,new,1,8787335
,tracers,2,8787335
,viability,1,8787335
,currently,3,8787335
,evaluation,2,8787335
,positron,2,8787335
,positron emission tomography,1,8787335
,emission,1,8787335
,tomography,1,8787335
,pet,1,8787335
,reference,1,8787335
,technique,2,8787335
,detection,2,8787335
,numerous,1,8787335
,parallel,1,8787335
,cellular,1,8787335
,cellular metabolism,1,8787335
,metabolism,1,8787335
,myocardial perfusion,1,8787335
,perfusion,1,8787335
,type,1,8787335
,not,1,8787335
,available,1,8787335
,use,1,8787335
,emitter,1,8787335
,conventional,1,8787335
,cameras,1,8787335
,results,2,8787335
,other,1,8787335
,imaging devices,1,8787335
,devices,1,8787335
,stress,1,8787335
,ultrasonography,2,8787335
,good,1,8787335
,contrast,1,8787335
,magnetic,1,8787335
,magnetic resonance,1,8787335
,magnetic resonance imaging,1,8787335
,resonance,1,8787335
,development,1,8787335
,treatments,1,8787334
,ischemic,1,8787334
,cardiopathies,1,8787334
,modalities,1,8787334
,prescription,1,8787334
,aspirin,1,8787334
,french,1,8787334
,centers,1,8787334
,french,1,8787334
,centres,4,8787334
,frequencies,1,8787334
,myocardial,1,8787334
,myocardial infarction,1,8787334
,infarction,1,8787334
,not,1,8787334
,hospital,3,8787334
,mortality,3,8787334
,day,2,8787334
,excess,1,8787334
,hospital mortality,1,8787334
,infarct,1,8787334
,patients,7,8787334
,emergency,1,8787334
,management,1,8787334
,coronary,2,8787334
,subsequently,1,8787334
,coronary heart disease,1,8787334
,heart,1,8787334
,heart disease,1,8787334
,disease,1,8787334
,characteristics,1,8787334
,admission,1,8787334
,differences,1,8787334
,therapeutic,1,8787334
,strategies,1,8787334
,angioplasty,2,8787334
,predominant,1,8787334
,together,1,8787334
,prescription,2,8787334
,calcium,1,8787334
,calcium channel,1,8787334
,calcium channel blockers,1,8787334
,channel,1,8787334
,channel blockers,1,8787334
,aspirin,3,8787334
,high,1,8787334
,other,1,8787334
,acute,3,8787334
,acute phase,3,8787334
,phase,3,8787334
,cardiologists,1,8787334
,department,1,8787334
,rarely,1,8787334
,fibrinolysis,1,8787334
,more,1,8787334
,variable,1,8787334
,dosage,2,8787334
,greater,1,8787334
,equal,1,8787334
,while,1,8787334
,only,1,8787334
,anticoagulation,1,8787333
,cardiology,1,8787333
,various,1,8787333
,applications,1,8787333
,anticoagulation,2,8787333
,cardiology,1,8787333
,concern,1,8787333
,primary,1,8787333
,primary prevention,1,8787333
,prevention,1,8787333
,treatment,3,8787333
,angina,1,8787333
,infarction,1,8787333
,revascularization,1,8787333
,angioplasty,1,8787333
,bypass,1,8787333
,bypass grafts,1,8787333
,grafts,1,8787333
,artificial,1,8787333
,valve,1,8787333
,replacement,1,8787333
,atrial,1,8787333
,atrial fibrillation,1,8787333
,fibrillation,1,8787333
,precaution,1,8787333
,case,1,8787333
,impaired,1,8787333
,ventricular,1,8787333
,ventricular function,1,8787333
,function,1,8787333
,several,1,8787333
,methods,1,8787333
,indications,1,8787333
,antagonists,2,8787333
,vitamin,1,8787333
,thrombolytics,1,8787333
,last,1,8787333
,group,1,8787333
,not,1,8787333
,article,1,8787333
,acute,1,8787332
,mitral,1,8787332
,mitral valve,1,8787332
,mitral valve insufficiency,1,8787332
,valve,1,8787332
,insufficiency,1,8787332
,type,1,8787332
,disease,3,8787332
,recent,2,8787332
,decades,1,8787332
,progress,1,8787332
,ultrasound,2,8787332
,ultrasound technique,1,8787332
,technique,1,8787332
,new,1,8787332
,methods,1,8787332
,medical,2,8787332
,surgical,2,8787332
,surgical treatment,1,8787332
,treatment,5,8787332
,mitral,5,8787332
,mitral incompetence,3,8787332
,incompetence,3,8787332
,categories,1,8787332
,mechanism,2,8787332
,valve,4,8787332
,lesions,2,8787332
,usually,4,8787332
,secondary,2,8787332
,bacterial,2,8787332
,bacterial endocarditis,2,8787332
,endocarditis,2,8787332
,sometimes,3,8787332
,trauma,1,8787332
,percutaneous,1,8787332
,percutaneous valvuloplasty,1,8787332
,rupture,3,8787332
,chordae,2,8787332
,chordae tendineae,2,8787332
,spontaneous,1,8787332
,bac,1,8787332
,context,1,8787332
,valvular heart disease,1,8787332
,heart,1,8787332
,heart disease,1,8787332
,degenerative,1,8787332
,papillary,3,8787332
,papillary muscle,3,8787332
,muscle,3,8787332
,head,1,8787332
,myocardial,1,8787332
,myocardial infarction,1,8787332
,infarction,1,8787332
,biological,1,8787332
,mechanical,1,8787332
,prosthesis,1,8787332
,dysfunction,1,8787332
,consequences,1,8787332
,acute,4,8787332
,aetiology,3,8787332
,presence,2,8787332
,absence,3,8787332
,previous,1,8787332
,mitral valve,1,8787332
,mitral valve disease,1,8787332
,factors,1,8787332
,clinical,3,8787332
,clinical presentation,1,8787332
,presentation,1,8787332
,prognosis,1,8787332
,volume,6,8787332
,regurgitation,4,8787332
,ventricular,6,8787332
,ventricular function,2,8787332
,function,2,8787332
,atrial,2,8787332
,compliance,1,8787332
,pure,1,8787332
,forms,1,8787332
,profile,1,8787332
,marked,1,8787332
,elevation,1,8787332
,pressures,2,8787332
,mean,1,8787332
,systolic,2,8787332
,systolic pressures,1,8787332
,large,1,8787332
,wave,1,8787332
,reduction,2,8787332
,cardiac,2,8787332
,cardiac output,2,8787332
,output,2,8787332
,left,2,8787332
,ventricular enddiastolic volume,2,8787332
,moderately,1,8787332
,normal,1,8787332
,ejection,1,8787332
,ejection fraction,1,8787332
,fraction,1,8787332
,picture,1,8787332
,ventricular failure,1,8787332
,failure,1,8787332
,systolic murmur,1,8787332
,murmur,1,8787332
,mitral regurgitation,1,8787332
,pulmonary,2,8787332
,pulmonary hypertension,1,8787332
,hypertension,2,8787332
,syndrome,1,8787332
,left ventricular hypertrophy,1,8787332
,ventricular hypertrophy,1,8787332
,hypertrophy,1,8787332
,electrocardiogram,1,8787332
,dilatation,1,8787332
,radiological,1,8787332
,examination,1,8787332
,nature,1,8787332
,disturbances,1,8787332
,diagnosis,1,8787332
,doppler,1,8787332
,doppler ultrasound,1,8787332
,need,1,8787332
,invasive,1,8787332
,investigation,1,8787332
,clinical course,1,8787332
,course,1,8787332
,vasodilators,2,8787332
,sodium,1,8787332
,infusion,1,8787332
,rapid,1,8787332
,pulmonary artery,1,8787332
,artery,1,8787332
,capillary,1,8787332
,not,1,8787332
,counterpulsation,1,8787332
,useful,1,8787332
,emergency,1,8787332
,surgery,2,8787332
,improvement,1,8787332
,state,1,8787332
,replacement,1,8787332
,surgical repair,1,8787332
,repair,1,8787332
,excellent,1,8787332
,results,1,8787332
,active,1,8787332
,other,1,8787332
,cases,1,8787332
,control,1,8787332
,acute phase,1,8787332
,phase,1,8787332
,chronic,1,8787332
,project,1,8787328
,authors,2,8787328
,various,2,8787328
,aspects,1,8787328
,project,2,8787328
,monitoring,1,8787328
,trends,1,8787328
,determinants,1,8787328
,cardiovascular,1,8787328
,cardiovascular diseases,1,8787328
,diseases,1,8787328
,world,1,8787328
,world health,1,8787328
,world health organization,1,8787328
,health,2,8787328
,health organization,1,8787328
,organization,1,8787328
,study,4,8787328
,comprises,1,8787328
,geographical,1,8787328
,administrative,1,8787328
,entity,1,8787328
,infarction,7,8787328
,registry,4,8787328
,population,6,8787328
,population surveys,3,8787328
,surveys,4,8787328
,treatment,1,8787328
,acute,2,8787328
,acute phase,1,8787328
,phase,1,8787328
,myocardial,2,8787328
,myocardial infarction,2,8787328
,collaborative,1,8787328
,centres,5,8787328
,continents,1,8787328
,main,2,8787328
,not,2,8787328
,years,1,8787328
,last,1,8787328
,population survey,1,8787328
,survey,1,8787328
,results,1,8787328
,date,1,8787328
,publications,1,8787328
,more,3,8787328
,articles,1,8787328
,wealth,1,8787328
,information,1,8787328
,clinicians,1,8787328
,public,1,8787328
,public health,1,8787328
,example,1,8787328
,marked,1,8787328
,regional,2,8787328
,regional differences,2,8787328
,differences,3,8787328
,coronary,3,8787328
,bed,1,8787328
,requirements,1,8787328
,mortality,1,8787328
,mortality rates,1,8787328
,women,1,8787328
,end,1,8787328
,men,1,8787328
,course,1,8787328
,risk,2,8787328
,risk factors,2,8787328
,factors,2,8787328
,levels,1,8787328
,different,1,8787328
,less,1,8787328
,aggressive,1,8787328
,approach,1,8787328
,primary,2,8787328
,primary prevention,1,8787328
,prevention,2,8787328
,presence,1,8787328
,study protocols,1,8787328
,protocols,1,8787328
,several,1,8787328
,examples,1,8787328
,techniques,1,8787328
,able,1,8787328
,aetiology,1,8787328
,coronary heart disease,1,8787328
,heart,1,8787328
,heart disease,1,8787328
,disease,2,8787328
,consequently,1,8787328
,reduction,1,8787328
,adequate,1,8787328
,secondary,1,8787328
,secondary prevention,1,8787328
,evidence,1,8778159
,thyroid,1,8778159
,damage,1,8778159
,amiodaroneinduced thyrotoxicosis,1,8778159
,thyrotoxicosis,1,8778159
,thyrotoxicosis,4,8778159
,patients,2,8778159
,chronic,1,8778159
,amiodarone,3,8778159
,treatment,4,8778159
,most,1,8778159
,cases,1,8778159
,pathogenesis,2,8778159
,iodine,3,8778159
,iodine overload,2,8778159
,presence,1,8778159
,thyroid,6,8778159
,abnormalities,1,8778159
,multinodular,1,8778159
,diffuse,1,8778159
,diffuse goiter,1,8778159
,goiter,1,8778159
,nodule,1,8778159
,minority,1,8778159
,apparently,2,8778159
,normal,2,8778159
,glands,2,8778159
,pictures,1,8778159
,thyroiditis,1,8778159
,recent,1,8778159
,evidence,2,8778159
,direct,1,8778159
,toxic,2,8778159
,toxic effect,1,8778159
,effect,1,8778159
,consequent,1,8778159
,release,1,8778159
,circulation,1,8778159
,patient,2,8778159
,amiodaroneinduced thyrotoxicosis,2,8778159
,thyroid effects,1,8778159
,effects,1,8778159
,electron,1,8778159
,electron microscopy,1,8778159
,microscopy,1,8778159
,fineneedle aspiration biopsy,1,8778159
,aspiration,1,8778159
,aspiration biopsy,1,8778159
,biopsy,1,8778159
,main,1,8778159
,pathologic,1,8778159
,pathologic findings,1,8778159
,findings,2,8778159
,lysosomal,3,8778159
,inclusions,1,8778159
,glycogen,1,8778159
,ultrastructural findings,1,8778159
,cell,2,8778159
,microscopic,1,8778159
,morphological,1,8778159
,pattern,1,8778159
,hyperfunction,1,8778159
,inflammatory,1,8778159
,inflammatory changes,1,8778159
,changes,2,8778159
,plasma,3,8778159
,plasma thyroglobulin levels,1,8778159
,thyroglobulin,3,8778159
,thyroglobulin levels,1,8778159
,levels,1,8778159
,high,1,8778159
,non,1,8778159
,simultaneous,1,8778159
,administration,1,8778159
,methimazole,2,8778159
,dose,2,8778159
,potassium,1,8778159
,potassium perchlorate,1,8778159
,perchlorate,1,8778159
,days,1,8778159
,still,1,8778159
,possible,1,8778159
,role,2,8778159
,dexamethasone,1,8778159
,months,1,8778159
,plasma thyroglobulin level,1,8778159
,thyroglobulin level,1,8778159
,level,1,8778159
,subsequent,2,8778159
,subclinical,1,8778159
,subclinical hypothyroidism,1,8778159
,hypothyroidism,2,8778159
,substitution,1,8778159
,levothyroxine,1,8778159
,view,1,8778159
,primary,1,8778159
,lysosome,1,8778159
,function,1,8778159
,proteolysis,1,8778159
,molecules,1,8778159
,transport,1,8778159
,monoiodotyrosine,1,8778159
,lysosomal membrane,1,8778159
,membrane,1,8778159
,salvage,1,8778159
,pathological,1,8778159
,mitochondrial,1,8778159
,marker,1,8778159
,observations,1,8778159
,usefulness,1,8778159
,evaluation,1,8778159
,serial,1,8778159
,determinations,1,8778159
,mechanisms,1,8778159
,thyroid glands,1,8778159
,more,1,8778159
,knowledge,1,8778159
,prognostic,1,8778159
,stratification,1,8778159
,guides,1,8778159
,survival,1,8775861
,acute,1,8775861
,acute intestinal infarction,1,8775861
,intestinal,1,8775861
,intestinal infarction,1,8775861
,infarction,1,8775861
,cardiac,1,8775861
,cardiac transplan,1,8775861
,transplan,1,8775861
,case,1,8775861
,male,1,8775861
,total,1,8775861
,orthotopic,1,8775861
,heart,1,8775861
,heart transplantation,1,8775861
,transplantation,1,8775861
,ischemic,1,8775861
,ischemic cardiomyopathy,1,8775861
,cardiomyopathy,1,8775861
,postoperative,1,8775861
,course,1,8775861
,acute,2,8775861
,acute intestinal infarction,1,8775861
,intestinal,1,8775861
,intestinal infarction,1,8775861
,infarction,1,8775861
,surgical,2,8775861
,surgical exploration,1,8775861
,exploration,1,8775861
,subtotal,1,8775861
,subtotal colectomy,1,8775861
,colectomy,1,8775861
,brooke ileostomy,1,8775861
,ileostomy,1,8775861
,closure,1,8775861
,distal,1,8775861
,sigmoid,1,8775861
,days,1,8775861
,patient,1,8775861
,nutritional,1,8775861
,nutritional support,1,8775861
,support,1,8775861
,broad,1,8775861
,antibiotic,1,8775861
,antibiotic prophylaxis,1,8775861
,prophylaxis,1,8775861
,review,1,8775861
,literature,1,8775861
,abdominal,1,8775861
,complications,2,8775861
,operations,1,8775861
,cardiopulmonary,1,8775861
,cardiopulmonary bypass,1,8775861
,bypass,1,8775861
,usually,1,8775861
,fatal,1,8775861
,detection,1,8775861
,diagnosis,1,8775861
,treatment,1,8775861
,immunosuppression,1,8775861
,cardiac,1,8775861
,cardiac transplan,1,8775861
,transplan,1,8775861
,poor,1,8775861
,poor prognosis,1,8775861
,prognosis,1,8775861
,management,1,8775861
,high,1,8775861
,level,1,8775861
,suspicion,1,8775861
,early,1,8775861
,aggressive,1,8775861
,diagnostic,1,8775861
,measures,1,8775861
,swift,1,8775861
,surgical intervention,1,8775861
,intervention,1,8775861
,essential,1,8775861
,survival,1,8775861
,years,1,8775860
,experience,1,8775860
,centrifugal,1,8775860
,centrifugal pump,1,8775860
,pump,1,8775860
,patients,1,8775860
,cardiogenic,1,8775860
,cardiogenic shock,1,8775860
,shock,1,8775860
,september,1,8775860
,patients,7,8775860
,years,1,8775860
,age,1,8775860
,mechanical,1,8775860
,mechanical circulatory support,1,8775860
,circulatory,1,8775860
,support,2,8775860
,means,1,8775860
,centrifugal,1,8775860
,centrifugal pump,1,8775860
,pump,1,8775860
,groups,4,8775860
,indication,1,8775860
,group,8,8775860
,early,2,8775860
,cardiogenic,5,8775860
,cardiogenic shock,5,8775860
,shock,5,8775860
,late,2,8775860
,group ii,2,8775860
,acute,2,8775860
,acute myocardial infarction,1,8775860
,myocardial,1,8775860
,myocardial infarction,1,8775860
,infarction,1,8775860
,other,1,8775860
,etiologies,1,8775860
,duration,1,8775860
,hours,1,8775860
,survival,1,8775860
,survival rates,1,8775860
,iii,4,8775860
,most,1,8775860
,frequent,1,8775860
,complications,1,8775860
,acute renal failure,1,8775860
,renal,1,8775860
,renal failure,1,8775860
,failure,4,8775860
,multiple,3,8775860
,multiple organ failure,3,8775860
,organ,3,8775860
,organ failure,3,8775860
,major,1,8775860
,causes,1,8775860
,death,1,8775860
,comparison,1,8775856
,early,1,8775856
,results,1,8775856
,coronary,1,8775856
,coronary artery,1,8775856
,coronary artery bypass,1,8775856
,artery,1,8775856
,bypass,1,8775856
,extracorporeal,1,8775856
,extracorporeal circulation,1,8775856
,circulation,1,8775856
,safety,1,8775856
,efficacy,1,8775856
,coronary,2,8775856
,coronary artery,2,8775856
,coronary artery bypass,2,8775856
,artery,2,8775856
,bypass,4,8775856
,extracorporeal,1,8775856
,extracorporeal circulation,1,8775856
,circulation,1,8775856
,standard,2,8775856
,cardiopulmonary,2,8775856
,cardiopulmonary bypass,2,8775856
,technique,3,8775856
,certain,1,8775856
,early,1,8775856
,postoperative,1,8775856
,criteria,1,8775856
,randomized,1,8775856
,prospective,1,8775856
,prospective study,1,8775856
,study,1,8775856
,similar,2,8775856
,groups,3,8775856
,patients,2,8775856
,hemodynamic,1,8775856
,data,1,8775856
,cardiac,2,8775856
,cardiac index,1,8775856
,index,1,8775856
,systemic,1,8775856
,systemic vascular resistance,1,8775856
,vascular,1,8775856
,vascular resistance,1,8775856
,resistance,1,8775856
,mechanical,2,8775856
,support,2,8775856
,needs,1,8775856
,enzyme,1,8775856
,enzyme levels,1,8775856
,levels,1,8775856
,sgot,1,8775856
,well,1,8775856
,mortality,2,8775856
,perioperative,2,8775856
,infarction,2,8775856
,rate,1,8775856
,homologous,2,8775856
,transfusion,2,8775856
,requirements,2,8775856
,first,1,8775856
,ups,1,8775856
,myocardial,1,8775856
,myocardial infarction,1,8775856
,group,2,8775856
,blood,1,8775856
,consumption,1,8775856
,percentages,1,8775856
,greater,1,8775856
,results,1,8775856
,cases,1,8775856
,offpump coronary artery bypass,1,8775856
,offpump coronary artery bypass surgery,1,8775856
,coronary artery bypass surgery,1,8775856
,bypass surgery,1,8775856
,surgery,1,8775856
,efficient,1,8775856
,cannulation,1,8775856
,hypothermia,1,8775856
,properties,1,8775856
,place,1,8775856
,cardiac surgeons,1,8775856
,surgeons,1,8775856
,cardiac,1,8775548
,sequelae,1,8775548
,kawasaki,1,8775548
,kawasaki disease,1,8775548
,disease,1,8775548
,japan,1,8775548
,years,1,8775548
,secular,1,8775548
,secular trend,1,8775548
,trend,1,8775548
,proportion,3,8775548
,kawasaki,3,8775548
,kawasaki disease,3,8775548
,disease,4,8775548
,patients,5,8775548
,cardiac,4,8775548
,sequelae,4,8775548
,japan,1,8775548
,surveys,2,8775548
,years,4,8775548
,july,1,8775548
,dilatation,1,8775548
,stenosis,1,8775548
,coronary,1,8775548
,coronary arteries,1,8775548
,arteries,1,8775548
,myocardial,1,8775548
,myocardial infarction,1,8775548
,infarction,1,8775548
,lesions,1,8775548
,month,1,8775548
,more,1,8775548
,onset,1,8775548
,percentage,2,8775548
,high,1,8775548
,males,1,8775548
,infants,1,8775548
,year,1,8775548
,children,3,8775548
,age,3,8775548
,overall,1,8775548
,prevalence,1,8775548
,observed,1,8775548
,period,1,8775548
,not,2,8775548
,intravenous,2,8775548
,intravenous gamma globulin,2,8775548
,gamma,2,8775548
,gamma globulin,2,8775548
,globulin,2,8775548
,untreated,1,8775548
,consequence,1,8775548
,increased,1,8775548
,number,1,8775548
,annually,1,8775548
,ecg,1,8771133
,criteria,1,8771133
,supraventricular tachycardia,1,8771133
,tachycardia,2,8771133
,ventricular,1,8771133
,ventricular tachycardia,1,8771133
,aspects,1,8771133
,immediate,1,8771133
,care,1,8771133
,setting,1,8771133
,ecg,4,8771133
,criteria,8,8771133
,supraventricular tachycardia,1,8771133
,tachycardia,2,8771133
,aberrant,2,8771133
,conduction,2,8771133
,ventricular,1,8771133
,ventricular tachycardia,1,8771133
,wide,2,8771133
,wide qrs tachycardias,2,8771133
,tachycardias,4,8771133
,patients,1,8771133
,invasive,1,8771133
,study,1,8771133
,surface,1,8771133
,standard,2,8771133
,mcl,1,8771133
,leads,2,8771133
,correct,1,8771133
,diagnosis,3,8771133
,studies,1,8771133
,morphology,2,8771133
,highly,2,8771133
,specific,2,8771133
,svt,2,8771133
,specificity,1,8771133
,morphological,3,8771133
,analysis,1,8771133
,immediate,1,8771133
,care,1,8771133
,setting,1,8771133
,results,1,8771133
,useful,1,8771133
,not,3,8771133
,lead,4,8771133
,different,1,8771133
,cases,1,8771133
,inferior,1,8771133
,most,1,8771133
,established,1,8771133
,very,1,8771133
,sensitive,1,8771133
,individual,1,8771133
,width,2,8771133
,seconds,1,8771133
,monophasic,1,8771133
,wave,1,8771133
,pattern,1,8771133
,conclusions,1,8771133
,differentiation,1,8771133
,often,1,8771133
,certain,1,8771133
,multiple,1,8771133
,accurate,1,8771133
,assessment,1,8771133
,presence,1,8771133
,av dissociation,1,8771133
,dissociation,1,8771133
,block,1,8771133
,qrs axis,1,8771133
,axis,1,8771133
,use,1,8771133
,predictive,1,8771132
,accuracy,1,8771132
,spectral,1,8771132
,analysis,2,8771132
,monomorphic ventricular tachycardia,1,8771132
,ventricular,1,8771132
,ventricular tachycardia,1,8771132
,tachycardia,1,8771132
,postinfarction,1,8771132
,patients,1,8771132
,conduction,1,8771132
,conduction defects,1,8771132
,defects,1,8771132
,electrocardiograms,1,8771132
,postinfarction,1,8771132
,patients,3,8771132
,right,1,8771132
,right bundle branch,1,8771132
,right bundle branch block,1,8771132
,bundle branch,2,8771132
,bundle branch block,2,8771132
,branch,2,8771132
,block,2,8771132
,bbb,2,8771132
,intraventricular,1,8771132
,intraventricular conduction,1,8771132
,intraventricular conduction defect,1,8771132
,conduction,2,8771132
,conduction defect,1,8771132
,defect,1,8771132
,analysis,2,8771132
,spectral,2,8771132
,approach,1,8771132
,more,5,8771132
,effective,2,8771132
,marker,1,8771132
,sustained,1,8771132
,monomorphic ventricular tachycardia,1,8771132
,ventricular,1,8771132
,ventricular tachycardia,1,8771132
,tachycardia,1,8771132
,parameter,1,8771132
,root,1,8771132
,square,1,8771132
,value,1,8771132
,last,1,8771132
,complex,1,8771132
,duration,1,8771132
,low,2,8771132
,low amplitude signal,1,8771132
,amplitude,1,8771132
,signal,1,8771132
,summation,1,8771132
,lead,1,8771132
,parameters,1,8771132
,correlation,3,8771132
,standard,1,8771132
,standard deviation,1,8771132
,deviation,1,8771132
,slice,1,8771132
,ratio,1,8771132
,entropy,1,8771132
,filters,1,8771132
,study,1,8771132
,total,1,8771132
,total patient population,1,8771132
,patient,1,8771132
,population,1,8771132
,noise,5,8771132
,noise levels,4,8771132
,levels,4,8771132
,subset,1,8771132
,techniques,1,8771132
,effectiveness,1,8771132
,positive,1,8771132
,positive predictive values,1,8771132
,predictive,2,8771132
,predictive values,2,8771132
,values,2,8771132
,ppv,2,8771132
,negative,1,8771132
,negative predictive values,1,8771132
,sensitivity,1,8771132
,specificity,1,8771132
,rbbb,1,8771132
,tool,1,8771132
,filter,1,8771132
,lbbb,1,8771132
,consistently,1,8771132
,isolated,1,8771132
,exceptions,1,8771132
,conduction defects,1,8771132
,defects,1,8771132
,equal,1,8771132
,exception,1,8771132
,noise level,1,8771132
,level,1,8771132
,addition,1,8771132
,ejection,1,8771132
,ejection fraction,1,8771132
,fraction,1,8771132
,data,1,8771132
,score,1,8771132
,further,1,8771132
,overall,1,8771132
,improvement,1,8771132
,performance,1,8771132
,conclusions,1,8771132
,unchanged,1,8771132
,assessment,1,8770336
,coronary,1,8770336
,coronary artery,1,8770336
,coronary artery disease,1,8770336
,artery,1,8770336
,artery disease,1,8770336
,disease,1,8770336
,dobutamine,1,8770336
,dobutamine stress echocardiography,1,8770336
,stress,1,8770336
,stress echocardiography,1,8770336
,echocardiography,1,8770336
,background,1,8770336
,stress,2,8770336
,stress echocardiography,1,8770336
,echocardiography,2,8770336
,new,1,8770336
,noninvasive,1,8770336
,imaging,1,8770336
,imaging modality,1,8770336
,modality,1,8770336
,twodimensional echocardiography,1,8770336
,cardiovascular,1,8770336
,dobutamine,1,8770336
,infusion,1,8770336
,use,1,8770336
,patients,9,8770336
,suspected,1,8770336
,coronary,3,8770336
,coronary artery,1,8770336
,coronary artery disease,1,8770336
,artery,1,8770336
,artery disease,1,8770336
,disease,1,8770336
,cad,3,8770336
,currently,1,8770336
,extensive,1,8770336
,investigation,1,8770336
,aims,1,8770336
,clinical,1,8770336
,utility,1,8770336
,safety,1,8770336
,diagnostic,1,8770336
,value,1,8770336
,methods,1,8770336
,consecutive,1,8770336
,coronary angiography,2,8770336
,angiography,2,8770336
,results,1,8770336
,eleven,1,8770336
,not,1,8770336
,poor,1,8770336
,image,1,8770336
,image quality,1,8770336
,quality,1,8770336
,target,1,8770336
,target heart rate,1,8770336
,heart,1,8770336
,heart rate,1,8770336
,rate,1,8770336
,end,1,8770336
,end point,1,8770336
,point,1,8770336
,side,1,8770336
,side effects,1,8770336
,effects,1,8770336
,none,1,8770336
,premature,1,8770336
,termination,1,8770336
,procedure,1,8770336
,cardiac,2,8770336
,cardiac arrhythmias,1,8770336
,arrhythmias,1,8770336
,only,1,8770336
,intervention,1,8770336
,sensitivity,1,8770336
,specificity,1,8770336
,presence,1,8770336
,significant,2,8770336
,uncomplicated,1,8770336
,myocardial,1,8770336
,myocardial infarction,1,8770336
,infarction,2,8770336
,positive,1,8770336
,negative,1,8770336
,negative predictive values,1,8770336
,predictive,1,8770336
,predictive values,1,8770336
,values,1,8770336
,cardiac events,1,8770336
,events,1,8770336
,followup,1,8770336
,period,1,8770336
,conclusions,1,8770336
,well,1,8770336
,useful,2,8770336
,test,1,8770336
,postinfarctional,1,8770336
,prognostic,1,8770336
,information,1,8770336
,directional coronary atherectomy,1,8770330
,coronary,1,8770330
,coronary atherectomy,1,8770330
,atherectomy,1,8770330
,lesions,1,8770330
,proximal,1,8770330
,anterior,1,8770330
,descending,1,8770330
,artery,1,8770330
,initial,1,8770330
,clinical,1,8770330
,results,1,8770330
,complications,1,8770330
,histopathological,1,8770330
,findings,1,8770330
,background,1,8770330
,directional coronary atherectomy,2,8770330
,coronary,6,8770330
,coronary atherectomy,3,8770330
,atherectomy,4,8770330
,percutaneous,2,8770330
,percutaneous technique,1,8770330
,technique,1,8770330
,role,1,8770330
,balloon,2,8770330
,balloon angioplasty,2,8770330
,angioplasty,3,8770330
,eccentric,1,8770330
,coronary lesions,1,8770330
,lesions,6,8770330
,aims,1,8770330
,early,1,8770330
,early experience,1,8770330
,experience,1,8770330
,clinical,1,8770330
,results,2,8770330
,complications,3,8770330
,histopathological,1,8770330
,findings,1,8770330
,proximal,4,8770330
,left,1,8770330
,left anterior,1,8770330
,anterior,1,8770330
,artery,4,8770330
,lad,5,8770330
,ste,1,8770330
,methods,1,8770330
,study,2,8770330
,patients,6,8770330
,directional atherectomy,1,8770330
,proximal lad artery,2,8770330
,atherectomy device,1,8770330
,device,1,8770330
,procedures,1,8770330
,stenosis,3,8770330
,males,1,8770330
,females,1,8770330
,mean,5,8770330
,age,1,8770330
,years,1,8770330
,stable,1,8770330
,stable angina,1,8770330
,angina,1,8770330
,unstable,1,8770330
,ang,1,8770330
,previous,1,8770330
,previous myocardial infarction,1,8770330
,myocardial,1,8770330
,myocardial infarction,1,8770330
,infarction,1,8770330
,angiographic,2,8770330
,success,1,8770330
,lesion,1,8770330
,length,1,8770330
,diameter,6,8770330
,minimal,2,8770330
,luminal,3,8770330
,percentage,2,8770330
,acute,2,8770330
,occlusion,1,8770330
,patient,3,8770330
,local,1,8770330
,vascular,1,8770330
,vascular complications,1,8770330
,loss,1,8770330
,histology,1,8770330
,fibrous,1,8770330
,cap,1,8770330
,atherosclerotic,1,8770330
,atherosclerotic plaque,1,8770330
,plaque,1,8770330
,media,1,8770330
,internal,1,8770330
,internal elastic lamina,1,8770330
,elastic,1,8770330
,lamina,1,8770330
,intimal,1,8770330
,intimal hyperplasia,1,8770330
,hyperplasia,1,8770330
,native,1,8770330
,restenosis,2,8770330
,followup,1,8770330
,conclusion,1,8770330
,initial,1,8770330
,effective,1,8770330
,procedure,1,8770330
,treatment,1,8770330
,large,2,8770330
,appearance,1,8770330
,coronary angioplasty,1,8770330
,complication,1,8770330
,low,1,8770330
,transluminal,1,8770330
,coronary balloon angioplasty,1,8770330
,therapy,1,8750250
,secondary,1,8750250
,secondary prevention,1,8750250
,prevention,1,8750250
,coronary,1,8750250
,coronary heart disease,1,8750250
,heart,1,8750250
,heart disease,1,8750250
,disease,1,8750250
,scandinavian,1,8750250
,simvastatin,2,8750250
,survival,2,8750250
,study,1,8750250
,decrease,1,8750250
,reduction,1,8750250
,coronary,3,8750250
,mortality,1,8750250
,period,1,8750250
,time,1,8750250
,year,1,8750250
,divergence,1,8750250
,placebo,1,8750250
,groups,1,8750250
,reasons,1,8750250
,effect,2,8750250
,lipid,1,8750250
,rapid,1,8750250
,stabilization,1,8750250
,coronary lesions,1,8750250
,lesions,1,8750250
,effects,1,8750250
,endothelium,1,8750250
,studies,1,8750250
,acute,1,8750250
,stage,1,8750250
,coronary heart disease,1,8750250
,heart,1,8750250
,heart disease,1,8750250
,disease,1,8750250
,occupational,1,8749740
,mortality,1,8749740
,firefighters,1,8749740
,association,1,8749740
,occupational,2,8749740
,occupational exposure,1,8749740
,exposure,2,8749740
,variety,1,8749740
,toxic,1,8749740
,fire,2,8749740
,fire fighters,2,8749740
,risk,15,8749740
,number,1,8749740
,diseases,1,8749740
,current,1,8749740
,literature,1,8749740
,disease,4,8749740
,disease risk,1,8749740
,findings,1,8749740
,magnitude,4,8749740
,standard,1,8749740
,mortality,1,8749740
,ratio,1,8749740
,equal,1,8749740
,attributable,1,8749740
,attributable risk,1,8749740
,sufficient,3,8749740
,most,1,8749740
,workers,1,8749740
,workers compensation,1,8749740
,compensation,1,8749740
,systems,1,8749740
,risks,1,8749740
,approach,2,8749740
,smr,1,8749740
,equivalent,1,8749740
,risk estimate,1,8749740
,estimate,1,8749740
,mind,1,8749740
,confidence,1,8749740
,confidence intervals,1,8749740
,intervals,1,8749740
,estimates,1,8749740
,wide,1,8749740
,criteria,1,8749740
,conclusions,1,8749740
,respect,1,8749740
,general,7,8749740
,lung,4,8749740
,lung cancer,1,8749740
,cancer,4,8749740
,evidence,7,8749740
,association,7,8749740
,not,3,8749740
,cardiovascular,1,8749740
,death,2,8749740
,overall,1,8749740
,heart,3,8749740
,heart disease,1,8749740
,sudden,1,8749740
,sudden death,1,8749740
,myocardial,1,8749740
,myocardial infarction,1,8749740
,infarction,1,8749740
,fatal,1,8749740
,arrhythmia,1,8749740
,stress,1,8749740
,job,1,8749740
,likely,1,8749740
,heart attacks,1,8749740
,attacks,1,8749740
,work,2,8749740
,aortic,1,8749740
,aortic aneurysm,1,8749740
,aneurysm,1,8749740
,incomplete,2,8749740
,probably,1,8749740
,compatible,1,8749740
,cancers,1,8749740
,genitourinary,1,8749740
,genitourinary tract,1,8749740
,tract,1,8749740
,kidney,1,8749740
,ureter,1,8749740
,bladder,1,8749740
,strong,1,8749740
,brain,1,8749740
,possible,1,8749740
,consistent,1,8749740
,lymphatic,1,8749740
,hematopoietic,1,8749740
,hematopoietic tissue,1,8749740
,tissue,1,8749740
,group,1,8749740
,aggregation,1,8749740
,colon,1,8749740
,rectum,1,8749740
,lung disease,2,8749740
,unusual,1,8749740
,exposures,1,8749740
,fumes,1,8749740
,plastics,1,8749740
,severe,1,8749740
,toxicity,1,8749740
,permanent,1,8749740
,disability,1,8749740
,lifetime risk,1,8749740
,chronic,1,8749740
,chronic lung disease,1,8749740
,high,1,8748390
,high dose,1,8748390
,dose,1,8748390
,transdermal,1,8748390
,nicotine,2,8748390
,therapy,1,8748390
,heavy,1,8748390
,heavy smokers,1,8748390
,smokers,1,8748390
,safety,1,8748390
,tolerability,1,8748390
,measurement,1,8748390
,cotinine,1,8748390
,levels,1,8748390
,transdermal,2,8748390
,nicotine,13,8748390
,nicotine withdrawal,1,8748390
,withdrawal,1,8748390
,smoking,8,8748390
,smoking cessation,4,8748390
,cessation,4,8748390
,clinical,1,8748390
,clinical trials,1,8748390
,dose,2,8748390
,steady,2,8748390
,steady state,2,8748390
,state,2,8748390
,serum,2,8748390
,less,1,8748390
,information,1,8748390
,available,1,8748390
,nicotine patch,4,8748390
,patch,9,8748390
,doses,1,8748390
,better,1,8748390
,optimal,1,8748390
,therapy,6,8748390
,study,1,8748390
,safety,1,8748390
,tolerability,1,8748390
,subjects,4,8748390
,cigarettes,2,8748390
,day,1,8748390
,forty,1,8748390
,smokers,2,8748390
,weeks,5,8748390
,entire,1,8748390
,nonsmokers,3,8748390
,week,4,8748390
,mean,1,8748390
,nicotine level,1,8748390
,level,3,8748390
,cotinine,3,8748390
,percent,2,8748390
,replacement,5,8748390
,state level,1,8748390
,baseline,1,8748390
,usual,1,8748390
,number,1,8748390
,nicotine replacement,2,8748390
,biochemically,1,8748390
,point,1,8748390
,prevalence,1,8748390
,months,1,8748390
,most,1,8748390
,common,1,8748390
,effect,1,8748390
,skin,1,8748390
,skin irritation,1,8748390
,irritation,1,8748390
,site,1,8748390
,single,1,8748390
,subject,2,8748390
,myocardial,1,8748390
,myocardial infarction,1,8748390
,infarction,1,8748390
,not,2,8748390
,adverse event,1,8748390
,event,1,8748390
,complaints,2,8748390
,phase,1,8748390
,other,1,8748390
,infrequent,1,8748390
,24h,1,8748390
,heavy,1,8748390
,heavy smokers,1,8748390
,significant,1,8748390
,adverse events,1,8748390
,events,1,8748390
,hydrogen,1,8746221
,hydrogen peroxide,1,8746221
,peroxide,1,8746221
,protective agent,1,8746221
,agent,1,8746221
,reperfusion,1,8746221
,study,1,8746221
,isolated,1,8746221
,rabbit,1,8746221
,heart,1,8746221
,regional,1,8746221
,ischemia,1,8746221
,extensive,1,8746221
,research,1,8746221
,last,1,8746221
,decade,1,8746221
,not,2,8746221
,possible,1,8746221
,endogenously,1,8746221
,hydrogen,4,8746221
,hydrogen peroxide,3,8746221
,peroxide,3,8746221
,oxygen,1,8746221
,species,1,8746221
,sufficient,1,8746221
,concentration,1,8746221
,reperfusion,9,8746221
,myocardial,1,8746221
,myocardial ischemia,1,8746221
,ischemia,2,8746221
,significantly,1,8746221
,cell,2,8746221
,cell injury,1,8746221
,injury,1,8746221
,attempt,1,8746221
,further,1,8746221
,test,1,8746221
,hypothesis,1,8746221
,rabbit,1,8746221
,hearts,1,8746221
,min,5,8746221
,regional,1,8746221
,low,1,8746221
,levels,1,8746221
,catalase,5,8746221
,first,1,8746221
,total,1,8746221
,different,1,8746221
,groups,1,8746221
,controls,1,8746221
,microm,6,8746221
,alone,2,8746221
,initial,1,8746221
,part,1,8746221
,end,1,8746221
,area,1,8746221
,risk,2,8746221
,fluorescent,1,8746221
,particles,1,8746221
,infarct,2,8746221
,zone,2,8746221
,size,2,8746221
,tetrazolium,1,8746221
,staining,1,8746221
,results,1,8746221
,control,1,8746221
,control group,1,8746221
,group,3,8746221
,reduction,2,8746221
,not present,1,8746221
,present,2,8746221
,solution,1,8746221
,infarction,2,8746221
,heart,1,8746221
,amount,1,8746221
,cell death,1,8746221
,death,1,8746221
,study,1,8746221
,delay,1,8746221
,only,1,8746221
,treatment,1,8746221
,period,1,8746221
,mechanism,1,8746221
,protection,1,8746221
,endocardial,1,8746219
,epicardial,1,8746219
,infarct,1,8746219
,size,1,8746219
,partial,1,8746219
,coronary,1,8746219
,coronary artery,1,8746219
,coronary artery occlusion,1,8746219
,artery,1,8746219
,artery occlusion,1,8746219
,occlusion,1,8746219
,reperfusion,1,8746219
,degree,1,8746219
,duration,1,8746219
,flow,1,8746219
,reduction,1,8746219
,objective,1,8746219
,recently,1,8746219
,partial,2,8746219
,coronary,6,8746219
,coronary artery,4,8746219
,coronary artery occlusion,3,8746219
,artery,4,8746219
,artery occlusion,3,8746219
,occlusion,3,8746219
,immediately,3,8746219
,infarct,3,8746219
,size,2,8746219
,now,1,8746219
,protection,3,8746219
,coronary artery occlusions,1,8746219
,artery occlusions,1,8746219
,occlusions,1,8746219
,severity,1,8746219
,duration,2,8746219
,flow,4,8746219
,reduction,3,8746219
,different,2,8746219
,myocardial,3,8746219
,layers,2,8746219
,methods,1,8746219
,pigs,2,8746219
,groups,2,8746219
,ventricular,1,8746219
,area,2,8746219
,risk,1,8746219
,endocardial,3,8746219
,epicardial,5,8746219
,results,1,8746219
,control,2,8746219
,control animals,1,8746219
,animals,2,8746219
,total,1,8746219
,min,11,8746219
,reperfusion,2,8746219
,rep,4,8746219
,highly,2,8746219
,linear,1,8746219
,relations,1,8746219
,endocardium,3,8746219
,epicardium,4,8746219
,prior,2,8746219
,less,1,8746219
,slopes,1,8746219
,blood,1,8746219
,blood flow,1,8746219
,same,1,8746219
,degree,1,8746219
,endo,2,8746219
,half,2,8746219
,not,3,8746219
,most,1,8746219
,most likely,1,8746219
,likely,1,8746219
,infarction,3,8746219
,more,1,8746219
,severe,2,8746219
,control group,1,8746219
,group,1,8746219
,mild,2,8746219
,damage,1,8746219
,conclusions,1,8746219
,thirty,1,8746219
,reductions,1,8746219
,myocardial infarction,1,8746219
,limited,1,8746219
,findings,1,8746219
,perfusion,1,8746219
,abnormalities,1,8746219
,source,1,8746219
,variability,1,8746219
,patients,1,8746219
,pathway,1,8746214
,gene,1,8746214
,gene regulation,1,8746214
,regulation,1,8746214
,hyp,1,8746214
,objectives,2,8746214
,endothelin1,1,8746214
,vasoconstrictor,1,8746214
,endothelial,4,8746214
,endothelial cells,2,8746214
,cells,5,8746214
,many,1,8746214
,other,2,8746214
,other cells,1,8746214
,tissues,1,8746214
,plasma,1,8746214
,levels,2,8746214
,peptide,1,8746214
,ischemic,1,8746214
,ischemic heart disease,1,8746214
,heart,1,8746214
,heart disease,1,8746214
,disease,1,8746214
,atherosclerosis,1,8746214
,myocardial,1,8746214
,myocardial infarction,1,8746214
,infarction,1,8746214
,current,1,8746214
,study,1,8746214
,tissue,1,8746214
,tissue specificity,1,8746214
,specificity,1,8746214
,induction,6,8746214
,gene,3,8746214
,hyp,2,8746214
,hypoxia,6,8746214
,regulatory,2,8746214
,regulatory pathway,1,8746214
,pathway,3,8746214
,same,1,8746214
,genes,1,8746214
,contributions,1,8746214
,protein,9,8746214
,protein kinases,1,8746214
,kinases,1,8746214
,basal,3,8746214
,induced,2,8746214
,expression,3,8746214
,methods,1,8746214
,transcript,1,8746214
,northern,1,8746214
,northern blot,1,8746214
,quantitative,1,8746214
,polymerase,1,8746214
,polymerase chain reaction,1,8746214
,chain,1,8746214
,reaction,1,8746214
,exposure,1,8746214
,steps,2,8746214
,aerobic,1,8746214
,hypoxic,2,8746214
,cultures,1,8746214
,cycloheximide,2,8746214
,pma,1,8746214
,series,1,8746214
,protein kinase,5,8746214
,protein kinase inhibitors,1,8746214
,kinase,7,8746214
,kinase inhibitors,1,8746214
,inhibitors,3,8746214
,transition,2,8746214
,transition metals,2,8746214
,metals,2,8746214
,effects,1,8746214
,transcripts,1,8746214
,inducible,1,8746214
,pyruvate,1,8746214
,pyruvate kinase,1,8746214
,results,1,8746214
,vitro,1,8746214
,early,1,8746214
,passage,1,8746214
,treatment,2,8746214
,protein synthesis,2,8746214
,protein synthesis inhibitor,1,8746214
,synthesis,2,8746214
,inhibitor,1,8746214
,not,1,8746214
,calciumcalmodulin dependent protein kinase,1,8746214
,dependent,2,8746214
,cyclic,1,8746214
,cyclic gmp,1,8746214
,cyclic gmp dependent protein kinase,1,8746214
,gmp,1,8746214
,tyrosine,2,8746214
,conclusions,1,8746214
,new,1,8746214
,haeme,1,8746214
,oxygen,1,8746214
,protein tyrosine kinase,1,8746214
,tyrosine kinase,1,8746214
,step,1,8746214
,well,1,8746210
,application,1,8746210
,exchange,1,8746210
,inhibitor,1,8746210
,infarct,1,8746210
,size,1,8746210
,pigs,1,8746210
,background,1,8746210
,reperfusion,5,8746210
,ischaemic,2,8746210
,myocardium,2,8746210
,exchange,5,8746210
,promotes,1,8746210
,recovery,1,8746210
,acidosis,1,8746210
,intracellular,1,8746210
,cell,2,8746210
,necrosis,2,8746210
,reperfusion injury,2,8746210
,injury,2,8746210
,methods,1,8746210
,results,1,8746210
,specific,1,8746210
,inhibitor,1,8746210
,able,2,8746210
,infarct,6,8746210
,size,5,8746210
,swine,1,8746210
,experiments,1,8746210
,pigs,1,8746210
,min,4,8746210
,occlusion,4,8746210
,left,1,8746210
,left anterior,1,8746210
,left anterior descending coronary artery,1,8746210
,anterior,1,8746210
,anterior descending coronary artery,1,8746210
,descending,1,8746210
,coronary,1,8746210
,coronary artery,1,8746210
,artery,1,8746210
,groups,1,8746210
,animals,2,8746210
,group,6,8746210
,infusion,2,8746210
,end,2,8746210
,onset,2,8746210
,ischaemia,4,8746210
,control,2,8746210
,control group,2,8746210
,vehicle,1,8746210
,alone,1,8746210
,protocol,1,8746210
,ventricular,1,8746210
,risk,1,8746210
,region,1,8746210
,tetrazolium,1,8746210
,method,1,8746210
,treatment,2,8746210
,prior,1,8746210
,significantly,2,8746210
,more,2,8746210
,conclusion,1,8746210
,significant,1,8746210
,reduction,1,8746210
,inhibition,1,8746210
,role,1,8746210
,pathogenesis,1,8746210
,evidence,1,8746210
,effective,1,8746210
,additional,1,8746210
,effect,1,8746210
,due,1,8746210
,down,1,8746210
,cycle,1,8746210
,atp,1,8746210
,dietary,1,8746207
,dietary magnesium,1,8746207
,magnesium,1,8746207
,magnesium deficiency,1,8746207
,deficiency,1,8746207
,increases,1,8746207
,alpha,1,8746207
,levels,1,8746207
,rat,1,8746207
,rat heart,1,8746207
,heart,1,8746207
,myocardial,1,8746207
,myocardial infarction,1,8746207
,infarction,1,8746207
,objective,1,8746207
,magnesium,1,8746207
,function,4,8746207
,proteins,2,8746207
,roles,1,8746207
,effects,1,8746207
,beta,1,8746207
,beta adrenergic agonists,1,8746207
,adrenergic,1,8746207
,adrenergic agonists,1,8746207
,agonists,1,8746207
,heart,4,8746207
,heart failure,1,8746207
,failure,1,8746207
,study,1,8746207
,not,5,8746207
,dietary,3,8746207
,deficiency,9,8746207
,functional,1,8746207
,activity,2,8746207
,levels,2,8746207
,major,1,8746207
,ventricular,1,8746207
,alpha,6,8746207
,myocardial,3,8746207
,myocardial infarction,1,8746207
,infarction,1,8746207
,methods,1,8746207
,week,2,8746207
,old,1,8746207
,rats,3,8746207
,adequate,2,8746207
,deficient,2,8746207
,diet,3,8746207
,weeks,2,8746207
,end,1,8746207
,coronary,1,8746207
,coronary artery,1,8746207
,artery,1,8746207
,artery ligation,1,8746207
,ligation,1,8746207
,sham,1,8746207
,operation,1,8746207
,control,1,8746207
,surgery,1,8746207
,animals,6,8746207
,diets,1,8746207
,then,1,8746207
,cardiac,2,8746207
,cardiac function,2,8746207
,plasma,3,8746207
,tissue,1,8746207
,results,1,8746207
,severe,1,8746207
,hypomagnesemia,1,8746207
,plasma catecholamine,1,8746207
,plasma catecholamine level,1,8746207
,catecholamine,1,8746207
,catecholamine level,1,8746207
,level,3,8746207
,significant,1,8746207
,reduction,1,8746207
,concentration,1,8746207
,elevated,1,8746207
,calcium,1,8746207
,concentrations,1,8746207
,further,1,8746207
,alone,3,8746207
,protein,1,8746207
,groups,1,8746207
,gppnhp,1,8746207
,adenylyl cyclase,1,8746207
,adenylyl cyclase activity,1,8746207
,cyclase activity,1,8746207
,slightly,1,8746207
,conclusion,1,8746207
,findings,1,8746207
,expression,1,8746207
,aspirin,1,8746200
,not,1,8746200
,effect,1,8746200
,suboptimal,1,8746200
,dose,1,8746200
,thrombin,1,8746200
,thrombin inhibitor,1,8746200
,inhibitor,1,8746200
,inogatran,1,8746200
,coronary,1,8746200
,coronary thrombolysis,1,8746200
,thrombolysis,1,8746200
,objectives,1,8746200
,coronary,4,8746200
,coronary artery,4,8746200
,artery,4,8746200
,often,2,8746200
,thrombolytic,1,8746200
,thrombolytic therapy,1,8746200
,therapy,1,8746200
,recombinant,2,8746200
,recombinant tissueplasminogen activator (r,2,8746200
,tissueplasminogen activator (r,2,8746200
,tpa,2,8746200
,reocclusion,4,8746200
,due,1,8746200
,platelet,1,8746200
,platelet activation,1,8746200
,activation,1,8746200
,thrombin,1,8746200
,aspirin,2,8746200
,inhibitors,1,8746200
,patients,1,8746200
,acute,1,8746200
,acute myocardial infarction,1,8746200
,myocardial,1,8746200
,myocardial infarction,1,8746200
,infarction,1,8746200
,study,1,8746200
,modulation,1,8746200
,coronary artery reocclusion,2,8746200
,novel,1,8746200
,low,3,8746200
,molecular,1,8746200
,molecular weight,1,8746200
,weight,1,8746200
,direct,2,8746200
,inhibitor,2,8746200
,inogatran,6,8746200
,methods,1,8746200
,dogs,8,8746200
,occlusive,1,8746200
,intracoronary,1,8746200
,thrombus,1,8746200
,saline,1,8746200
,group,8,8746200
,high,2,8746200
,high dose,2,8746200
,dose,4,8746200
,bolus,3,8746200
,low dose,2,8746200
,aspirin+,1,8746200
,min,6,8746200
,blood,2,8746200
,blood flow,2,8746200
,flow,2,8746200
,administration,1,8746200
,results,1,8746200
,reperfusion,2,8746200
,similar,2,8746200
,groups,4,8746200
,time,4,8746200
,shortest,1,8746200
,end,1,8746200
,infusion,1,8746200
,prothrombin,1,8746200
,prothrombin time,1,8746200
,partial,1,8746200
,aptt,2,8746200
,times,1,8746200
,control,1,8746200
,value,1,8746200
,changes,1,8746200
,generation,1,8746200
,activity,1,8746200
,rise,1,8746200
,complex,1,8746200
,levels,2,8746200
,fibrinogen,1,8746200
,fibrinogen levels,1,8746200
,most,1,8746200
,marked,1,8746200
,less,1,8746200
,conclusions,1,8746200
,data,1,8746200
,not,1,8746200
,effect,1,8746200
,suboptimal,1,8746200
,doses,1,8746200
,insulinlike growth factor,1,8746194
,growth,1,8746194
,growth factor,1,8746194
,factor,1,8746194
,binding,1,8746194
,binding proteins,1,8746194
,proteins,1,8746194
,cardiovascular,1,8746194
,cardiovascular system,1,8746194
,system,1,8746194
,large,1,8746194
,body,1,8746194
,evidence,2,8746194
,conclusively,1,8746194
,igf,13,8746194
,essential,1,8746194
,regulator,1,8746194
,developmental,1,8746194
,developmental growth,1,8746194
,growth,7,8746194
,mice,2,8746194
,null,2,8746194
,mutation,2,8746194
,ir gene,1,8746194
,gene,2,8746194
,birth,1,8746194
,high,1,8746194
,neonatal,1,8746194
,neonatal mortality,1,8746194
,mortality,1,8746194
,mortality rate,1,8746194
,rate,1,8746194
,marked,1,8746194
,growth retardation,1,8746194
,effects,3,8746194
,likely,1,8746194
,system,1,8746194
,role,3,8746194
,cardiovascular,4,8746194
,development,3,8746194
,potential,2,8746194
,pathophysiology,1,8746194
,interest,2,8746194
,last,1,8746194
,several,1,8746194
,years,1,8746194
,strong,1,8746194
,critical,1,8746194
,determinant,1,8746194
,vascular,3,8746194
,responses,4,8746194
,vitro,1,8746194
,vivo,1,8746194
,regulation,1,8746194
,availability,1,8746194
,control,2,8746194
,convergence,1,8746194
,point,1,8746194
,multiple,1,8746194
,growth factors,1,8746194
,factors,1,8746194
,clinical,3,8746194
,clinical studies,1,8746194
,studies,3,8746194
,hypertension,2,8746194
,extremely,1,8746194
,limited,1,8746194
,significant,2,8746194
,data,2,8746194
,animal,2,8746194
,animal studies,1,8746194
,now,2,8746194
,mediator,3,8746194
,animal data,1,8746194
,cardiac,1,8746194
,cardiac hypertrophic,1,8746194
,hypertrophic,1,8746194
,specific,1,8746194
,pharmacologic,1,8746194
,inhibitor,1,8746194
,rational,1,8746194
,clinical trials,1,8746194
,function,2,8746194
,areas,1,8746194
,great,1,8746194
,prevention,1,8746194
,restenosis,1,8746194
,atherosclerotic,1,8746194
,lesion,1,8746194
,progression,1,8746194
,complications,1,8746194
,hypertensive,1,8746194
,hypertensive vascular disease,1,8746194
,vascular disease,2,8746194
,disease,2,8746194
,use,2,8746194
,myocardial,1,8746194
,post,1,8746194
,infarction,1,8746194
,angiogenesis,1,8746194
,collateral,1,8746194
,artery,1,8746194
,formation,1,8746194
,setting,1,8746194
,peripheral,1,8746194
,peripheral vascular disease,1,8746194
,other,1,8746194
,directions,1,8746194
,future,1,8746194
,research,2,8746194
,healing,1,8746194
,recovery,1,8746194
,acute,1,8746194
,acute renal failure,1,8746194
,renal,1,8746194
,renal failure,1,8746194
,failure,1,8746194
,glucose,1,8746194
,glucose control,1,8746194
,currently,1,8746194
,investigation,1,8746194
,ongoing,1,8746194
,mechanisms,1,8746194
,receptor,1,8746194
,binding,1,8746194
,binding proteins,1,8746194
,proteins,1,8746194
,tissues,1,8746194
,rationale,1,8746194
,novel,1,8746194
,clinical research,1,8746194
,hemodynamic,1,8731859
,renal,1,8731859
,effects,1,8731859
,strong,1,8731859
,diuretic,1,8731859
,atrial,1,8731859
,atrial natriuretic peptide,1,8731859
,natriuretic,1,8731859
,natriuretic peptide,1,8731859
,peptide,1,8731859
,patients,1,8731859
,acute,1,8731859
,acute myocardial infarction,1,8731859
,myocardial,1,8731859
,myocardial infarction,1,8731859
,infarction,1,8731859
,hemodynamic,1,8731859
,renal,1,8731859
,effects,1,8731859
,strong,5,8731859
,diuretic,5,8731859
,atrial,2,8731859
,atrial natriuretic peptide,1,8731859
,natriuretic,1,8731859
,natriuretic peptide,1,8731859
,peptide,1,8731859
,patients,2,8731859
,acute,1,8731859
,acute myocardial infarction,1,8731859
,myocardial,1,8731859
,myocardial infarction,1,8731859
,infarction,1,8731859
,anp,4,8731859
,bolus,1,8731859
,injection,1,8731859
,micrograms,1,8731859
,continuous,1,8731859
,continuous infusion,1,8731859
,infusion,4,8731859
,minutes,1,8731859
,right,2,8731859
,right atrium,1,8731859
,atrium,1,8731859
,catheter,1,8731859
,increase,1,8731859
,cardiac,1,8731859
,cardiac index,1,8731859
,index,2,8731859
,volume,3,8731859
,right atrial pressure,1,8731859
,atrial pressure,1,8731859
,pressure,4,8731859
,pulmonary,3,8731859
,pulmonary arterial pressure,1,8731859
,arterial,2,8731859
,arterial pressure,1,8731859
,pulmonary capillary,1,8731859
,pulmonary capillary wedge pressure,1,8731859
,capillary,1,8731859
,wedge,1,8731859
,wedge pressure,1,8731859
,systemic,1,8731859
,systemic vascular resistance,1,8731859
,vascular,2,8731859
,vascular resistance,2,8731859
,resistance,2,8731859
,pulmonary vascular resistance,1,8731859
,maximal,1,8731859
,responses,1,8731859
,observed,1,8731859
,immediately,1,8731859
,significant,2,8731859
,change,1,8731859
,arterial blood,1,8731859
,arterial blood pressure,1,8731859
,blood,1,8731859
,blood pressure,1,8731859
,heart,1,8731859
,heart rate,1,8731859
,rate,1,8731859
,urine,1,8731859
,urine volume,1,8731859
,urinary,3,8731859
,sodium,1,8731859
,chloride,1,8731859
,potassium,1,8731859
,results,1,8731859
,changes,1,8731859
,hemodynamics,1,8731859
,development,1,8731859
,severe,1,8731859
,circulatory,1,8731859
,volume overload,1,8731859
,ami,1,8731859
,assessment,1,8731299
,myocardial,1,8731299
,functional,1,8731299
,reserve,1,8731299
,patients,1,8731299
,left,1,8731299
,left ventricular aneurysm,1,8731299
,ventricular,1,8731299
,ventricular aneurysm,1,8731299
,aneurysm,1,8731299
,radionuclide,1,8731299
,radionuclide ventriculography,1,8731299
,ventriculography,1,8731299
,response,1,8731299
,isotonic,1,8731299
,isotonic exercise,1,8731299
,exercise,1,8731299
,purpose,1,8731299
,global,3,8731299
,regional,3,8731299
,left,1,8731299
,ventricular,2,8731299
,ejection,1,8731299
,ejection fractions,1,8731299
,fractions,1,8731299
,radionuclide,3,8731299
,radionuclide ventriculography,3,8731299
,ventriculography,3,8731299
,patients,8,8731299
,aneurysm,3,8731299
,rest,3,8731299
,isotonic,1,8731299
,isotonic exercise,1,8731299
,exercise,5,8731299
,methods,1,8731299
,cineangiography,1,8731299
,post,1,8731299
,myocardial,1,8731299
,myocardial infarction,1,8731299
,infarction,1,8731299
,results,1,8731299
,groups,3,8731299
,other,2,8731299
,normal,3,8731299
,response,5,8731299
,values,2,8731299
,same,1,8731299
,behavior,1,8731299
,half,2,8731299
,abnormal,2,8731299
,changes,1,8731299
,not,1,8731299
,due,1,8731299
,lateral,1,8731299
,wall,1,8731299
,group,2,8731299
,stress,1,8731299
,conclusion,1,8731299
,evaluation,1,8731299
,better,1,8731299
,discriminates,1,8731299
,functional,1,8731299
,reserve,1,8731299
,findings,1,8731299
,decision,1,8731299
,therapeutic,1,8731299
,approach,1,8731299
,specific,1,8731299
,specific group,1,8731299
,role,1,8731298
,heparin,1,8731298
,unstable,1,8731298
,ang,1,8731298
,myocardial,1,8731298
,myocardial infarction,1,8731298
,infarction,1,8731298
,percutaneous,1,8731298
,percutaneous transluminal coronary angioplasty,1,8731298
,transluminal,1,8731298
,coronary,1,8731298
,coronary angioplasty,1,8731298
,angioplasty,1,8731298
,purpose,1,8731298
,clinical,2,8731298
,clinical efficacy,2,8731298
,efficacy,2,8731298
,safety,2,8731298
,subcutaneous,1,8731298
,low,1,8731298
,low molecular weight heparin,1,8731298
,molecular,1,8731298
,molecular weight,1,8731298
,weight,1,8731298
,heparin,2,8731298
,intravenous,1,8731298
,non,1,8731298
,nfh,3,8731298
,unstable,2,8731298
,ang,2,8731298
,myocardial,2,8731298
,myocardial infarction,2,8731298
,infarction,2,8731298
,transluminal,2,8731298
,coronary,2,8731298
,coronary angioplasty,2,8731298
,angioplasty,2,8731298
,methods,1,8731298
,patients,6,8731298
,groups,2,8731298
,group,4,8731298
,lmwh,3,8731298
,1st,1,8731298
,phase,1,8731298
,dosage,3,8731298
,2nd,1,8731298
,bolus,1,8731298
,activated,1,8731298
,partial,1,8731298
,time,1,8731298
,results,1,8731298
,not,1,8731298
,statistically,1,8731298
,statistically significant,1,8731298
,significant,1,8731298
,difference,1,8731298
,relation,1,8731298
,cardiac,1,8731298
,cardiac events,1,8731298
,events,1,8731298
,hemorrhagic,1,8731298
,complications,1,8731298
,deaths,1,8731298
,conclusion,1,8731298
,similar,1,8731298
,dosages,1,8731298
,study,1,8731298
,ventricular,1,8729374
,ventricular tachycardia,1,8729374
,tachycardia,1,8729374
,paroxysmal,1,8729374
,paroxysmal atrial fibrillation,1,8729374
,atrial,1,8729374
,atrial fibrillation,1,8729374
,fibrillation,1,8729374
,severe,1,8729374
,myocardial,1,8729374
,myocardial ischemia,1,8729374
,ischemia,1,8729374
,authors,1,8729374
,cases,2,8729374
,spontaneous,2,8729374
,paroxysmal,2,8729374
,paroxysmal atrial fibrillation,2,8729374
,atrial,3,8729374
,atrial fibrillation,3,8729374
,fibrillation,3,8729374
,ventricular,4,8729374
,ventricular tachycardia,2,8729374
,tachycardia,2,8729374
,cardiac,1,8729374
,cardiac arrest,1,8729374
,arrest,1,8729374
,defibrillation,1,8729374
,patients,2,8729374
,men,1,8729374
,years,1,8729374
,past,1,8729374
,past history,1,8729374
,history,1,8729374
,myocardial,3,8729374
,myocardial infarction,1,8729374
,infarction,1,8729374
,arrhythmias,1,8729374
,severe,1,8729374
,myocardial ischaemia,2,8729374
,ischaemia,2,8729374
,coronary,2,8729374
,coronary arteriography,1,8729374
,arteriography,1,8729374
,tight,1,8729374
,stenoses,1,8729374
,main,1,8729374
,coronary artery,1,8729374
,artery,1,8729374
,normal,1,8729374
,left,1,8729374
,left ventricular function,1,8729374
,ventricular function,1,8729374
,function,1,8729374
,rare,2,8729374
,occurrence,1,8729374
,sequence,1,8729374
,events,1,8729374
,accessory,1,8729374
,conduction,1,8729374
,pathways,1,8729374
,hypertrophic,1,8729374
,hypertrophic cardiomyopathy,1,8729374
,cardiomyopathy,1,8729374
,complication,1,8729374
,ischemic,1,8729374
,ischemic heart disease,1,8729374
,heart,1,8729374
,heart disease,1,8729374
,disease,1,8729374
,only,1,8729374
,very,1,8729374
,few,1,8729374
,probably,1,8729374
,cause,1,8729374
,arrhythmia,1,8729374
,together,1,8729374
,contractions,1,8729374
,responsible,1,8729374
,long,1,8729374
,cycle,1,8729374
,sequences,1,8729374
,changes,1,8729374
,thrombolytic,1,8729370
,thrombolytic therapy,1,8729370
,therapy,1,8729370
,acute,1,8729370
,acute myocardial infarction,1,8729370
,myocardial,1,8729370
,myocardial infarction,1,8729370
,infarction,1,8729370
,thrombolytic,2,8729370
,thrombolytic therapy,2,8729370
,therapy,2,8729370
,mortality,1,8729370
,acute,1,8729370
,acute myocardial infarction,1,8729370
,myocardial,1,8729370
,myocardial infarction,1,8729370
,infarction,1,8729370
,first,1,8729370
,hours,1,8729370
,onset,1,8729370
,author,1,8729370
,evidence,1,8729370
,more,1,8729370
,difficult,1,8729370
,aspects,1,8729370
,treatment,2,8729370
,patients,1,8729370
,same,1,8729370
,benefits,1,8729370
,early,1,8729370
,possible,1,8729370
,value,1,8729370
,late,1,8729370
,best,1,8729370
,agent,1,8729370
,optimal,1,8729370
,mode,1,8729370
,administration,1,8729370
,article,1,8729370
,state,1,8729370
,art,1,8729370
,beginning,1,8729370
,rapidly,1,8729370
,field,1,8729370
,therapeutics,1,8729370
,indium,1,8729367
,iii,1,8729367
,monoclonal,1,8729367
,antibody,1,8729367
,scintigraphy,1,8729367
,detection,1,8729367
,chronic,1,8729367
,myocardial,1,8729367
,myocardial infarction,1,8729367
,infarction,1,8729367
,acute,1,8729367
,acute phase,1,8729367
,phase,1,8729367
,fab,1,8729367
,scintigraphy,2,8729367
,sensitive,1,8729367
,specific,1,8729367
,acute,3,8729367
,myocardial,4,8729367
,myocardial necrosis,1,8729367
,necrosis,1,8729367
,study,1,8729367
,preoperative,1,8729367
,frequency,1,8729367
,uptake,4,8729367
,patients,6,8729367
,coronary,5,8729367
,coronary artery,3,8729367
,coronary artery bypass,1,8729367
,coronary artery bypass surgery,1,8729367
,artery,3,8729367
,bypass,2,8729367
,bypass surgery,1,8729367
,surgery,1,8729367
,results,1,8729367
,other,2,8729367
,criteria,2,8729367
,myocardial infarction,2,8729367
,infarction,2,8729367
,sixteen,1,8729367
,consecutive,1,8729367
,recent,4,8729367
,months,1,8729367
,accurate,1,8729367
,localization,2,8729367
,cases,2,8729367
,classic,1,8729367
,more,1,8729367
,old,2,8729367
,wave,1,8729367
,one,1,8729367
,not,3,8729367
,territory,2,8729367
,second,1,8729367
,patient,1,8729367
,year,1,8729367
,old infarct,1,8729367
,infarct,1,8729367
,events,2,8729367
,intense,1,8729367
,consistent,1,8729367
,ecg,4,8729367
,angiographic,1,8729367
,stable,1,8729367
,stable angina,1,8729367
,angina,1,8729367
,limited,2,8729367
,uptakes,2,8729367
,medical,1,8729367
,medical history,1,8729367
,history,1,8729367
,left,1,8729367
,left ventricle,1,8729367
,ventricle,2,8729367
,angiography,2,8729367
,normal,1,8729367
,location,1,8729367
,occluded,1,8729367
,tight,1,8729367
,stenosis,1,8729367
,bypass graft,1,8729367
,graft,1,8729367
,probably,1,8729367
,small,1,8729367
,necroses,2,8729367
,ventricular,1,8729367
,ventricular segmental,1,8729367
,segmental,1,8729367
,segmental wall motion,1,8729367
,wall,1,8729367
,wall motion,1,8729367
,motion,1,8729367
,diagnosis,1,8729367
,recent myocardial infarction,1,8729367
,detectable,1,8729367
,changes,1,8729367
,detection,1,8729362
,endothelial,1,8729362
,endothelial cells,1,8729362
,cells,1,8729362
,new,1,8729362
,diagnostic,1,8729362
,diagnostic test,1,8729362
,test,1,8729362
,angina,1,8729362
,rest,1,8729362
,diagnosis,3,8729362
,spontaneous,5,8729362
,angina,3,8729362
,electrocardiographic,1,8729362
,electrocardiographic changes,1,8729362
,changes,1,8729362
,simple,2,8729362
,biological,3,8729362
,biological test,2,8729362
,test,4,8729362
,retrospective,2,8729362
,attack,2,8729362
,usually,1,8729362
,instability,1,8729362
,atheromatous,2,8729362
,atheromatous plaque,2,8729362
,plaque,2,8729362
,fissures,1,8729362
,endothelial,4,8729362
,endothelial cells,4,8729362
,cells,5,8729362
,stream,1,8729362
,detection,3,8729362
,cold,1,8729362
,sign,1,8729362
,condition,1,8729362
,technique,1,8729362
,method,1,8729362
,groups,1,8729362
,patients,6,8729362
,hospital,1,8729362
,hours,1,8729362
,group,6,8729362
,comprised,1,8729362
,acute,1,8729362
,acute myocardial infarction,1,8729362
,myocardial,1,8729362
,myocardial infarction,1,8729362
,infarction,1,8729362
,group ii,2,8729362
,st segment,1,8729362
,st segment depression,1,8729362
,segment,1,8729362
,depression,1,8729362
,significant,1,8729362
,coronary,2,8729362
,arterial,1,8729362
,arterial ste,1,8729362
,arterial ste nosis,1,8729362
,ste,1,8729362
,chest,1,8729362
,chest pain,1,8729362
,pain,1,8729362
,coronary angiography,1,8729362
,angiography,1,8729362
,normal,1,8729362
,provocative test,1,8729362
,spasm,1,8729362
,negative,3,8729362
,only,1,8729362
,iii,1,8729362
,results,1,8729362
,specificity,1,8729362
,positive,1,8729362
,value,3,8729362
,sensitivity,2,8729362
,negative predictive value,2,8729362
,predictive,2,8729362
,predictive value,2,8729362
,reliable,1,8729362
,ang,2,8729362
,mechanism,1,8729362
,other,1,8729362
,cases,1,8729362
,spasm,1,8729361
,normal,1,8729361
,irregular,1,8729361
,coronary,1,8729361
,coronary arteries,1,8729361
,arteries,1,8729361
,outcome,1,8729361
,patients,1,8729361
,outcome,2,8729361
,patients,7,8729361
,spasm,3,8729361
,normal,2,8729361
,coronary,12,8729361
,coronary arteries,1,8729361
,arteries,2,8729361
,only,2,8729361
,small,1,8729361
,series,1,8729361
,authors,2,8729361
,average,1,8729361
,period,1,8729361
,months,2,8729361
,men,1,8729361
,women,1,8729361
,mean,1,8729361
,age,1,8729361
,years,1,8729361
,coronary angiography,7,8729361
,angiography,7,8729361
,cases,8,8729361
,not,2,8729361
,stenosis,1,8729361
,greater,1,8729361
,positive,1,8729361
,methergin,1,8729361
,test,1,8729361
,ecg,1,8729361
,prinzmetal,1,8729361
,prinzmetal angina,1,8729361
,angina,2,8729361
,nearly,2,8729361
,calcium,1,8729361
,calcium antagonists,1,8729361
,antagonists,1,8729361
,end,1,8729361
,deaths,1,8729361
,cardiac,1,8729361
,myocardial,3,8729361
,myocardial infarctions,1,8729361
,infarctions,1,8729361
,repeat,2,8729361
,more,1,8729361
,new,2,8729361
,significant,3,8729361
,coronary lesions,1,8729361
,lesions,1,8729361
,persistence,1,8729361
,chest,2,8729361
,chest pain,2,8729361
,pain,2,8729361
,severity,1,8729361
,symptoms,1,8729361
,attack,1,8729361
,month,1,8729361
,coronary disease,1,8729361
,disease,1,8729361
,asymptomatic,1,8729361
,statistical,1,8729361
,statistical analysis,1,8729361
,analysis,1,8729361
,hypertension,1,8729361
,appearances,1,8729361
,initial,1,8729361
,predictive,1,8729361
,predictive factors,1,8729361
,factors,1,8729361
,events,1,8729361
,myocardial infarction,2,8729361
,infarction,2,8729361
,coronary spasm,1,8729361
,well,1,8729361
,responsible,1,8729361
,death,1,8729361
,year,1,8729361
,risk,1,8723020
,stratification,1,8723020
,malignant,1,8723020
,events,1,8723020
,patients,1,8723020
,acute,1,8723020
,acute myocardial infarction,1,8723020
,myocardial,1,8723020
,myocardial infarction,1,8723020
,infarction,1,8723020
,role,1,8723020
,open,1,8723020
,artery,1,8723020
,ecg,1,8723020
,background,1,8723020
,evidence,1,8723020
,open,2,8723020
,artery,6,8723020
,results,2,8723020
,increased,1,8723020
,electrical,1,8723020
,stability,1,8723020
,heart,1,8723020
,effect,1,8723020
,part,1,8723020
,responsible,1,8723020
,favorable,1,8723020
,outcome,1,8723020
,patients,7,8723020
,thrombolytic,1,8723020
,era,1,8723020
,optimal,1,8723020
,strategy,1,8723020
,risk,2,8723020
,stratification,1,8723020
,study,1,8723020
,predictors,1,8723020
,serious,1,8723020
,events,4,8723020
,first,1,8723020
,year,1,8723020
,myocardial,3,8723020
,myocardial infarction,3,8723020
,infarction,3,8723020
,methods,1,8723020
,total,1,8723020
,acute,2,8723020
,acute myocardial infarction,2,8723020
,thrombolysis,1,8723020
,hospital,2,8723020
,hospital discharge,2,8723020
,discharge,2,8723020
,electrocardiography,2,8723020
,subjects,2,8723020
,holter monitoring,3,8723020
,monitoring,3,8723020
,coronary,1,8723020
,coronary angiography,1,8723020
,angiography,1,8723020
,ventricular,7,8723020
,ventricular ejection,2,8723020
,ventricular ejection fraction,2,8723020
,ejection,3,8723020
,ejection fraction,3,8723020
,fraction,3,8723020
,incidence,1,8723020
,late,3,8723020
,potentials,3,8723020
,event,1,8723020
,followup,1,8723020
,sudden,1,8723020
,sudden death,1,8723020
,death,1,8723020
,ventricular tachyarrhythmias,1,8723020
,tachyarrhythmias,1,8723020
,syncope,1,8723020
,signalaveraged electrocardiography,1,8723020
,sensitivity,2,8723020
,specificity,2,8723020
,prediction,1,8723020
,occluded,4,8723020
,sensitive,3,8723020
,specific,3,8723020
,only,1,8723020
,combination,4,8723020
,positive,2,8723020
,positive predictive value,2,8723020
,predictive,3,8723020
,predictive value,2,8723020
,value,2,8723020
,low,1,8723020
,variables,1,8723020
,several,1,8723020
,risk factors,1,8723020
,factors,1,8723020
,highest,1,8723020
,abnormal,2,8723020
,ecg,3,8723020
,complex,2,8723020
,ventricular arrhythmias,2,8723020
,arrhythmias,2,8723020
,ambulatory,1,8723020
,ambulatory ecg,1,8723020
,multivariate analysis,1,8723020
,analysis,1,8723020
,rank,1,8723020
,order,1,8723020
,presence,1,8723020
,ventricular ectopic,1,8723020
,ventricular ectopic activity,1,8723020
,ectopic,1,8723020
,activity,1,8723020
,conclusion,1,8723020
,occurrence,1,8723020
,malignant,1,8723020
,ventricular dysfunction,1,8723020
,dysfunction,1,8723020
,time,1,8723020
,gad,1,8722051
,antibodies,1,8722051
,followup,1,8722051
,diagnosis,1,8722051
,objective,1,8722051
,study,3,8722051
,frequency,1,8722051
,antibodies,4,8722051
,glutamic acid,1,8722051
,glutamic acid decarboxylase,1,8722051
,acid,1,8722051
,decarboxylase,1,8722051
,gad,10,8722051
,islet cell,1,8722051
,cell,1,8722051
,predictive,3,8722051
,predictive value,3,8722051
,value,3,8722051
,respect,1,8722051
,development,2,8722051
,insulin,5,8722051
,deficiency,4,8722051
,newly,3,8722051
,patients,7,8722051
,noninsulindependent diabetes mellitus,1,8722051
,diabetes,2,8722051
,diabetes mellitus,1,8722051
,niddm,4,8722051
,control,3,8722051
,subjects,2,8722051
,persistence,1,8722051
,diabetic,3,8722051
,research,1,8722051
,research design,1,8722051
,design,1,8722051
,methods,1,8722051
,study participants,1,8722051
,participants,1,8722051
,group,1,8722051
,followup,1,8722051
,examinations,1,8722051
,years,1,8722051
,baseline,1,8722051
,absolute,3,8722051
,relative,3,8722051
,stimulated,1,8722051
,cpeptide,1,8722051
,level,1,8722051
,undetectable,1,8722051
,retrospectively,1,8722051
,samples,1,8722051
,results,1,8722051
,overall,1,8722051
,prevalence,2,8722051
,gad antibody,7,8722051
,antibody,7,8722051
,ica,3,8722051
,time,3,8722051
,diagnosis,3,8722051
,control population,1,8722051
,population,2,8722051
,sensitivity,2,8722051
,specificity,1,8722051
,negative,1,8722051
,negative predictive value,1,8722051
,antibody testing,1,8722051
,testing,1,8722051
,positive,1,8722051
,positive predictive value,1,8722051
,nature,1,8722051
,high,1,8722051
,levels,1,8722051
,persistent,1,8722051
,conclusions,1,8722051
,latent,1,8722051
,autoimmune,1,8722051
,autoimmune diabetes,1,8722051
,adults,1,8722051
,specific,1,8722051
,predictors,1,8722051
,subsequent,1,8722051
,dependency,1,8722051
,measurements,1,8722051
,aid,1,8722051
,clinician,1,8722051
,choice,1,8722051
,treatment,1,8722051
,preoperative,1,8719937
,evaluation,1,8719937
,risk,1,8719937
,risk factors,1,8719937
,factors,1,8719937
,complications,1,8719937
,patients,1,8719937
,primary,1,8719937
,primary hyperparathyroidism,1,8719937
,hyperparathyroidism,1,8719937
,impairments,2,8719937
,cardiovascular,2,8719937
,respiratory,2,8719937
,kidney,2,8719937
,kidney function,2,8719937
,function,2,8719937
,risk,2,8719937
,risk factors,1,8719937
,factors,1,8719937
,complications,1,8719937
,surgery,4,8719937
,indication,1,8719937
,asymptomatic,2,8719937
,primary,1,8719937
,primary hyperparathyroidism,1,8719937
,hyperparathyroidism,1,8719937
,patients,4,8719937
,control,3,8719937
,subjects,2,8719937
,common,1,8719937
,surgical,1,8719937
,surgical procedures,1,8719937
,procedures,1,8719937
,preoperatively,1,8719937
,age,1,8719937
,control group,1,8719937
,group,3,8719937
,serum,1,8719937
,serum calcium,1,8719937
,calcium,1,8719937
,creatinine,1,8719937
,glucose,2,8719937
,peak,1,8719937
,peak expiratory flow,1,8719937
,expiratory,1,8719937
,flow,1,8719937
,pef,1,8719937
,controls,3,8719937
,more,2,8719937
,often,1,8719937
,antihypertensive,1,8719937
,medication,1,8719937
,likely,1,8719937
,history,1,8719937
,congestive,1,8719937
,congestive heart disease,1,8719937
,heart,2,8719937
,heart disease,1,8719937
,disease,1,8719937
,thromboembolic,1,8719937
,thromboembolic diseases,1,8719937
,diseases,1,8719937
,stroke,1,8719937
,diabetes,1,8719937
,diabetes mellitus,1,8719937
,frequencies,1,8719937
,depression,1,8719937
,abnormalities,1,8719937
,electrocardiography,1,8719937
,together,1,8719937
,prevalence,1,8719937
,heart enlargement,1,8719937
,enlargement,1,8719937
,visible,1,8719937
,chest,1,8719937
,chest radiography,1,8719937
,radiography,1,8719937
,patient,1,8719937
,myocardial,1,8719937
,myocardial infarction,1,8719937
,infarction,1,8719937
,postoperative,1,8719937
,postoperative period,1,8719937
,period,1,8719937
,present,1,8719937
,study,1,8719937
,preoperative,1,8719937
,risk factor,1,8719937
,factor,1,8719937
,profile,1,8719937
,respiratory functions,1,8719937
,functions,1,8719937
,well,1,8719937
,glucose control,1,8719937
,findings,1,8719937
,mind,1,8719937
,indications,1,8719937
,contribution,1,8719812
,tumour,1,8719812
,tumour necrosis,1,8719812
,necrosis,1,8719812
,increase,1,8719812
,coronary,1,8719812
,resistance,1,8719812
,hearts,1,8719812
,rats,1,8719812
,endotoxin,1,8719812
,inflammatory,3,8719812
,inflammatory disease,2,8719812
,disease,2,8719812
,states,2,8719812
,myocardial,2,8719812
,myocardial infarction,1,8719812
,infarction,1,8719812
,effects,1,8719812
,systemic,1,8719812
,systemic inflammatory response syndrome,1,8719812
,inflammatory response,1,8719812
,response,1,8719812
,syndrome,1,8719812
,lipopolysaccharide,1,8719812
,circulatory,1,8719812
,circulatory shock,1,8719812
,shock,2,8719812
,rats,3,8719812
,coronary,5,8719812
,vascular,3,8719812
,lps,4,8719812
,hearts,5,8719812
,min,4,8719812
,later,1,8719812
,perfusion,5,8719812
,constant,1,8719812
,flow,1,8719812
,technique,1,8719812
,once,1,8719812
,ex vivo,1,8719812
,ex vivo perfusion,1,8719812
,vivo,2,8719812
,pressure,3,8719812
,control,1,8719812
,mmhg,1,8719812
,increase,3,8719812
,resistance,2,8719812
,not,1,8719812
,reduction,1,8719812
,endothelial,1,8719812
,endothelial cell,1,8719812
,cell,1,8719812
,cell function,1,8719812
,function,1,8719812
,vasodilator,1,8719812
,responses,1,8719812
,bradykinin,1,8719812
,unchanged,1,8719812
,injection,2,8719812
,rise,1,8719812
,changes,1,8719812
,pretreatment,1,8719812
,cycloheximide,1,8719812
,necrosis,1,8719812
,tnfalpha,5,8719812
,antibody,2,8719812
,continuous,1,8719812
,continuous infusion,1,8719812
,infusion,1,8719812
,vitro,1,8719812
,endothelin,1,8719812
,eta,2,8719812
,receptor,2,8719812
,antagonist,2,8719812
,greatly,1,8719812
,vascular resistance,1,8719812
,data,1,8719812
,release,2,8719812
,endothelin1,1,8719812
,mediates,1,8719812
,part,1,8719812
,vasoconstriction,1,8719812
,hypothesis,1,8719812
,administration,1,8719812
,levels,1,8719812
,septic,1,8719812
,septic shock,1,8719812
,sequential,1,8719812
,predisposition,1,8719812
,myocardial ischaemia,1,8719812
,ischaemia,1,8719812
,inactivation,1,8719812
,antibody as,1,8719812
,well,1,8719812
,blockade,1,8719812
,pathway,1,8719812
,evidence,1,8719395
,dynamic,1,8719395
,coronary,1,8719395
,vasoconstriction,1,8719395
,vessels,1,8719395
,acute,1,8719395
,acute myocardial infarction,1,8719395
,myocardial,1,8719395
,myocardial infarction,1,8719395
,infarction,1,8719395
,role,1,8719395
,coronary,2,8719395
,vasoconstriction,1,8719395
,acute,3,8719395
,acute myocardial infarction,3,8719395
,myocardial,3,8719395
,myocardial infarction,3,8719395
,infarction,3,8719395
,patients,1,8719395
,angiography,1,8719395
,early,1,8719395
,hours,1,8719395
,reversible,1,8719395
,spasm,1,8719395
,vessels,1,8719395
,coronary vasospasm,1,8719395
,vasospasm,1,8719395
,generalized,1,8719395
,phenomenon,1,8719395
,effects,1,8719378
,technique,1,8719378
,modification,1,8719378
,immediate,1,8719378
,results,1,8719378
,high,1,8719378
,high speed rotational atherectomy,1,8719378
,speed,1,8719378
,rotational,1,8719378
,rotational atherectomy,1,8719378
,atherectomy,1,8719378
,procedures,1,8719378
,patients,1,8719378
,high,2,8719378
,high speed rotational atherectomy,1,8719378
,speed,2,8719378
,rotational,2,8719378
,rotational atherectomy,1,8719378
,atherectomy,1,8719378
,sra,1,8719378
,procedures,2,8719378
,single,1,8719378
,consecutive,1,8719378
,series,1,8719378
,patients,4,8719378
,alone,1,8719378
,adjunctive,2,8719378
,low,1,8719378
,pressure,2,8719378
,atm,2,8719378
,balloon,2,8719378
,balloon angioplasty,2,8719378
,angioplasty,2,8719378
,unfavorable,1,8719378
,type,1,8719378
,lesions,1,8719378
,study,1,8719378
,group,1,8719378
,success,1,8719378
,rate,1,8719378
,emergency,1,8719378
,coronary,2,8719378
,coronary artery,1,8719378
,coronary artery bypass,1,8719378
,coronary artery bypass surgery,1,8719378
,artery,1,8719378
,bypass,1,8719378
,bypass surgery,1,8719378
,surgery,1,8719378
,cases,2,8719378
,wave,1,8719378
,myocardial,1,8719378
,myocardial infarction,1,8719378
,infarction,1,8719378
,death,1,8719378
,procedure,1,8719378
,consequent,1,8719378
,incidence,1,8719378
,flow,1,8719378
,dissections,1,8719378
,distal,1,8719378
,spasm,1,8719378
,phenomenon,1,8719378
,recent,1,8719378
,technique,3,8719378
,modifications,1,8719378
,continuous,1,8719378
,catheter,1,8719378
,infusion,1,8719378
,mixture,1,8719378
,limitation,1,8719378
,duration,1,8719378
,lesion,2,8719378
,engagement,1,8719378
,burr,3,8719378
,increase,2,8719378
,size,1,8719378
,decrease,3,8719378
,control,1,8719378
,rpm,1,8719378
,drop,1,8719378
,ablation,1,8719378
,evolution,1,8719378
,interventional,1,8719378
,trends,1,8719378
,use,1,8719378
,conjunction,1,8719378
,steady,1,8719378
,percentage,1,8719378
,time,1,8719378
,changes,1,8719378
,complete,1,8719378
,absence,1,8719378
,well,1,8719378
,generalized,1,8719378
,overall,1,8719378
,vascular,1,8719378
,vascular reactivity,1,8719378
,acute,1,8714449
,acute stroke,1,8714449
,stroke,1,8714449
,use,1,8714449
,fibrinolytic,1,8714449
,fibrinolytic agents,1,8714449
,acute,2,8714449
,acute ischemic,1,8714449
,ischemic,1,8714449
,ischemic stroke,1,8714449
,stroke,1,8714449
,attention,1,8714449
,due,1,8714449
,completion,1,8714449
,several,1,8714449
,prospective,1,8714449
,prospective studies,1,8714449
,studies,1,8714449
,efficacy,1,8714449
,safety,1,8714449
,drugs,1,8714449
,clinical,1,8714449
,clinical setting,1,8714449
,setting,1,8714449
,experience,1,8714449
,plasminogen,3,8714449
,plasminogen activators,1,8714449
,recanalization,1,8714449
,carotid,2,8714449
,vertebrobasilar,1,8714449
,territory,1,8714449
,occlusion,1,8714449
,hours,1,8714449
,symptom,1,8714449
,onset,1,8714449
,optimal,1,8714449
,plasminogen activator,2,8714449
,delivery,1,8714449
,delivery system,1,8714449
,system,1,8714449
,not,2,8714449
,phase,2,8714449
,trial,1,8714449
,european,1,8714449
,cooperative,1,8714449
,study,1,8714449
,potential,1,8714449
,benefit,1,8714449
,outcome,1,8714449
,recombinant,1,8714449
,recombinant tissue plasminogen activator,1,8714449
,tissue,1,8714449
,tissue plasminogen activator,1,8714449
,tpa,1,8714449
,risk,1,8714449
,hemorrhage,1,8714449
,attributable,1,8714449
,patients,2,8714449
,early,1,8714449
,signs,1,8714449
,ischemia,1,8714449
,complete,1,8714449
,cervical,1,8714449
,internal,1,8714449
,internal carotid,1,8714449
,internal carotid artery,1,8714449
,internal carotid artery occlusions,1,8714449
,carotid artery,1,8714449
,carotid artery occlusions,1,8714449
,artery,2,8714449
,artery occlusions,1,8714449
,occlusions,2,8714449
,thrombosis,1,8714449
,more,1,8714449
,resistant,1,8714449
,stem,1,8714449
,major,1,8714449
,middle,1,8714449
,middle cerebral artery,1,8714449
,cerebral,1,8714449
,cerebral artery,1,8714449
,issue,1,8714449
,hemorrhagic,1,8714449
,transformation,1,8714449
,delayed,1,8714449
,intervention,1,8714449
,hand,1,8714449
,different,1,8714449
,observed,1,8714449
,placebo,1,8714449
,series,1,8714449
,california,1,8688923
,hospital,2,8688923
,outcomes,1,8688923
,project,1,8688923
,administrative,1,8688923
,data,1,8688923
,performance,1,8688923
,background,1,8688923
,california,2,8688923
,hospital,5,8688923
,outcomes,6,8688923
,project,3,8688923
,act,1,8688923
,state,1,8688923
,legislature,1,8688923
,office,1,8688923
,health,1,8688923
,health planning,1,8688923
,planning,1,8688923
,development,1,8688923
,annual,1,8688923
,annual reports,1,8688923
,reports,2,8688923
,medical,1,8688923
,surgical,1,8688923
,obstetric,1,8688923
,obstetric patients,1,8688923
,patients,1,8688923
,indicators,1,8688923
,inhospital mortality,1,8688923
,mortality,1,8688923
,days,1,8688923
,acute,1,8688923
,acute myocardial infarction,1,8688923
,myocardial,1,8688923
,myocardial infarction,1,8688923
,infarction,1,8688923
,ami,2,8688923
,postoperative,2,8688923
,postoperative complications,1,8688923
,complications,1,8688923
,diskectomy,4,8688923
,delivery,2,8688923
,length,1,8688923
,weeks,1,8688923
,discharge,1,8688923
,abstracts,1,8688923
,hospitals,7,8688923
,outcome,3,8688923
,risk,2,8688923
,risk adjustment,1,8688923
,adjustment,1,8688923
,models,1,8688923
,values,1,8688923
,likelihood,1,8688923
,observed,1,8688923
,number,2,8688923
,chance,1,8688923
,results,2,8688923
,first,1,8688923
,report,4,8688923
,june,2,8688923
,public,1,8688923
,december,1,8688923
,total,1,8688923
,better,1,8688923
,expecte,1,8688923
,cervical,1,8688923
,lumbar,1,8688923
,second,1,8688923
,response,3,8688923
,conclusions,1,8688923
,letters,1,8688923
,coding,2,8688923
,practices,1,8688923
,quality,1,8688923
,care,2,8688923
,media,1,8688923
,media coverage,1,8688923
,coverage,1,8688923
,sometimes,1,8688923
,critical,1,8688923
,failure,1,8688923
,worse,1,8688923
,providers,1,8688923
,concerns,1,8688923
,validation,1,8688923
,validation study,1,8688923
,study,1,8688923
,differences,2,8688923
,risk factors,1,8688923
,factors,1,8688923
,reported,1,8688923
